Fpwatch Study Reference Document MYANMAR Private Outlet Survey 2016

FPwatch Study Reference Document MYANMAR Private Outlet Survey 2016

February 2017

Suggested citation FPwatch Group. (2016). FPwatch Study Reference Document: Myanmar 2016. Washington DC: PSI.

Contact Ms. Tarryn Haslam Dr. May Me Thet Deputy Director, Malaria & Child Deputy Director (Strategic Information Department) Survival Department PSI/Myanmar PSI | 1120 19th St NW Suit 600 No 16 West Shwe Gone Dine 4th Street Washington DC 20036 Bahan Township Yangon Email: [email protected] Email: [email protected]

Acknowledgements FPwatch is funded by the 3 Milleneum Development Goal (3MDG) Fund. This study was implemented by Population Services International (PSI)/Myanmar. Our thanks will go to PSI/Myanmar staff for supporting the study. The study team would also like to thank Myanmar Marketing Research and Development Co., Ltd and part-time field workers for fieldwork and data entry processes. Finally, the study team would like to express their gradititude to all respondents for taking part in this FPwatch Outlet Survey.

PSI-Myanmar Hlaing Myint Tun Daw Ngone Kalay Daw Toe Toe Win U Hein Ko Ko Thant Dr. Tin Aung Naw Lel Pwe Htoo Daw Kay Kay Thwe U Kaung Myat Thar Daw Ingyin Phyo Daniel Crapper Nay Lin Tun Daw Aye Mon Kyi U Myo Thwin U Ar.Kar Min Saw Pa Pa Naing Phoo Phoo Soe U Nay Win Htut Daw Thandar Aye U Arkar Soe Dr. Swai Mon Oo Saw Win Daw Thazin Aung U Ye Kyaw Thu Dr. Aye Kyawt Paing Thet Swe Fieldworker Quality U Kyaw Kyaw Khant Daw Su Myat Noe Leah Mari-Richards Zaw Min Htet Bo Controllers U Kyaw Kyaw Naing U Wai Yan Oo Dr. May Me Thet Tun Tun Min U Wai Yan Oo (Tamwe) Daw Aye Mya Mon (ShwePyiThar) Barry Whittle Dr. Zaw Wai Yan Bo U Wai Phyo Hla Daw Ei Ei Maw U Win Kyaw Dr. Myint Myint Win Dr. Nay Linn U Nyi Nyi Soe Daw Ei Ei Phyo U Min Chit Thu Dr. Myo Thiha U Shine Tun Oo U Tin Htun Aung Daw Thandar Htwe FPwatch-DC Dr. Khin Moe Moe Aung U Nyein Chan Tun Daw Zar Zar Win Daw Htoo Htoo Shwe Dr. Katie Bates Dr. Thel Su Hlaing U Myo Min Paing Daw Latt Latt Maw Daw Naw Carnation Phaw Keith Esch U So Pyay Htet U Zayar Phyo (N/Oakala) U Nyi Nyi Lwin Danielle Garfinkel Market Research and U Win Naing Oo U Phyo Si Thu Daw Thet Thet Khaing Coley Gray Development Co., Ltd. U Sit Naing Win Daw Zin Min Hlaing Daw War War Aye Tarryn Haslam U Aung Min U De Zin Ko Daw Wai Wai Hlaing U Aung Myat Phyo Catherine Hurley U Wanna More U Aung Myo Kyaw U Htat Htat Aung U Hein Si Thu Aliza Lailari U Win Thein U Aung Zay Oo U Win Moe Hein Daw Thet Su Mon Dr. Megan Littrell Daw Tin Mar Oo U Pyae Sone Aung U Win Thiha Tun U Kyaw Lynn Hein Jen Pope U Min Thu U Ye Lin Naing Daw Su Myat Nwe Daw Phue Pyae Zone Aye Dr. Justin Rahariniaina Daw Thandar Myint U Kyaw Zin Hein Daw Hnin Khine Christina Riley U Thaung Win Htike U Saw Sar Law Eh U Soe Pyae Sone Mac Schoen U Pyae Sone Aung Oo Daw Hla Thaung Tin Dr. Bryan Shaw Fieldwork Supervisors U Pyae Phyo Thu Daw Hlaing Hlaing Phyo Katherine Thanel Daw Thidar Myint U Kyaw Zay Aung U Thaw Zin Htut U Phyo Zaw Hein Daw Lin Thinzar Htet Technical Advisory Group Daw Myat Thaint Thaint Fieldworkers U Kyaw Kyaw Dr. Jane Bertrand Swe U Zin Ko Ko Daw Thet Mar Oo Veronique Dupont Daw Phyu Phyu Aung U Lwin Maung Maung Than U Khin Zaw Janine Hum Daw Swe Swe Win U Min Than Tun Daw Myat Mon Soe Amy Lin U Kyaw Kyaw Lwin Daw May La Pyae Woon Daw Myint Myint Maw Dr. Scott Radloff U Saw Jimmy Aung Thein Daw Soe Soe Mu U Zayar Phyo (KyaukTan) Dr. Prashant Yadav U Ye Zaw Min Daw Htet Htet Aung Myint U San Kyaw U Aung Khant Daw Khaing Yin Mon Daw Saw Yu Wai PSI Fieldwork Higher-Level Daw Khin Nwe Oo U Soe Pyae Aung Daw Su Su Thein Supervisors Daw Su Yee Phyo Daw Yamin Oo U Kyaw San Dr. Ei Ei Khaing U San Lin Soe U Zaw Zaw Pyae Sone U Kyaw Soe Htun Sandar Oo Daw Yu Hlaing Hnin U Aung Min Oo Daw Khaing Khaing Win Dr. Aung Min Htut Daw Sandar Win U Aung Kyaw Moe Daw Thin Thin Khaing Dr. Nan Yu Wai Daw Biak Tha Sung U Zin Wai Lin U Aye Chan Ko

www.FPwatch.info Page 1

Table of Contents

LIST OF TABLES ...... 3 LIST OF FIGURES ...... 4 ACRONYMS ...... 5 DEFINITIONS ...... 6 INTRODUCTION ...... 11 SUMMARY OF METHODS AND DATA COLLECTION ...... 12 MYANMAR ...... 14 MYANMAR STRATA ...... 38 ANNEXES ...... 81 ANNEX 1: FPWATCH BACKGROUND ...... 81 ANNEX 2: MYANMAR BACKGROUND ...... 83 ANNEX 3: OUTLET SURVEY METHODS ...... 87 ANNEX 4: SAMPLED CLUSTERS ...... 90 ANNEX 5: MAP OF SAMPLED TOWNSHIPS ...... 105 ANNEX 6: DETAILED SAMPLE DESCRIPTIONS ...... 106 ANNEX 7: QUESTIONNAIRE ...... 108 ANNEX 8: DETAILED BRAND LISTING ...... 125 ANNEX 9. SAMPLING WEIGHTS ...... 127 ANNEX 10: FPWATCH INDICATOR LIST ...... 129 ANNEX 11. COUPLE-YEARS OF PROTECTION ...... 142 ANNEX 12: CONTRACEPTIVE METHOD VOLUMES ...... 144

www.FPwatch.info Page 2

List of Tables

Core Indicators Table A1: Modern contraceptive method market composition: Relative proportion of outlets with 1 or more methods, by outlet type – Myanmar, 2016 ...... 14 Table A2: Availability of modern contraceptive method categories, among outlets screened, by outlet type – Myanmar, 2016 ...... 15 Table A3: Availability of selected contraceptive commodities, among outlets screened, by outlet type – Myanmar, 2016 ...... 16 Table A4: Availability of modern contraceptive method diversity, among outlets screened, by outlet type – Myanmar, 2016 ...... 17 Table A5: Current stock out of selected modern contraceptive commodities on day of survey, among outlets reportedly stocking method in previous 3 months, by outlet type – Myanmar, 2016 ...... 18 Table A6: Median price of selected modern contraceptive methods in Myanmar Kyat , USD and USD per CYP, by private outlet type – Myanmar, 2016 ...... 19 Table A7: Median markup percentage for selected modern contraceptive commodities with interquartile range, by private outlet type – Myanmar, 2016 ...... 23 Table A8: Contraceptive method market share: Relative proportion of total CYP sold/distributed, by method and outlet type – Myanmar, 2016 ...... 24 Table A9: Contraceptive method market share within outlet type: Relative proportion of total CYP sold/distributed within outlet type, by method – Myanmar, 2016 ...... 25 Table A10: Availability of selected contraceptive services, among outlets screened, by outlet type – Myanmar, 2016 ...... 26 Table A11: Service readiness to provide provider-dependent contraceptive services, among outlets reportedly offering the procedure, by outlet type – Myanmar, 2016 ...... 27 Table B1: Modern contraceptive method market composition: Relative proportion of outlets with 1 or more methods, by outlet type – Myanmar Strata, 2016 ...... 38 Table B2: Availability of modern contraceptive method categories, among outlets screened, by outlet type – Myanmar Strata, 2016...... 39 Table B3: Availability of selected contraceptive methods, among outlets screened, by outlet type – Myanmar Strata, 2016 ...... 41 Table B4: Availability of modern contraceptive method diversity, among outlets screened, by outlet type – Myanmar Strata, 2016...... 44 Table B5: Current stock out of selected modern contraceptive commodities on day of survey, among outlets reportedly stocking method in previous 3 months, by outlet type – Myanmar Strata, 2016 ...... 46 Table B6: Median price of selected modern contraceptive methods in Myanmar Kyat , USD and USD per CYP, by private outlet type, Myanmar Strata – 2016 ...... 48 Table B7: Median markup percentage for selected modern contraceptive commodities with interquartile range, by private outlet type – Myanmar Strata, 2016 ...... 57 Table B8: Contraceptive method market share: Relative proportion of total CYP sold/distributed, by method and outlet type – Myanmar Strata, 2016 ...... 59 Table B9: Contraceptive method market share within outlet type: Relative proportion of total CYP sold/distributed within outlet type, by method – Myanmar Strata, 2016 ...... 62 Table B10: Availability of selected contraceptive services, among outlets screened, by outlet type – Myanmar Strata, 2016 ...... 65

www.FPwatch.info Page 3

Table B11: Service readiness to provide provider-dependent contraceptive services, among outlets reportedly offering the procedure, by outlet type – Myanmar Metropolitan/Urban/Rural, 2016 ...... 67 Table X1: Myanmar Sample Description ...... 106 Table X2: Myanmar Metropolitan/Urban/Rural Sample Description ...... 107 Table X3: CYP Conversion Factors ...... 142 Table X4: Reported Contraceptive Method Volumes: Myanmar ...... 144 Table X5: Reported Contraceptive Method Volumes: Myanmar – Metropolitan ...... 146 Table X6: Reported Contraceptive Method Volumes: Myanmar – Urban ...... 148 Table X7: Reported Contraceptive Method Volumes: Myanmar – Rural ...... 150

Grey text for data appearing in report tables indicates that the estimate provided was derived from a small sample size. Specifically, grey text is used to indicate point estimates for availability indicators derived from an n of equal to or less than 50 and estimates for price indicators derived from an n of equal to or less than 5. List of Figures

Figure A1. Modern contraceptive method market composition – Myanmar, 2016 ...... 29 Figure A2. Percentage of modern contraceptive commodity-stocking outlets with selected contraceptives available – Myanmar, 2016 ...... 30 Figure A3. Percentage of modern contraceptive commodity-stocking outlets with method mixes available available – Myanmar, 2016 ...... 31 Figure A4. Percentage outlets with stock outs of selected contraceptive methods – Myanmar, 2016 ...... 32 Figure A5. Price of contraceptive methods in the private sector – Myanmar, 2016 ...... 33 Figure A6. Percentage market share for contraceptive methods – Myanmar, 2016 ...... 34 Figure A7. Within outlet market share for contraceptive methods – Myanmar, 2016 ...... 35 Figure A8. Percentage of outlets with selected contraceptive services available – Myanmar, 2016 ...... 36 Figure A9. Service readiness to offer provider-dependent contraceptive services – Myanmar, 2016 ...... 37 Figure B1. Modern contraceptive method market composition – Myanmar Strata, 2016 ...... 70 Figure B2. Percentage of modern contraceptive commodity-stocking outlets with selected contraceptives available – Myanmar Strata, 2016 ...... 71 Figure B3. Percentage of outlets with selected method mixes available – Myanmar Strata, 2016 ...... 72 Figure B4. Percentage of outlets with stock outs of selected contraceptive methods – Myanmar Strata, 2016 ... 73 Figure B5. Price of contraceptive methods in the private sector – Myanmar Metropolitan, 2016 ...... 74 Figure B6. Price of contraceptive methods in the private sector – Myanmar Urban, 2016 ...... 75 Figure B7. Price of contraceptive methods in the private sector – Myanmar Rural, 2016 ...... 76 Figure B8. Percentage market share for contraceptives methods – Myanmar Strata, 2016 ...... 77 Figure B9. Within outlet market share for contraceptive methods – Myanmar Strata, 2016 ...... 78 Figure B10. Percentage of outlets with selected contraceptive services available – Myanmar Strata, 2016 ...... 79 Figure B11. Service readiness to offer provider-dependent contraceptive services – Myanmar Strata, 2016 ...... 80 Figure X1. Map of Myanmar ...... 84 Figure X2. Map of Selected Townships ...... 105

www.FPwatch.info Page 4

Acronyms

3MDG The Three Millennium Development Goal Fund BMGF The Bill and Melinda Gates Foundation CHW Community Health Worker CHSP Community Health Services Officer CI 95% Confidence Interval COC Combined Oral Contraceptive CSPro Census and Survey Processing System CYP Couple Years of Protection DHS Demographic and Health Survey DMPA Depogestin Medroxyprogesterone Acetate FP/RH Family Planning/Reproductive Health FP2020 Family Planning 2020 Initiative GPS Global Positioning System HA Health Assistant IQR Interquartile Range IRB Institutional Review Board IUD Intrauterine Device KII Key Informant Interview LA/PM Long-Acting Reversible Contraceptive or Permanent Method LARC Long-Acting Reversible Contraceptive LHV Lady Health Visitor mCPR Modern Contraceptive Prevalence Rate M&E Monitoring and Evaluation MFDBA Myanmar Food and Drug Board of Authority MMR Maternal Mortality Ratio MOHS Ministry of Health and Sports-Myanmar MSI Marie Stopes International NGO Non-Governmental Organization OS Outlet Survey PI Principal Investigator PM Permanent Methods POP Progesterone-only pill PPS Probability Proportionate to Population Size PSI Population Services International PSI-DC Population Services International-Washington DC PSI-M Population Services International- Myanmar REB Research Ethics Board-PSI RHC Rural Health Center SQH Sun Quality Health SPH Sun Primary Health STI Sexually Transmitted Infections TFR Total Fertility Rate TOT Training of the Trainers UNFPA United Nations Population Fund USAID United States Agency for International Development USD United States Dollar WHO World Health Organization WRA Women of Reproductive Age

www.FPwatch.info Page 5

Definitions

Survey Methods Definitions

Outlet Any service delivery point or point of sale for commodities. Outlets are not restricted to stationary points of sale and may include mobile units or individuals. In Myanmar, only private outlets were considered eligible for the study. Outlets eligible Private outlets were administered a full questionnaire if they met at least for inclusion in one of three inclusion criteria: (1) had one or more modern contraceptive the study commodities (oral contraceptives, emergency contraceptives, injectable contraceptives, contraceptive implants, intrauterine devices (IUDs),) in stock at the time of the survey visit; (2) reportedly had one or more modern contraceptive commodities in stock in the previous three months; or (3) provide modern contraceptive services (contraceptive injections, implant insertions, IUD insertions, male/female sterilization) but do not sell/distribute contraceptive commodities. Outlets not providing services to the general public (e.g. military clinics, brothels, etc.) were excluded from the study. Unlike other FPwatch countries, public outlets were excluded from the study. Cluster The primary sampling unit, or cluster, for the outlet survey. It is an (Metropolitan administrative unit designated by the Census of Myanmar that hosts a and urban wards population size amenable to facility/outlet survey (approximately 10 – or rural village 15,000 population). These units are defined by political boundaries of the tracts) urban wards and a small number of village tracts from metropolitan- designated areas for metropolitan strata, urban wards from urban- designated areas for urban strata and rural village tracts for rural strata). Censused A cluster where field teams conducted a full census of all outlets with the Ward/village potential to sell, distribute or provide contraceptive commodities and/or tract contraceptive services.

www.FPwatch.info Page 6

Family Planning Terminology

Family planning The ability of individuals and couples to anticipate and attain their desired number of children and the spacing and timing of their births. (Modern) Used in reference to the actual product. This is any commodity recognized by the World Contraceptive Health Organization (WHO) as a modern form for the prevention of pregnancy and commodity assigned a Couple-Years of Protection (CYP) conversion factor by the United States Agency for International Development (USAID) (https://www.usaid.gov/what-we-do/global- health/family-planning/couple-years-protection-cyp). Traditional methods (e.g., herbs) not recognized by the WHO/USAID were not included in analysis. Behavioral methods without a tangible commodity but with a CYP conversion factor (e.g., fertility awareness methods) were not included in analysis. Contraceptive Used in reference to the provider-assisted procedure associated for use of some service contraceptive commodities. This is a medical procedure to deliver a contraceptive commodity or a surgical procedure to prevent pregnancy. For analysis, these include the delivery of an injection for an injectable contraceptive, an insertion of a contraceptive implant, an insertion of an intrauterine device (IUD) and/or a male/female sterilization procedure. Procedures typically require specialized training and equipment. These are also referred to as provider-dependent procedures. Male sterilizations are illegal in Myanmar, but a small number of outlets reportedly offered this service. Contraceptive Contraceptive method is used in a general sense to distinguish among categories of ‘choice’ method for a consumer regardless of whether a commodity or service. Couple years of CYP is the estimated protection provided by contraceptive methods during a one-year protection period, based upon the volume of all contraceptives sold or distributed free of charge to (CYP) clients during that period. The CYP is calculated by multiplying the quantity of each method distributed to clients by a conversion factor, to yield an estimate of the duration of contraceptive protection provided per unit of that method. See Annex 11 for more description of how CYP was used in the study. Diversity/range Indicators that measure contraceptive method choice for an individual consumer. of methods Commonly accepted indicators include three or more and five or more methods available to a consumer from: male condoms, female condoms, oral contraceptives, emergency contraceptives, injectable contraceptives, contraceptive implants, IUDs, male sterilizations, female sterilizations, vaginal rings, birth control patches, vaginal pessaries and/or standard days method with commodity (e.g. Cyclebeads). Short-acting Short-acting methods are those that are designed to offer a one-time or up to three methods months of protection against pregnancy. They include male and female condoms, CycleBeads, vaginal rings, birth control patches, oral contraceptives, vaginal pessaries, emergency contraceptives and injectables. In Myanmar, CycleBeads, vaginal rings, birth control patches and vaginal pessaries were not found. Both combined oral contraceptives (COCs) and progestin-only pills (POPs) were found. All injectables were depot medroxyprogesterone acetate (DMPA) injectables. Both three month DMPA and one month (rare) DMPA injectables were offered. Noristerat injectables were not found. Long-acting, Long-acting contraceptives are those that offer more than one year of protection against reversible pregnancy. They include all types of implants and IUDs. In Myanmar, small numbers of both contraceptive Implanon and Jadelle implants were found. In Myanmar, all IUDs found were copper T (LARC) methods IUDs. No hormonal IUDs were found.

www.FPwatch.info Page 7

Permanent Permanent methods include male (vasectomy) and female (tubal ligations) sterilizations methods and typically provide life-time protection against pregnancy and are not easily reversible. They are often grouped together with LARCs for analytic purposes as long-acting and permanent methods (LA/PMs).

www.FPwatch.info Page 8

Outlet Categories for Myanmar

Community CHWs are formally trained healthworkers offering CHWs can provide all short-acting health non-facility based and/or community-based services. methods. Injectables can be sold workers These providers may practice within government and injection services can be (CHWs) health facilities and see patients privately outside of performed by trained CHWs. CHWs working hours. They typically are midwives, health may provide LARC methods, but assistants, nurses, auxiliary nurse midwives, village often do not provide implant or malaria volunteers, community health services IUD insertion services unless providers (CHSPs), etc. If they have a medical specifically trained. doctorate, they are grouped in the private health facility category.

Estimates are given grouping all of these providers into the Community Health Worker category. Estimates are also grouped in with other outlet types into the Private Medical category. Not-for-profit This included non-governmental organizations Not-for-profit organizations, trust health (NGOs), trust or faith-based/mission health facilities hospitals/clinics can provide facilities including hospitals, health centers and clinics. These services on family planning facilities provide commodities and services for a including the short-acting and LARC nominal service fee and are staffed by providers with methods. health qualifications.

Estimates are given grouping all facilities into the Not-For-Profit category. Estimates are also grouped in with other outlet types into the Private Medical category. Private health Private healthcare facilities include private hospitals, The majority of private higher and facilities private doctors and clinics/poly-clinics. medium health facilities can provide all short-acting and LARC Estimates are given grouping all providers and methods including sterilization. facilities into the Private Health Facility category. Estimates are also grouped in with other outlet types into the Private Medical category. Pharmacies / Pharmacies are licensed by the Myanmar Food and Pharmacies can provide all short- drug shops Drug Board of Authority (MFDBA) to qualified acting methods. Injectables can be degree/diploma holders. This category also may sold and injection services can be include unregistered pharmacies. performed by trained pharmacists. Pharmacies may provide LARC Estimates are given grouping all of these outlets into methods, but are not typically the Pharmacy category. Estimates are also grouped trained to provide implant or IUD in with other outlet types into the Private Medical insertion services. category. General General retailers consist of general stores and village General retailers may provide retailers shops which sell fast-moving consumer goods and short-acting methods, but are not

www.FPwatch.info Page 9

may stock family planning products. General retailers regulated. are typically not registered with any national regulatory authority and have no formal training in provision of family planning products or services.

Estimates are given grouping all of these outlets into the General Retailer category. Estimates are also grouped in with other outlet types into the Private Other category. Itinerant drug IDVs are mobile vendors selling medicines and other Itinerant drug vendors may provide vendors (IDVs) goods. short-acting methods, but are not regulated. Estimates are given grouping all of these vendors into the Itinerant Drug Vendor category. Estimates are also grouped in with other outlet types into the Private Other category.

www.FPwatch.info Page 10

Introduction This country reference document is a detailed presentation of the 2016 FPwatch outlet survey conducted in Myanmar. The survey was conducted in 94 townships of Myanmar. These townships were selected to investigate a variety of urban, rural and metropolitan zones and areas of the country expected to be different in terms of availability of family planning products and services.

FPwatch is a multi-country research project implemented by Population Services International (PSI) (www.psi.org). The project is designed to provide timely, relevant and high-quality, modern contraceptive commodity and associated services market evidence, and employs standardized tools and approaches to provide comparable data across countries and over time. The goal of providing this market evidence is to inform and monitor national and global policy, strategy and funding decisions for improving availability of a range of quality FP information and contraceptive methods. FPwatch was launched in 2014 with funding from the Bill and Melinda Gates Foundation (BMGF) for Ethiopia, Nigeria, the Democratic Republic of the Congo (DRC) and India, and is currently funded through 2016 by the BMGF. The project is an expansion of PSI’s ACTwatch project, focusing on national antimalarial markets, and a response to the Family Planning 2020 (FP2020) goal to enable 120 million additional women and girls to have informed choice and access to family planning information and a range of modern contraceptive methods. Additional funding was secured through the Three Millennium Development Goal (3MDG) Fund for FPwatch in Myanmar. See Annex 1 for more information about the FPwatch project.

FPwatch contraceptive method market monitoring in Myanmar has been implemented in the context of strategies designed and implemented to improve availability and choice in contraceptive methods. See Annex 2 for more information about the family planning (FP) context in the Myanmar. In particular, FP2020 pledges were made toward:

1. Increasing mCPR to 50% by 2015 and above 60% by 2020; 2. Reducing unmet need to less than 10% by 2015; 3. Increasing demand satisfaction to 80% by 2015; and 4. Improving method mix with increased use of LAPMs and decentralization to districts.

Report notes

 This document is a complete reference for the 2015 outlet survey. Please see annexes for information about the study context, design, implementation and data analysis.  Grey text for data appearing in report tables indicates that the estimate provided was derived from a small sample size. Specifically, grey text is used to indicate point estimates for availability indicators derived from an n of equal to or less than 50 and estimates for price indicators derived from an n of equal to or less than 5.  Contraceptive commodity and service prices are reported in US dollars. Price information is captured in local currency and converted to US dollars based on exchange rates available from http://www.oanda.com/currency/historical-rates using the historical exchange rates tool. The average exchange rate over the entire data collection period is used for converting local currency captured during data collection to US dollars.

www.FPwatch.info Page 11

Summary of Methods and Data Collection

A geographically-representative FP-focused outlet survey was conducted between February 29th and May 20th of 2016. A full description of research design and methods is provided in Annex 3. Briefly, a representative sample of clusters (geographic areas) was selected from each of three domains: urban, rural and metropolitan. Within selected geographic clusters, a census of all private outlets and providers with the potential to sell or distribute modern contraceptives and/or provide associated FP services was completed.

Only private outlets and providers were considered for the Myanmar FPwatch survey.

Outlets were then screened to determine eligibility. Outlets eligible for the survey met at least one of three criteria: 1) one or more modern contraceptive commodities (including cycle beads, oral contraceptives, emergency contraceptives, injectables, implants and/or IUDs were in stock on the day of the survey; 2) one or more modern contraceptive commodities were in stock in the three months preceding the survey; and/or 3) contraceptive services associated with commodities (contraceptive injections, implant insertions, IUD insertions) and/or permanent methods with no commodity (male/female sterilizations) were available. Questions relating to condoms were asked of all outlets, regardless of eligibility for the full audit or provider interview. Outlets or providers that provide only wholesale services and outlets that provide only condoms for prevention of sexually- transmitted infections (STIs) such as restaurants, bars or brothels were not considered for the FPwatch study. The results of the census are summarized in Figure 1. A detailed sample summary is provided in Annex 6.

A structured questionnaire was used to complete an audit of all modern contraceptive commodities as well as a provider interview for questions relating to contraceptive services (see Annex 7 for the FPwatch 2016 Myanmar questionnaire). See Annex 8 for detailed summaries of modern contraceptive commodities audited. Key informant interviews (KIIs) were conducted with specific stakeholders to supplement information for the country background.

Paper-based questionnaire was used for the FPwatch Myanmar survey. Data entry was performed with Census and Survey Processing System (CSPro) software. All data cleaning and analysis was performed using Stata 13.1 (©StataCorp, College Station, TX). Data were weighted to account for variation in probability of outlet selection (see Annex 9), and standard error calculation reflected clustering of outlets at urban ward/village tract level. Standard indicators were constructed according to definitions applied across FPwatch project countries (see Annex 10).

www.FPwatch.info Page 12

Figure 1: Survey flow diagram, Myanmar 2016

A Outlets enumerated* 37,781

Outlets not Interview interrupted screened 3 1,058 Respondents not available B 217 † Outlets screened Outlets closed at time of 36,723 visit 399 Outlets screened with Outlets closed condoms permanently 1,894 190 Other Outlets that did not 12 meet screening Refused criteria C 237 28,913 Outlets that met ‡ 1 = [2,012] screening criteria 2 = [31] 7,810 3 = [42] 1 = 6,688 2 = 627 3 = 495

Outlets not Outlets with interview 1 = [2,009] interviewed interrupted 2= [31] 19 2 3= [42] D Other Outlets interviewed§ 17 7,791

1 = 6,684 2 = 625 3 = 482

1: Modern contraceptive (including oral contraceptives, emergency contraceptives, injectables, implants or IUDs) in stock on day of visit 2: Modern contraceptives reportedly in stock during the previous 3 months but not on the day of the visit 3: Modern family planning services (including injections, implant or IUD insertions, or sterilizations) available but no modern contraceptives in stock

* Identified as outlets with potential to sell or distribute modern contraceptive commodities (condoms, oral contraceptives, emergency contraceptives, injectables, implants, IUDs) and/or provide contraceptive procedures (contraceptive injections, implant insertions, IUD insertionss, male/female sterilizations) during the census † Administered questions assessing condom availability, price and volume regardless of eligibility ‡ Administered questions to assess current or recent (previous 3 months) availability of modern contraceptives and modern family planning services § A partial or complete interview was conducted with an outlet representative

www.FPwatch.info Page 13

Summary of Key Findings Myanmar

Table A1: Modern contraceptive method market composition: Relative proportion of outlets with 1 or more methods, by outlet type – Myanmar, 2016 Private For- Community Private Not- Private General Itinerant Drug Private Other Profit Health Pharmacy Health Worker For-Profit Medical Total* Retailer Vendor Total* Facility Proportion of outlet types stocking / providing at least 1 modern contraceptive method on the day of % % % % % % % % the survey, of all outlets stocking / providing at least (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) 1 modern contraceptive method†: Any method available, including condoms only 15.9 0.1 14.7 24.7 39.4 42.7 1.9 44.5 outlets‡ N=6,911 (14.5, 17.4) (0.1, 0.3) (13.5, 16.1) (21.8, 27.9) (36.1, 42.8) (39.9, 45.5) (1.5, 2.3) (41.7, 47.4) Any method available, excluding condoms only 15.4 0.1 15.2 25.0 40.2 42.4 1.9 44.2 outlets§ (14.0, 16.9) (0.1, 0.3) (13.9, 16.6) (22.1, 28.2) (36.9, 43.7) (39.5, 45.2) (1.5, 2.4) (41.4, 47.2) N=6,680 * Private Medical Total category = community health worker + private not-for-profit + private for-profit health facility + pharmacy categories; Private Other Total category = general retailer + itinerant drug vendor categories † Contraceptive commodity-stocking outlets have at least one family planning commodity in stock on the day of the survey, verified by the presence of at least one family planning commodity recorded in an audit sheet. There were 19 family planning commodity-stocking outlets in Myanmar with partially completed interviews, which were excluded from the denominator. ‡ Includes: male condoms, female condoms, cyclebeads, vaginal pessaries, oral contraceptives, emergency contraceptive pills, contraceptive injectables, contraceptive implants and/or IUDs. Cyclebeads, vaginal pessaries, birth control patches, diaphragms or vaginal rings were not found in Myanmar by the FPwatch study. § Includes: oral contraceptives, emergency contraceptive pills, contraceptive injectables, contraceptive implants and/or IUDs. Source: FPwatch Outlet Survey, Myanmar, 2016

www.FPwatch.info Page 14

Table A2: Availability of modern contraceptive method categories, among outlets screened, by outlet type – Myanmar, 2016 Private For- Community Private Not-For- Private Medical Itinerant Drug Private Other Profit Health Pharmacy General Retailer Health Worker Profit Total* Vendor Total* Facility % % % % % % % %

(95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) Proportion of outlets screened, N=1,898 N=7 N=1,311 N=1,661 N=4,877 N=31,368 N=478 N=31,846 currently stocking / providing†: 55.5 81.0 72.1 92.2 72.9 9.4 25.6 9.7 Any modern method (52.4, 58.6) (45.7, 95.6) (67.7, 76.1) (90.2, 93.8) (70.6, 75.2) (8.8, 10.1) (20.8, 31.1) (9.0, 10.4) 55.5 81.0 71.8 92.2 72.9 9.4 25.6 9.7 Any short-acting method (52.4, 58.6) (45.7, 95.6) (67.4, 75.7) (90.2, 93.8) (70.5, 75.1) (8.8, 10.1) (20.8, 31.1) (9.0, 10.4) 1.9 49.0 5.0 0.7 2.4 0.0 0.0 0.0 Any LARC method (1.3, 2.7) (16.5, 82.4) (3.8, 6.6) (0.3, 1.6) (1.9, 3.0) (0.0, 0.1) - (0.0, 0.1) 0.0 0.0 2.2 0.0 0.6 0.0 0.0 0.0 Any permanent method (0.0, 0.2) - (1.4, 3.5) - (0.4, 1.0) - - - 1.9 49.0 5.9 0.7 2.7 0.0 0.0 0.0 Any LA/PM (1.3, 2.8) (16.5, 82.4) (4.5, 7.7) (0.3, 1.6) (2.1, 3.4) (0.0, 0.1) - (0.0, 0.1) * Private Medical Total category = community health worker + private not-for-profit + private for-profit health facility + pharmacy categories; Private Other Total category = general retailer + itinerant drug vendor categories † There were 19 family planning commodity-stocking outlets in Myanmar with partially completed interviews, which were excluded from the denominator. Source: FPwatch Outlet Survey, Myanmar, 2016

www.FPwatch.info Page 15

Table A3: Availability of selected contraceptive commodities, among outlets screened, by outlet type – Myanmar, 2016 Private For- Community Private Not-For- Private Medical Itinerant Drug Private Other Profit Health Pharmacy General Retailer Health Worker Profit Total* Vendor Total* Facility % % % % % % % %

(95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) Proportion of outlets screened, N=1,898 N=7 N=1,311 N=1,661 N=4,877 N=31,368 N=478 N=31,846 currently stocking†: 16.0 49.0 16.4 58.6 31.2 1.0 1.3 1.0 Male condoms (13.8, 18.5) (16.5, 82.4) (13.8, 19.3) (55.4, 61.8) (29.0, 33.5) (0.8, 1.2) (0.7, 2.3) (0.8, 1.2) 0.5 22.8 0.8 0.6 0.7 0.0 0.0 0.0 Female condoms (0.3, 0.9) (3.7, 69.3) (0.4, 1.6) (0.3, 1.4) (0.5, 1.0) (0.0, 0.1) - (0.0, 0.1) 25.9 81.0 36.5 87.4 50.5 8.7 4.7 8.6 Oral contraceptives (23.3, 28.7) (45.7, 95.6) (33.1, 40.2) (85.2, 89.3) (47.9, 53.1) (8.0, 9.4) (3.1, 7.2) (8.0, 9.3) 24.6 81.0 35.0 84.7 48.7 4.6 3.6 4.6 Combined oral contraceptives (22.1, 27.4) (45.7, 95.6) (31.7, 38.6) (82.5, 86.8) (46.2, 51.3) (4.2, 5.0) (2.2, 5.9) (4.2, 5.0) 3.8 0.0 6.3 34.2 15.2 6.4 1.9 6.3 Progestin-only pills (2.7, 5.3) - (4.9, 8.0) (30.5, 38.0) (13.6, 16.8) (5.8, 7.0) (1.0, 3.3) (5.7, 6.9) 2.7 49.0 12.3 38.6 18.0 0.3 0.4 0.3 Emergency contraceptives (2.0, 3.8) (16.5, 82.4) (10.0, 15.1) (34.4, 42.8) (15.7, 20.6) (0.3, 0.5) (0.1, 1.1) (0.3, 0.5) 47.4 81.0 67.9 48.3 53.3 1.1 24.2 1.5 Contraceptive injectables (All DMPA) (44.3, 50.5) (45.7, 95.6) (63.7, 71.8) (44.5, 52.2) (51.2, 55.4) (0.9, 1.3) (19.6, 29.6) (1.3, 1.7) 47.4 81.0 67.8 48.3 53.3 1.1 24.2 1.5 3 month DMPA injectables (44.3, 50.5) (45.7, 95.6) (63.6, 71.7) (44.5, 52.2) (51.1, 55.4) (0.9, 1.3) (19.6, 29.6) (1.3, 1.7) 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 1 month DMPA injectables - - (0.1, 0.6) - (0.0, 0.2) (0.0, 0.1) - (0.0, 0.1) 0.0 26.2 0.8 0.0 0.3 0.0 0.0 0.0 Contraceptive implants - (4.4, 73.0) (0.3, 2.0) - (0.1, 0.6) - - - 0.0 26.2 0.5 0.0 0.2 0.0 0.0 0.0 Implanon implants - (4.4, 73.0) (0.1, 2.0) - (0.1, 0.6) - - - 0.0 26.2 0.4 0.0 0.2 0.0 0.0 0.0 Jadelle implants - (4.4, 73.0) (0.1, 2.2) - (0.0, 0.6) - - - 1.9 49.0 4.8 0.7 2.4 0.0 0.0 0.0 IUDs (All Copper T) (1.3, 2.7) (16.5, 82.4) (3.6, 6.4) (0.3, 1.6) (1.9, 3.0) (0.0, 0.1) - (0.0, 0.1) * Public Medical Total category = community health worker + private not-for-profit + private for-profit health facility + pharmacy categories; Private Other Total category = general retailer + itinerant drug vendor categories † There were 19 family planning commodity-stocking outlets in Myanmar with partially completed interviews, which were excluded from the denominator. Source: FPwatch Outlet Survey, Myanmar, 2016

www.FPwatch.info Page 16

Table A4: Availability of modern contraceptive method diversity, among outlets screened, by outlet type – Myanmar, 2016 Private For- Community Private Not-For- Private Medical Itinerant Drug Private Other Profit Health Pharmacy General Retailer Health Worker Profit Total* Vendor Total* Facility % % % % % % % %

(95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) Proportion of outlets screened, N=1,898 N=7 N=1,311 N=1,661 N=4,877 N=31,368 N=478 N=31,846 currently stocking / providing†: 9.4 49.0 19.1 48.2 25.8 0.2 0.4 0.2 3+ methods‡ (7.7, 11.3) (16.5, 82.4) (16.3, 22.2) (44.6, 51.9) (23.4, 28.3) (0.2, 0.3) (0.2, 1.1) (0.2, 0.3) 1.6 49.0 3.9 0.7 2.0 0.0 0.0 0.0 3+ methods with LARC (1.1, 2.5) (16.5, 82.4) (2.8, 5.3) (0.3, 1.6) (1.6, 2.6) (0.0, 0.1) - (0.0, 0.1) 1.7 49.0 4.4 0.7 2.2 0.0 0.0 0.0 3+ methods with LA/PM (1.1, 2.5) (16.5, 82.4) (3.3, 6.0) (0.3, 1.6) (1.7, 2.8) (0.0, 0.1) - (0.0, 0.1) 0.2 49.0 1.7 0.5 0.8 0.0 0.0 0.0 5+ methods§ (0.1, 0.4) (16.5, 82.4) (1.0, 2.9) (0.2, 1.2) (0.5, 1.2) (0.0, 0.1) - (0.0, 0.1) * Private Medical Total category = community health worker + private not-for-profit + private for-profit health facility + pharmacy categories; Private Other Total category = general retailer + itinerant drug vendor categories † The denominator includes 19 outlets that met screening criteria for a full interview but did not complete the interview (were not interviewed or completed a partial interview). ‡ 3 or more among: male condom, female condom, oral contraceptive, emergency contraceptive, contraceptive injectable, contraceptive implant, IUD commodities and/or male sterilization, female sterilization services. No other modern contraceptive methods were found in sampled outlets. § 5 or more among: male condom, female condom, oral contraceptive, emergency contraceptive, contraceptive injectable, contraceptive implant, IUD commodities and/or male sterilization, female sterilization services. No other modern contraceptive methods were found in sampled outlets. Source: FPwatch Outlet Survey, Myanmar, 2016

www.FPwatch.info Page 17

Table A5: Current stock out of selected modern contraceptive commodities on day of survey, among outlets reportedly stocking method in previous 3 months, by outlet type – Myanmar, 2016 Community Private Not-For- Private For-Profit Private Medical General Itinerant Drug Private Other Pharmacy Health Worker Profit Health Facility Total* Retailer Vendor Total* Proportion of outlets reportedly stocking method % % % % % % % % in previous 3 months, (95% CI) (n) (95% CI) (n) (95% CI) (n) (95% CI) (n) (95% CI) (n) (95% CI) (n) (95% CI) (n) (95% CI) (n) currently stocked out of†,‡: 19.7 8.1 11.1 3.9 8.8 13.4 22.8 13.5 Oral contraceptives [12.1, 14.9] [15.7, 24.5] (607) [1.1, 40.3] (6) [8.2, 14.7] (548) [2.6, 5.9] (1,529) [7.4, 10.6] (2,690) [11.8, 39.5] (43) [12.1, 15.0] (3,417) (3,374) 25.5 0.0 10.8 12.0 12.7 14.9 46.0 15.6 Emergency contraceptives [15.1, 39.6] (79) [0.0, 0.0] (2) [7.0, 16.3] (196) [9.8, 14.8] (733) [10.6, 15.1] (1,010) [8.8, 24.0] (119) [16.4, 78.7] (7) [9.6, 24.5] (126) 12.8 8.1 5.1 8.5 8.9 16.6 24.6 18.8 Contraceptive injectables [12.0, 22.4] [10.6, 15.4] (1,042) [1.1, 40.3] (6) [3.6, 7.1] (984) [6.6, 10.8] (865) [7.7, 10.2] (2,897) [13.5, 40.6] (148) [14.4, 24.3] (587) (439) - 0.0 25.7 - 21.7 - - - Contraceptive implants - (1) [8.1, 57.7] (14) - [7.0, 50.3] (15) - - - 19.7 0.0 4.9 15.5 10.9 - - - IUDs [8.0, 41.1] (44) [0.0, 0.0] (2) [1.8, 12.4] (63) [4.9, 39.8] (12) [5.7, 20.0] (121) - - - * Private Medical Total category = community health worker + private not-for-profit + private for-profit health facility + pharmacy categories; Private Other Total category = general retailer + itinerant drug vendor categories † This indicator is among all screened outlets that reportedly stocked the method in the previous 3 months. It does not account for whether the outlet is expected to provide the commodity according to national regulations. It is a point-in-time stock out indicator from https://www.rhsupplies.org/fileadmin/uploads/rhsc/Issues/Addressing_Stockouts/Takestock/Documents/Using_the_Power_of_Partnership_to_Speak_the_Same_Language_on_Stockouts.pdf. It is defined as the percentage of facilities reporting that they have stocked the method in the previous 3 months but were stocked out on the day of the assessment. ‡ The denominator includes 19 outlets that met screening criteria for a full interview but did not complete the interview (were not interviewed or completed a partial interview). Source: FPwatch Outlet Survey, Myanmar, 2016

www.FPwatch.info Page 18

Table A6: Median price of selected modern contraceptive methods in Myanmar Kyat , USD and USD per CYP, by private outlet type – Myanmar, 2016 Community Health Private For-Profit Private Medical Itinerant Drug Pharmacy General Retailer Private Other Total* Worker Health Facility Total* Vendor Median price of method, Median Median Median Median Median Median Median with interquartile range†,‡: [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) Male condoms Myanmar Kyat per 0 0 67 50 67 0 67 condom [0, 0] (194) [0, 67] (109) [50, 67] (305) [0, 67] (608) [50, 167] (227) [0, 67] (12) [50, 150] (239) 0.00 0.00 0.05 0.04 0.05 0.00 0.05 USD per condom§ [0.00, 0.00] (194) [0.00, 0.05] (109) [0.04, 0.05] (305) [0.00, 0.05] (608) [0.04, 0.14] (227) [0.00, 0.05] (12) [0.04, 0.12] (239) 0.00 0.00 6.60 4.95 6.60 0.00 6.60 USD per CYP∞ [0.00, 0.00] (194) [0.00, 6.60] (109) [4.95, 6.60] (305) [0.00, 6.60] (608) [4.95, 16.50] (227) [0.00, 6.60] (12) [4.95, 14.85] (239) Female condoms Myanmar Kyat per 0 0 0 0 - - - condom [0, 0] (7) [0, 0] (5) [0, 200] (3) [0, 0] (15) - - - 0.00 0.00 0.00 0.00 - - - USD per condom [0.00, 0.00] (7) [0.00, 0.00] (5) [0.00, 0.17] (3) [0.00, 0.00] (15) - - - 0.00 0.00 0.00 0.00 - - - USD per CYP [0.00, 0.00] (7) [0.00, 0.00] (5) [0.00, 19.80] (3) [0.00, 0.00] (15) - - - Oral contraceptives 200 500 500 500 300 400 300 Myanmar Kyat per cycle [0, 500] (671) [500, 900] (776) [400, 800] (3,953) [400, 700] (5,409) [200, 500] (4,291) [200, 500] (45) [200, 500] (4,336) 0.17 0.41 0.41 0.41 0.25 0.33 0.25 USD per cycle [0.00, 0.41] (671) [0.41, 0.74] (776) [0.33, 0.66] (3,953) [0.33, 0.58] (5,409) [0.17, 0.41] (4,291) [0.17, 0.41] (45) [0.17, 0.41] (4,336) 2.48 6.19 6.19 6.19 3.71 4.95 3.71 USD per CYP [0.00, 6.19] (671) [6.19, 11.14] (776) [4.95, 9.90] (3,953) [4.95, 8.66] (5,409) [2.48, 6.19] (4,291) [2.48, 6.19] (45) [2.48, 6.19] (4,336) Combined oral contraceptives 200 500 600 500 500 500 500 Myanmar Kyat per cycle [0, 500] (591) [500, 900] (690) [500, 1000] (3,318) [450, 800] (4,608) [500, 600] (2,130) [400, 600] (31) [500, 600] (2,161) 0.17 0.41 0.50 0.41 0.41 0.41 0.41 USD per cycle [0.00, 0.41] (591) [0.41, 0.74] (690) [0.41, 0.82] (3,318) [0.37, 0.66] (4,608) [0.41, 0.50] (2,130) [0.33, 0.50] (31) [0.41, 0.50] (2,161) 2.48 6.19 7.43 6.19 6.19 6.19 6.19 USD per CYP [0.00, 6.19] (591) [6.19, 11.14] (690) [6.19, 12.38] (3,318) [5.57, 9.90] (4,608) [6.19, 7.43] (2,130) [4.95, 7.43] (31) [6.19, 7.43] (2,161) Progestin-only pills 200 200 200 200 200 200 200 Myanmar Kyat per cycle [200, 300] (76) [150, 500] (86) [150, 250] (635) [150, 250] (797) [150, 245] (2,161) [150, 200] (14) [150, 200] (2,175) 0.17 0.17 0.17 0.17 0.17 0.17 0.17 USD per cycle [0.17, 0.25] (76) [0.12, 0.41] (86) [0.12, 0.21] (635) [0.12, 0.21] (797) [0.12, 0.20] (2,161) [0.12, 0.17] (14) [0.12, 0.17] (2,175) USD per CYP 2.48 2.48 2.48 2.48 2.48 2.48 2.48

www.FPwatch.info Page 19

Table A6: Median price of selected modern contraceptive methods in Myanmar Kyat , USD and USD per CYP, by private outlet type – Myanmar, 2016 Community Health Private For-Profit Private Medical Itinerant Drug Pharmacy General Retailer Private Other Total* Worker Health Facility Total* Vendor Median price of method, Median Median Median Median Median Median Median with interquartile range†,‡: [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [2.48, 3.71] (76) [1.86, 6.19] (86) [1.86, 3.09] (635) [1.86, 3.09] (797) [1.86, 3.03] (2,161) [1.86, 2.48] (14) [1.86, 2.48] (2,175) Emergency contraceptives 0 1000 900 900 1000 700 1000 Myanmar Kyat per dose [0, 800] (63) [600, 1000] (178) [800, 1000] (821) [750, 1000] (1,064) [900, 1050] (101) [0, 1500] (3) [900, 1050] (104) 0.00 0.82 0.74 0.74 0.82 0.58 0.82 USD per dose [0.00, 0.66] (63) [0.50, 0.82] (178) [0.66, 0.82] (821) [0.62, 0.82] (1,064) [0.74, 0.87] (101) [0.00, 1.24] (3) [0.74, 0.87] (104) 0.00 16.50 14.85 14.85 16.50 11.55 16.50 USD per CYP [0.00, 13.20] (63) [9.90, 16.50] (178) [13.20, 16.50] (821) [12.38, 16.50] (1,064) [14.85, 17.32] (101) [0.00, 24.75] (3) [14.85, 17.32] (104) Contraceptive injectables 1000 1500 550 1000 600 1000 800 Myanmar Kyat per dose [1000, 1500] (1,063) [1000, 2000] (989) [500, 700] (1,003) [550, 1500] (3,060) [550, 1000] (425) [1000, 1500] (130) [600, 1000] (555) 0.82 1.24 0.45 0.82 0.50 0.82 0.66 USD per dose [0.82, 1.24] (1,063) [0.82, 1.65] (989) [0.41, 0.58] (1,003) [0.45, 1.24] (3,060) [0.45, 0.82] (425) [0.82, 1.24] (130) [0.50, 0.82] (555) 3.30 4.95 1.82 3.30 1.98 3.30 2.64 USD per CYP [3.30, 4.95] (1,063) [3.30, 6.60] (989) [1.65, 2.31] (1,003) [1.82, 4.95] (3,060) [1.82, 3.30] (425) [3.30, 4.95] (130) [1.98, 3.30] (555) 3 month injectables 1000 1500 550 1000 600 1000 800 Myanmar Kyat per dose [1000, 1500] (1,063) [1000, 2000] (985) [500, 700] (1,003) [550, 1500] (3,056) [550, 1000] (425) [1000, 1500] (130) [600, 1000] (555) 0.82 1.24 0.45 0.82 0.50 0.82 0.66 USD per dose [0.82, 1.24] (1,063) [0.82, 1.65] (985) [0.41, 0.58] (1,003) [0.45, 1.24] (3,056) [0.45, 0.82] (425) [0.82, 1.24] (130) [0.50, 0.82] (555) 3.30 4.95 1.82 3.30 1.98 3.30 2.64 USD per CYP [3.30, 4.95] (1,063) [3.30, 6.60] (985) [1.65, 2.31] (1,003) [1.82, 4.95] (3,056) [1.82, 3.30] (425) [3.30, 4.95] (130) [1.98, 3.30] (555) 1 month injectables - 1000 - 1000 - - - Myanmar Kyat per dose - [400, 1500] (4) - [400, 1500] (4) - - - - 0.82 - 0.82 - - - USD per dose - [0.33, 1.24] (4) - [0.33, 1.24] (4) - - - - 10.72 - 10.72 - - - USD per CYP - [4.29, 16.09] (4) - [4.29, 16.09] (4) - - - Contraceptive implants - 15000 - 15000 - - - Myanmar Kyat per dose - [15000, 18000] (11) - [15000, 18000] (13) - - - - 12.38 - 12.38 - - - USD per dose - [12.38, 14.85] (11) - [12.38, 14.85] (13) - - -

www.FPwatch.info Page 20

Table A6: Median price of selected modern contraceptive methods in Myanmar Kyat , USD and USD per CYP, by private outlet type – Myanmar, 2016 Community Health Private For-Profit Private Medical Itinerant Drug Pharmacy General Retailer Private Other Total* Worker Health Facility Total* Vendor Median price of method, Median Median Median Median Median Median Median with interquartile range†,‡: [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) - 4.95 - 4.95 - - - USD per CYP - [3.26, 4.95] (5) - [3.26, 4.95] (7) - - - Implanon implants - 15000 - 15000 - - - Myanmar Kyat per dose - [15000, 15000] (3) - [15000, 15000] (4) - - - - 12.38 - 12.38 - - - USD per dose - [12.38, 12.38] (3) - [12.38, 12.38] (4) - - - - 4.95 - 4.95 - - - USD per CYP - [4.95, 4.95] (3) - [4.95, 4.95] (4) - - - Jadelle implants - 15000 - 15000 - - - Myanmar Kyat per dose - [15000, 15000] (2) - [15000, 15000] (3) - - - - 12.38 - 12.38 - - - USD per dose - [12.38, 12.38] (2) - [12.38, 12.38] (3) - - - - 3.26 - 3.26 - - - USD per CYP - [3.26, 3.26] (2) - [3.26, 3.26] (3) - - - IUDs 4000 6000 600 5000 0 , 0 Myanmar Kyat per IUD [0, 5000] (29) [2000, 10000] (57) [500, 700] (7) [1000, 7000] (95) [0, 800] (2) , [0, 800] (2) 3.30 4.95 0.50 4.13 0.00 , 0.00 USD per IUD [0.00, 4.13] (29) [1.65, 8.25] (57) [0.41, 0.58] (7) [0.82, 5.78] (95) [0.00, 0.66] (2) , [0.00, 0.66] (2) 0.72 1.08 0.11 0.90 0.00 , 0.00 USD per CYP [0.00, 0.90] (29) [0.36, 1.79] (57) [0.09, 0.13] (7) [0.18, 1.26] (95) [0.00, 0.14] (2) , [0.00, 0.14] (2) Female sterilization|| Myanmar Kyat per - 200000 - 200000 - - - sterilization - [30000, 400000] (6) - [30000, 400000] (6) - - - - 165.00 - 165.00 - - - USD per sterilization - [24.75, 330.00] (6) - [24.75, 330.00] (6) - - - - 16.02 - 16.02 - - - USD per CYP - [2.40, 32.04] (6) - [2.40, 32.04] (6) - - - * Private Medical Total category = community health worker + private not-for-profit + private for-profit health facility + pharmacy categories; Private Other Total category = general retailer + itinerant drug vendor categories † Price for all commodities with provider-dependent service (injectables, IUDs) may include a service charge. ‡ The number of family planning products captured in audits sheets with missing price information are as follows: 1,008 male condoms, 14 female condoms, 152 oral contraceptives, 33 emergency contraceptives, 47 injectables, 0 implants, 32 IUDs, 1 male sterilization and 19 female sterilizations. § Based on the average rate of exchange from February 26th to May 19th, 2016 of 1,212.121 Myanmar Kyat per 1 USD. ∞ This price is determined for the unit used in CYP conversion factors: condoms: 1 condom; cyclebeads: 1 product/string; vaginal pessaries: 1 tablet; oral contraceptives: 1 cycle or blister package; emergency contraceptives:

www.FPwatch.info Page 21

www.FPwatch.info Page 22

Table A7: Median markup percentage for selected modern contraceptive commodities with interquartile range, by private outlet type – Myanmar, 2016 Community Private For-Profit Private Medical Pharmacy General Retailer Itinerant Drug Vendor Private Other Total* Health Worker Health Facility Total* Median markup percentage of Median % Median % Median % Median % Median % Median % Median % commodity, with [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) interquartile range†,‡,§: 5.0 16.7 12.0 12.0 25.0 20.0 25.0 Oral contraceptives [0.0, 31.6] (578) [8.3, 33.3] (629) [8.3, 25.0] (3,563) [7.3, 25.0] (4,777) [12.5, 33.3] (3,728) [9.1, 40.0] (43) [12.5, 33.3] (3,771) 0.0 17.6 12.5 12.5 12.5 40.0 12.5 Emergency contraceptives [0.0, 11.1] (59) [7.7, 33.3] (126) [7.7, 20.5] (727) [7.1, 23.1] (912) [7.1, 17.6] (63) [0.0, 50.0] (3) [7.1, 17.6] (66) 100.0 185.7 11.1 81.8 20.0 100.0 27.3 Contraceptive injectables [66.7, 150.0] (893) [114.3, 233.3] (793) [9.1, 18.4] (924) [11.1, 167.9] (2,613) [11.1, 39.5] (386) [66.7, 150.0] (124) [11.1, 76.5] (510) - 20.0 - 20.0 - - - Contraceptive implants - [20.0, 140.0] (6) - [20.0, 140.0] (6) - - - 233.3 633.3 11.1 275.0 0.0 - 0.0 IUDs [0.0, 400.0] (18) [175.0, 1000.0] (42) [11.1, 27.3] (5) [20.8, 900.0] (65) [0.0, 33.3] (2) - [0.0, 33.3] (2) * Private Medical Total category = community health worker + private not-for-profit + private for-profit health facility + pharmacy categories; Private Other Total category = general retailer + itinerant drug vendor categories † Price for all commodities with provider-dependent service (injectables, implants, IUDs) may include service charge. ‡ The number of family planning products captured in audit sheets with missing retail and/or wholesale price information are as follows: 1,350 oral contraceptives, 223 emergency contraceptives, 539 injections, 7 implants and 62 IUDs. § To determine median markup percentage, we first determined the profit margin for selected modern contraceptives at private sector outlet categories: retail price – wholesale price. We then determined a profit margin proportion by: profit margin/retail price. Finally, we converted profit margin to markup by: wholesale price/(1- profit margin proportion). We converted to a percentage and determined the median markup with IQR range. Source: FPwatch Outlet Survey, Myanmar, 2016

www.FPwatch.info Page 23

Table A8: Contraceptive method market share: Relative proportion of total CYP sold/distributed, by method and outlet type – Myanmar, 2016 CYPs sold or distributed in previous Private For- Community Private Not- Private General Itinerant Drug Private Other Method 1 month by outlet type and Profit Health Pharmacy Health Worker For-Profit Medical Total* Retailer Vendor Total* Total∞ contraceptive method type as a % Facility of total CYPs sold / distributed†,‡: % % % % % % % % % 1. Male condoms 0.1 0.0 0.1 1.1 1.3 0.6 0.0 0.6 1.9 2. Female condoms 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3. Oral contraceptives 1.6 0.1 2.4 17.9 22.1 6.5 0.0 6.6 28.6 Combined oral contraceptives 1.4 0.1 2.2 13.9 17.7 2.9 0.0 2.9 20.6 Progestin-only pills 0.2 0.0 0.2 4.0 4.4 3.6 0.0 3.6 8.0 4. Emergency contraceptives 0.0 0.0 0.1 2.7 2.8 0.2 0.0 0.2 3.0 5. Contraceptive injectables 9.5 0.9 15.3 31.3 57.1 2.5 0.5 3.0 60.1 3 month injectables 9.5 0.9 15.3 31.3 57.1 2.5 0.5 3.0 60.1 1 month injectables 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6. Contraceptive implants 0.0 0.5 0.1 0.0 0.6 0.0 0.0 0.0 0.6 Implanon implants 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.3 Jadelle implants 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.3 7. IUDs 0.4 2.1 2.3 0.5 5.3 0.0 0.0 0.0 5.3 8. Male sterilization|| 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9. Female sterilization 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.4 OUTLET TYPE TOTAL∞ 11.7 3.7 20.8 53.5 89.7 9.7 0.6 10.3 100.0 * Private Medical Total category = community health worker + private not-for-profit + private for-profit health facility + pharmacy categories; Private Other Total category = general retailer + itinerant drug vendor categories † A total of 162,938 CYPs (weighted) were reportedly distributed in the previous 1 month in Myanmar. This is based on the number of commodities reportedly sold for categories 1-7 (not number of services performed for categories 5-7) and number of sterilizations reportedly performed for categories 8-9. ‡ In Myanmar 15,221 FP products were audited, not including condoms (9,897 oral contraceptives, 1,201 emergency contraceptives, 3,662 injectables, 33 implants, 129 IUDs). In addition, 227 outlets were audited for male condoms, 3 outlets for female condoms, and 1 outlet for female sterilization services. Volume information was excluded due to missing information or as a volume outlier for: 288 male condoms, 10 female condoms, 558 oral contraceptive tablets, 105 emergency contraceptive tablets, 3 injectables, 6 implants, no IUD products, no male sterilizations and 4 female sterilizations. ∞ Row total: CYP volume for the specified contraceptive method type. Column total: market share for the specified outlet type method categories 1-9. || Male sterilizations are illegal in Myanmar. A small number of outlets did report offering male sterilization services. However, no volumes were reported for the procedure. Source: FPwatch Outlet Survey, Myanmar, 2016

www.FPwatch.info Page 24

Table A9: Contraceptive method market share within outlet type: Relative proportion of total CYP sold/distributed within outlet type, by method – Myanmar, 2016 CYPs sold or distributed in Community Private Not-For- Private For-Profit Private Medical Itinerant Drug Private Other Pharmacy General Retailer previous 1 month by outlet type Health Worker Profit Health Facility Total* Vendor Total* and contraceptive method type as a % of total CYPs sold / % % % % % % % % distributed†,‡: 1. Male condoms 1.0 0.0 0.6 2.0 1.5 5.9 0.7 5.6 2. Female condoms 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3. Oral contraceptives 13.9 3.8 11.6 33.5 24.6 66.9 7.0 63.6 Combined oral contraceptives 12.3 3.8 10.6 26.0 19.7 29.9 4.5 28.5 Progestin-only pills 1.5 0.0 1.0 7.5 4.9 37.0 2.5 35.1 4. Emergency contraceptives 0.2 0.3 0.7 5.0 3.2 1.7 0.1 1.6 5. Contraceptive injectables 81.6 24.8 73.6 58.5 63.7 25.5 92.2 29.2 3 month injectables 81.6 24.8 73.5 58.5 63.7 25.5 92.2 29.2 1 month injectables 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6. Implants 0.0 13.1 0.5 0.0 0.6 0.0 0.0 0.0 Implanon implants 0.0 5.2 0.5 0.0 0.3 0.0 0.0 0.0 Jadelle implants 0.0 7.9 0.0 0.0 0.3 0.0 0.0 0.0 7. IUDs 3.1 58.0 11.0 1.0 5.9 0.0 0.0 0.0 8. Male sterilization∞ 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9. Female sterilization 0.0 0.0 2.1 0.0 0.5 0.0 0.0 0.0 * Private Medical Total category = community health worker + private not-for-profit + private for-profit health facility + pharmacy categories; Private Other Total category = general retailer + itinerant drug vendor categories † A total of 162,938 CYPs (weighted) were reportedly distributed in the previous 1 month in Myanmar. This is based on the number of commodities reportedly sold for categories 1-7 (not number of services performed for categories 5-7) and number of sterilizations reportedly performed for categories 8-9. ‡ In Myanmar 15,221 FP products were audited, not including condoms (9,897 oral contraceptives, 1,201 emergency contraceptives, 3,662 injectables, 33 implants, 129 IUDs). In addition, 227 outlets were audited for male condoms, 3 outlets for female condoms, and 1 outlet for female sterilization services. Volume information was excluded due to missing information or as a volume outlier for: 288 male condoms, 10 female condoms, 558 oral contraceptive tablets, 105 emergency contraceptive tablets, 3 injectables, 6 implants, no IUD products, no male sterilizations and 4 female sterilizations. ∞ Male sterilizations are illegal in Myanmar. A small number of outlets did report offering male sterilization services. However, no volumes were reported for the procedure. Categories 1 through 9 sum to 100% within each column. Source: FPwatch Outlet Survey, Myanmar, 2016

www.FPwatch.info Page 25

Table A10: Availability of selected contraceptive services, among outlets screened, by outlet type – Myanmar, 2016 Private For- Community Private Not-For- Private Medical Itinerant Drug Private Other Profit Health Pharmacy General Retailer Health Worker Profit Total* Vendor Total* Facility % % % % % % % %

(95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) Proportion of outlets screened, N=1,898 N=7 N=1,311 N=1,661 N=4877 N=31,368 N=478 N=31,846 providing†: 69.6 81.0 75.2 8.5 49.6 0.3 35.7 1.1 Contraceptive injection service (66.3, 72.7) (45.7, 95.6) (70.7, 79.1) (6.5, 11.2) (46.7, 52.5) (0.2, 0.4) (14.2, 65.0) (0.8, 1.5) 0.0 49.0 3.6 0.0 1.1 0.0 0.0 0.0 Contraceptive implant insertion service (0.0, 0.1) (16.5, 82.4) (2.2, 6.0) (0.0, 0.2) (0.7, 1.8) (0.0, 0.1) - - 2.3 61.0 7.8 0.0 3.1 0.0 0.0 0.0 IUD insertion service (1.6, 3.3) (25.6, 87.6) (6.1, 9.8) (0.0, 0.2) (2.5, 3.9) (0.0, 0.0) - - 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 Male sterilization service (0.0, 0.0) - (0.0, 0.5) - (0.0, 0.1) - - - 0.0 0.0 2.2 0.0 0.6 0.0 0.0 0.0 Female sterilization service‡ - - (1.4, 3.5) - (0.4, 0.9) - - - * Private Medical Total category = community health worker + private not-for-profit + private for-profit health facility + pharmacy categories; Private Other Total category = general retailer + itinerant drug vendor categories † The denominator includes 19 outlets that met screening criteria for a full interview but did not complete the interview (were not interviewed or completed a partial interview). ‡ Male sterilizations are illegal in Myanmar. A small number of outlets did report offering male sterilization services. Source: FPwatch Outlet Survey, Myanmar, 2016

www.FPwatch.info Page 26

Table A11: Service readiness to provide provider-dependent contraceptive services, among outlets reportedly offering the procedure, by outlet type – Myanmar, 2016 Private For- Community Private Not-For- Private Medical Itinerant Drug Private Other Profit Health Pharmacy General Retailer Health Worker Profit Total* Vendor Total* Facility Proportion of outlets offering service, % % % % % % % % with†,‡: [95%] (n) [95%] (n) [95%] (n) [95%] (n) [95%] (n) [95%] (n) [95%] (n) [95%] (n) Contraceptive injection service 66.4 100.0 89.5 90.1 77.4 78.3 37.8 47.6 Availability of commodity [63.0, 69.7] (1,364) [100.0, 100.0] (5) [86.5, 92.0] (1,014) [84.3, 94.0] (176) [75.1, 79.5] (2,559) [60.8, 89.3] (58) [29.4, 46.9] (285) [38.9, 56.4] (343) 47.6 100.0 98.4 71.9 69.9 46.5 3.4 13.8 Availability of credentials [43.9, 51.3] (1,364) [100.0, 100.0] (5) [97.4, 99.0] (1,014) [61.5, 80.4] (176) [67.1, 72.6] (2,559) [25.4, 68.9] (58) [1.6, 7.2] (285) [7.6, 23.9] (343) 69.8 96.0 85.8 85.1 77.3 80.7 54.6 61.0 Availability of equipment [66.5, 72.9] (1,363) [75.8, 99.5] (5) [82.6, 88.5] (1,013) [77.3, 90.6] (173) [74.9, 79.5] (2,554) [65.3, 90.3] (58) [41.6, 67.1] (284) [48.3, 72.3] (342) 30.8 96.0 77.7 57.1 51.7 32.1 2.8 9.9 Service readiness [27.7, 34.1] (1,363) [75.8, 99.5] (5) [74.1, 81.0] (1,013) [46.2, 67.3] (173) [48.9, 54.5] (2,554) [13.3, 59.3] (58) [1.2, 6.6] (284) [4.4, 20.6] (342) Contraceptive implant insertion service

Availability of commodity 0.0 53.4 21.7 0.0 24.3 0.0 - 0.0 (1) [7.8, 94.0] (2) [8.3, 46.1] (42) (1) [10.8, 45.9] (46) [0.0, 0.0] (2) - [0.0, 0.0] (2) 0.0 100.0 39.9 0.0 46.0 16.7 - 16.7 Availability of credentials (1) [100.0, 100.0] (2) [17.3, 67.8] (30) (1) [23.4, 70.5] (34) [1.4, 73.5] (2) - [1.4, 73.5] (2) 0.0 100.0 86.7 0.0 86.6 100.0 - 100.0 Availability of equipment (1) [100.0, 100.0] (2) [63.7, 96.0] (42) (1) [66.2, 95.5] (46) [100.0, 100.0] (2) - [100.0, 100.0] (2) 0.0 53.4 23.5 0.0 26.5 0.0 - 0.0 Service readiness (1) [7.8, 94.0] (2) [7.5, 54.0] (30) (1) [10.6, 52.3] (34) [0.0, 0.0] (2) - [0.0, 0.0] (2) IUD insertion service 53.3 80.4 59.7 0.0 58.4 83.3 - 83.3 Availability of commodity [35.9, 69.9] (44) [30.6, 97.5] (3) [45.6, 72.3] (86) [0.0, 0.0] (2) [47.9, 68.2] (135) [26.5, 98.6] (2) - [26.5, 98.6] (2) 28.1 80.4 45.7 32.8 41.7 16.7 - 16.7 Availability of credentials [15.8, 44.9] (43) [30.6, 97.5] (3) [31.5, 60.7] (72) [3.6, 86.6] (2) [31.0, 53.3] (120) [1.4, 73.5] (2) - [1.4, 73.5] (2) 55.1 80.4 92.7 32.8 81.5 100.0 - 100.0 Availability of equipment [37.5, 71.4] (43) [30.6, 97.5] (3) [77.4, 97.9] (85) [3.6, 86.6] (2) [71.2, 88.7] (133) [100.0, 100.0] (2) - [100.0, 100.0] (2) 16.0 80.4 32.4 0.0 29.3 0.0 - 0.0 Service readiness [6.9, 33.0] (42) [30.6, 97.5] (3) [19.7, 48.3] (72) [0.0, 0.0] (2) [19.6, 41.5] (119) [0.0, 0.0] (2) - [0.0, 0.0] (2) Female sterilization service∞ - - 100.0 - 100.0 - - - Availability of credentials - - [100.0, 100.0] (27) - [100.0, 100.0] (27) - - - - - 91.5 - 91.5 - - - Availability of equipment - - [78.1, 97.0] (27) - [78.1, 97.0] (27) - - - - - 91.5 - 91.5 - - - Service readiness - - [78.1, 97.0] (27) - [78.1, 97.0] (27) - - - * Private Medical Total category = community health worker + private not-for-profit + private for-profit health facility + pharmacy categories; Private Other Total category = general retailer + itinerant drug vendor categories † Full service readiness is defined as having available: 1. The commodity (not applicable for male/female sterilization); 2. A provider with credentials meeting the guidelines to perform the service (per correspondence with Myanmar Government Ministry of Health and Sports); and 3. A minimum set of sentinel equipment (http://www.cpc.unc.edu/measure/prh/rh_indicators/specific/long-acting-permanent-methods/percent-of-facilities-with-

www.FPwatch.info Page 27

Table A11: Service readiness to provide provider-dependent contraceptive services, among outlets reportedly offering the procedure, by outlet type – Myanmar, 2016 Private For- Community Private Not-For- Private Medical Itinerant Drug Private Other Profit Health Pharmacy General Retailer Health Worker Profit Total* Vendor Total* Facility Proportion of outlets offering service, % % % % % % % % with†,‡: [95%] (n) [95%] (n) [95%] (n) [95%] (n) [95%] (n) [95%] (n) [95%] (n) [95%] (n) appropriate) for providing the service. Observations that are missing information for commodity availability, provider credentials, or equipment are excluded from the ‘service readiness’ denominator. ‡ The denominator includes 19 outlets that met screening criteria for a full interview but did not complete the interview (were not interviewed or completed a partial interview). The list of family planning services with incomplete survey information are as follows: 31 IUD insertions, 29 implant insertions, 36 contraceptive injections, 1 male sterilization and 18 female sterilizations. ∞ Male sterilizations are illegal in Myanmar. A small number of outlets did report offering male sterilization services. However, no further information was collected for this procedure. Source: FPwatch Outlet Survey, Myanmar, 2016

www.FPwatch.info Page 28

Figure A1. Modern contraceptive method market composition – Myanmar, 2016 Among all outlets stocking at least one modern contraceptive or providing at least one contraceptive service, excluding condoms-only outlets, by outlet type

2% N = 6,680 Community Health Worker Not- For-Profit 16%

Private For-Profit Health Facility 42% 15% Pharmacy

General Retailer 25%

Itinerant Drug Vendor

In the Myanmar private sector, CHWs accounted for 15% of all private outlets stocking at least one modern contraceptive (above the level of condoms only), private not-for- profit outlets accounted for <1%, private for-profit health facilities for 15% and, pharmacies for one-quarter of the private market composition. General retailers accounted for an additional 42% and IDVs for 2% of the private market composition for modern contraceptives (excluding outlets carrying only male condoms).

www.FPwatch.info Page 29

Figure A2. Percentage of modern contraceptive commodity-stocking outlets with selected contraceptives available – Myanmar, 2016 Among all screened outlets, by outlet type 100 80 60 40 20 0 Community Health For-Profit Health Pharmacy General Retailer Itinerant Drug Vendor Worker Facility

Male condoms Female condoms Oral contraceptives Combined oral contraceptives Progestin-only pills Emergency contraceptives Contraceptive injectables Implants IUDs

In Myanmar, about 15% of CHWs and facilities, 60% of pharmacies and less than 3% of general retailers and IDVs had male condoms available of those outlets screened. Less than 1% of all outlet types stocked at least one brand of female condoms on the day of the survey of those screened. Looking at hormonal short-acting methods in the Myanmar private sector, about one-quarter of CHWs, 40% of facilities, over 80% of pharmacies and less than 10% of general retailers and IDVs stocked oral contraceptives on the day of the survey of those screened. Most oral contraceptives were combined oral contraceptives with less than 5% of all outlet types providing progestin-only pills. Emergency contraceptives were stocked by a handful of CHWs, about 10% of facilities, 40% of pharmacies and very rarely among general retailers and IDVs screened. Injectables were commonly stocked among CHWs (almost half), facilities (almost two-thirds), pharmacies (almost half) and IDVs (almost one-quarter). For LARCs, very few screened CHWs stocked implants and/or IUDs, about 1% and/or 3% of screened facilities stocked implants and/or IUDs, respectively. LARC methods were not commonly stocked among pharmacies, general retailers or IDVs.

www.FPwatch.info Page 30

Figure A3. Percentage of modern contraceptive commodity-stocking outlets with method mixes available available – Myanmar, 2016 Among all screened outlets, by outlet type 100

0 Community Health Private For-Profit Pharmacy General Retailer Itinerant Drug Vendor Worker Health Facility Any modern method 3+ methods 3+ methods with LARC/PM 5+ methods

In the Myanmar private sector, only about 10% of CHWs, 20% of facilities and about half of pharmacies screened stocked three or more methods of modern contraceptives on the day of the survey. Outlets stocking five or more methods were rare and very few general retailers and IDVs stocked three or more methods among those outlets screened.

www.FPwatch.info Page 31

Figure A4. Percentage outlets with stock outs of selected contraceptive methods – Myanmar, 2016 Among all outlets reportedly stocking the method at any time in the previous three months, by outlet type

This stock out graph is among only those outlets reportedly offering the service in the previous three months. Among these outlets, one-fifth of CHWs, about 10% of facilities, <5% of pharmacies, about 15% of general retailers and over 20% of IDVs who reported stocking oral contraceptives in the previous three months were stocked out of all brands of oral contraceptives on the day of the survey. For emergency contraceptives, about one-quarter of CHWs, 10% of facilities and pharmacies, 15% of general retailers and almost half of IDVs were stocked out of emergency contraceptives. For injectables, about 15% of CHWs, 5% of facilities, 10% of pharmacies and 20% of general retailers and IDVs reportedly stocking injectables in the previous three months were stocked out of all brands on the day of the survey. For LARC methods, about one-quarter of facilities were reportedly stocked out of implants, but this method was not carried by large numbers of any outlet. For IUDs, about one-quarter of CHWs, <5% of facilities and 15% of pharmacies were stocked out, but again, IUDs were not commonly stocked by any outlet type.

www.FPwatch.info Page 32

Figure A5. Price of contraceptive methods in the private sector – Myanmar, 2016 Median price in USD and USD/CYP with interquartile range, by contraceptive method and sector

Comparing median prices of methods in Myanmar, the median price per CYP ranged from $0.00 to $6.60 per CYP for male condoms (with median at $4.95 per CYP among CHWs, facilities and pharmacies), $3.71 to $6.19 per CYP for oral contraceptives (with median at $6.19 per CYP among CHWs, facilities and pharmacies), $11.55 to $16.50 per CYP for emergency contraceptives (with median at $14.85 per CYP among CHWs, facilities and pharmacies), $1.82 to $4.95 per CYP for contraceptive injectables (with median at $2.64 per CYP among CHWs, facilities and pharmacies), $4.95 per CYP for implants (with median at $4.95 per CYP among CHWs, facilities and pharmacies), and $0.00 to $1.08 per CYP for IUDs (with median at $0.90 per CYP among CHWs, facilities and pharmacies) for those commonly distributed methods in Myanmar. Prices tended to be slightly lower for oral contraceptives and injectables in general retailers and IDVs compared to other traditional outlet types and higher for male condoms and emergency contraceptives. Female sterilizations were not commonly offered, but the median price was $16.02 per CYP among the, largely, facilities that offered this service.

www.FPwatch.info Page 33

Figure A6. Percentage market share for contraceptive methods – Myanmar, 2016 As a percentage of total CYPs sold/distributed, by outlet type and sector

As a proportion of the total volume of CYP sold/distributed for all methods in the private sector accounted for by the FPwatch study in the Myanmar private sector, CHWs account for 12% of the total CYP, not-for-profits 4%, facilities 21%, pharmacies 54%, general retailers 10% and IDVs 1% of the total private CYP. Looking at methods, the largest CYP share was accounted for by injectables (60%) followed by 29% for oral contraceptives. Emergency contraceptives accounted for an additional 8% of private market share. Among LARCs, IUDS accounted for 5% and implants 1% of the total private market share. Male or female sterilizations did not account for an appreciable market share in the private sector of Myanmar.

www.FPwatch.info Page 34

Figure A7. Within outlet market share for contraceptive methods – Myanmar, 2016 As a % of total CYPs sold/distributed within outlet type and sector, by outlet type and sector

Looking at proportion of CYP volume by method within outlet types in Myanmar, the large majority of within outlet market share for CHWs and facilities was for injectables with about 10 – 15% for IUDs and oral contraceptives in both outlet types. Among total CYP for pharmacies, nearly 60% was from injectables and a further one-third was from oral contraceptives. The majority of CYP share from general retailers was from oral contraceptives (about 60%) with another one-quarter from injectables. IDV market share was predominantly from injectables.

www.FPwatch.info Page 35

Figure A8. Percentage of outlets with selected contraceptive services available – Myanmar, 2016 Among all screened outlets, among outlets screened, by outlet type

100

0 Community Health Private For-Profit Pharmacy General Retailer Itinerant Drug Vendor Worker Health Facility Contraceptive injection service Implant insertion service IUD insertion service Male sterilization Female sterilization

Among all screened outlets, the most common contraceptive service offered was contraceptive injections with about 70% of CHWs, three-quarters of facilities, 10% of pharmacies and one-third of IDVs reporting the provision of contraceptive injection services. Other services were relatively rare, with almost no CHWs and less than 3% of CHWs screened providing implant and/or IUD insertion services, respectively. Less than 5% of facilities screened offered implant insertion services and less than 10% offered IUD insertion services. Very small numbers (about 2%) of facilities screened offered female sterilizations and a handful suggested offering male sterilization services (despite the service being illegal). General retailers did not often provide any services and IDVs did not report any services other than injections.

www.FPwatch.info Page 36

Figure A9. Service readiness to offer provider-dependent contraceptive services – Myanmar, 2016 Among outlets reportedly offering the service, by outlet type

Service readiness is comprised of having a commodity, trained staff and a minimum level of equipment. Among private outlets in Myanmar, almost one-third of both CHWs and general retailers, over three-quarters of private health facilities, almost 60 percent of pharmacies, and less than 3 percent of IDVs that reportedly offer contraceptive injection services were found to meet all three criteria for service readiness. Less than half of CHWs and general retailers and less than 5 percent of IDVs were lacking injection credentials, leading to lower service readiness for contraceptive injections. For contraceptive implant insertions, only not-for-profit and private for-profit health facilities commonly offered this service. Among those facilities, 50 percent of not-for-profit and less than one-quarter of private facilities were found to meet all three criteria for service readiness, primarily due to lacking the physical commodity to provide implant insertions. Among outlets offering IUD services, 16 percent of CHWs, 80 percent of not-for-profit facilities, and slightly under two thirds of private for- profit health facilities were service ready; this was most often due to lack of credentials. Private facilities were also the only outlet type providing female sterilizations; roughly 90 percent of these facilities were service ready to provide female sterilizations.

www.FPwatch.info Page 37

Myanmar Strata

Table B1: Modern contraceptive method market composition: Relative proportion of outlets with 1 or more methods, by outlet type – Myanmar Strata, 2016 Private For- Community Private Not-For- Private Medical Itinerant Drug Private Other Profit Health Pharmacy General Retailer Health Worker Profit Total* Vendor Total* Facility Proportion of outlet types stocking / providing at least 1 modern contraceptive method on the day of % % % % % % % % the survey, of all outlets stocking / (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) providing at least 1 modern contraceptive method†: Any method available, including

condoms only outlets‡ Myanmar Metropolitan 3.2 0.2 27.3 39.0 66.4 30.2 0.0 30.2 N=1,437 (1.8, 5.8) (0.0, 1.0) (23.6, 31.4) (34.3, 44.0) (59.2, 72.9) (24.3, 36.8) (0.0, 0.3) (24.3, 36.8) Myanmar Urban 10.5 0.1 17.7 33.4 51.1 37.7 0.7 38.4 N=2,453 (8.5, 12.8) (0.0, 0.6) (15.5, 20.1) (27.8, 39.4) (45.1, 57.0) (33.0, 42.6) (0.4, 1.2) (33.6, 43.4) Myanmar Rural 30.9 0.1 2.9 4.6 7.5 57.0 4.5 61.5 N=3,021 (28.3, 33.5) (0.0, 0.5) (2.3, 3.6) (3.7, 5.8) (6.2, 9.0) (54.0, 60.0) (3.5, 5.8) (58.7, 64.2) Any method available, excluding

condoms only outlets§ Myanmar Metropolitan 3.2 0.2 28.9 40.5 69.4 27.2 0.0 27.2 N=1,368 (1.8, 5.9) (0.0, 1.1) (24.9, 33.2) (35.5, 45.7) (61.7, 76.1) (21.1, 34.2) (0.0, 0.3) (21.1, 34.3) Myanmar Urban 10.3 0.1 18.1 33.5 51.6 37.2 0.7 37.9 N=2,382 (8.4, 12.6) (0.0, 0.6) (15.9, 20.5) (28.0, 39.5) (45.7, 57.5) (32.6, 42.2) (0.4, 1.2) (33.2, 43.0) Myanmar Rural 29.3 0.1 3.0 4.7 7.7 58.3 4.6 62.8 N=2,930 (26.9, 31.9) (0.0, 0.5) (2.4, 3.8) (3.8, 5.9) (6.4, 9.2) (55.2, 61.3) (3.5, 5.9) (60.1, 65.5) * Private Medical Total category = community health worker + private not-for-profit + private for-profit health facility + pharmacy categories; Private Other Total category = general retailer + itinerant drug vendor categories † Contraceptive commodity-stocking outlets have at least one family planning commodity in stock on the day of the survey, verified by the presence of at least one family planning commodity recorded in an audit sheet. There were 19 family planning commodity-stocking outlets in Myanmar with partially completed interviews, which were excluded from the denominator (12 from metro stratum, 2 from urban stratum and 5 from rural stratum). ‡ Includes: male condoms, female condoms, cyclebeads, vaginal pessaries, oral contraceptives, emergency contraceptive pills, contraceptive injectables, contraceptive implants and/or IUDs. Cyclebeads, vaginal pessaries, birth control patches, diaphragms or vaginal rings were not found in Myanmar by the FPwatch study. § Includes: oral contraceptives, emergency contraceptive pills, contraceptive injectables, contraceptive implants and/or IUDs. Source: FPwatch Outlet Survey, Myanmar, 2016

www.FPwatch.info Page 38

Table B2: Availability of modern contraceptive method categories, among outlets screened, by outlet type – Myanmar Strata, 2016 Community Private Not-For- Private For-Profit Private Medical Itinerant Drug Private Other Pharmacy General Retailer Health Worker Profit Health Facility Total* Vendor Total* % % % % % % % %

(95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) Metro N=63 Metro N=1 Metro N=522 Metro N=657 Metro N=1,243 Metro N=6,136 Metro N=1 Metro N=6,137 Proportion of outlets screened, Urban N=357 Urban N=2 Urban N=626 Urban N=767 Urban N=1,752 Urban N=12,627 Urban N=58 Urban N=12,685 currently stocking / providing†: Rural N=1,478 Rural N=4 Rural N=163 Rural N=237 Rural N=1,882 Rural N=12,605 Rural N=419 Rural N=13,024 Any modern method 55.3 100.0 70.5 90.9 79.5 7.1 100.0 7.1 Myanmar Metropolitan (32.0, 76.4) - (61.2, 78.3) (86.5, 93.9) (73.3, 84.5) (5.6, 8.9) - (5.6, 9.0) 58.6 69.0 72.1 93.0 78.6 7.5 23.6 7.5 Myanmar Urban (52.1, 64.9) (13.8, 96.9) (68.0, 75.8) (90.6, 94.8) (75.4, 81.4) (6.6, 8.4) (14.2, 36.6) (6.7, 8.5) 54.3 81.7 83.5 92.1 58.8 14.1 25.9 14.6 Myanmar Rural (50.8, 57.8) (33.8, 97.5) (76.4, 88.8) (85.4, 95.9) (55.5, 62.0) (13.0, 15.3) (20.6, 32.1) (13.5, 15.8) Any short-acting method 55.3 100.0 70.3 90.9 79.4 7.1 100.0 7.1 Myanmar Metropolitan (32.0, 76.4) - (61.0, 78.1) (86.5, 93.9) (73.2, 84.4) (5.6, 8.9) - (5.6, 9.0) 58.6 69.0 71.6 93.0 78.4 7.5 23.6 7.5 Myanmar Urban (52.1, 64.9) (13.8, 96.9) (67.5, 75.4) (90.6, 94.8) (75.3, 81.3) (6.6, 8.4) (14.2, 36.6) (6.7, 8.5) 54.3 81.7 83.5 92.1 58.8 14.1 25.9 14.6 Myanmar Rural (50.8, 57.8) (33.8, 97.5) (76.4, 88.8) (85.4, 95.9) (55.5, 62.0) (13.0, 15.3) (20.6, 32.1) (13.5, 15.8) Any LARC method 3.2 100.0 3.2 0.1 1.9 0.0 0.0 0.0 Myanmar Metropolitan (0.6, 15.6) - (2.0, 5.2) (0.0, 0.9) (1.1, 3.2) - - - 2.4 69.0 6.4 1.1 3.2 0.0 0.0 0.0 Myanmar Urban (1.1, 4.8) (13.8, 96.9) (4.4, 9.1) (0.5, 2.7) (2.3, 4.3) (0.0, 0.1) - (0.0, 0.1) 1.6 0.0 5.4 0.3 1.7 0.0 0.0 0.0 Myanmar Rural (1.0, 2.5) - (2.2, 12.8) (0.0, 1.6) (1.1, 2.5) (0.0, 0.1) - (0.0, 0.1) Any permanent method 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 Myanmar Metropolitan - - (0.2, 1.9) - (0.1, 0.8) - - - 0.1 0.0 3.6 0.0 1.2 0.0 0.0 0.0 Myanmar Urban (0.0, 0.9) - (2.1, 6.0) - (0.7, 2.0) - - - 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 Myanmar Rural (0.0, 0.1) - (0.2, 5.9) - (0.0, 0.3) - - - Any LA/PM 3.2 100.0 3.3 0.1 1.9 0.0 0.0 0.0 Myanmar Metropolitan (0.6, 15.6) - (2.0, 5.3) (0.0, 0.9) (1.1, 3.2) - - - 2.5 69.0 8.1 1.1 3.7 0.0 0.0 0.0 Myanmar Urban (1.2, 4.9) (13.8, 96.9) (5.8, 11.2) (0.5, 2.7) (2.7, 5.2) (0.0, 0.1) - (0.0, 0.1)

www.FPwatch.info Page 39

www.FPwatch.info Page 40

Table B3: Availability of selected contraceptive methods, among outlets screened, by outlet type – Myanmar Strata, 2016 Community Private Not-For- Private For-Profit Private Medical Itinerant Drug Private Other Pharmacy General Retailer Health Worker Profit Health Facility Total* Vendor Total* % % % % % % % %

contraceptives 23.7 100.0 36.7 87.2 60.6 3.6 0.0 3.6 Myanmar Metropolitan (12.3, 40.9) - (30.1, 43.8) (83.0, 90.4) (55.5, 65.6) (2.7, 4.6) - (2.7, 4.6) 26.4 69.0 34.2 84.3 55.4 4.1 5.1 4.1 Myanmar Urban (20.8, 32.8) (13.8, 96.9) (30.5, 38.1) (81.2, 86.9) (51.5, 59.2) (3.5, 4.7) (1.4, 16.7) (3.5, 4.7) 24.0 81.7 31.0 75.8 28.5 6.0 3.4 5.9 Myanmar Rural (21.2, 27.0) (33.8, 97.5) (22.7, 40.7) (66.9, 83.0) (25.6, 31.5) (5.4, 6.8) (2.0, 5.5) (5.3, 6.7) Progestin-only pills 3.7 0.0 7.6 33.5 20.0 3.7 0.0 3.7 Myanmar Metropolitan (1.3, 10.2) - (5.3, 10.6) (28.6, 38.7) (16.8, 23.6) (2.5, 5.3) - (2.5, 5.3) 5.4 0.0 5.0 33.0 17.9 4.9 2.9 4.9 Myanmar Urban (2.5, 11.4) - (3.3, 7.3) (27.8, 38.7) (15.2, 20.9) (4.2, 5.8) (0.8, 10.3) (4.2, 5.8)

www.FPwatch.info Page 41

(All DMPA) 42.1 100.0 65.9 23.0 43.4 0.3 100.0 0.3 Myanmar Metropolitan (27.0, 58.9) - (57.4, 73.5) (19.2, 27.4) (39.0, 47.8) (0.1, 1.1) - (0.1, 1.1) 54.1 69.0 67.9 61.0 61.6 0.5 22.3 0.6 Myanmar Urban (48.4, 59.7) (13.8, 96.9) (63.7, 71.8) (56.4, 65.4) (58.9, 64.2) (0.3, 0.8) (13.1, 35.4) (0.4, 0.9) 45.1 81.7 81.4 72.8 49.2 2.6 24.5 3.5 Myanmar Rural (41.3, 48.9) (33.8, 97.5) (74.0, 87.1) (65.0, 79.5) (45.6, 52.9) (2.2, 3.2) (19.4, 30.6) (3.0, 4.1) 3 month DMPA

injectables 42.1 100.0 65.7 23.0 43.3 0.3 100.0 0.3 Myanmar Metropolitan (27.0, 58.9) - (57.2, 73.3) (19.2, 27.4) (39.0, 47.7) (0.1, 1.1) - (0.1, 1.1) 54.1 69.0 67.9 61.0 61.6 0.5 22.3 0.6 Myanmar Urban (48.4, 59.7) (13.8, 96.9) (63.7, 71.8) (56.4, 65.4) (58.9, 64.2) (0.3, 0.8) (13.1, 35.4) (0.4, 0.9) 45.1 81.7 81.4 72.8 49.2 2.6 24.5 3.5 Myanmar Rural (41.3, 48.9) (33.8, 97.5) (74.0, 87.1) (65.0, 79.5) (45.6, 52.9) (2.2, 3.2) (19.4, 30.6) (3.0, 4.1) 1 month DMPA

injectables 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 Myanmar Metropolitan - - (0.0, 0.9) - (0.0, 0.4) - - - 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 Myanmar Urban - - (0.1, 0.9) - (0.0, 0.3) (0.0, 0.1) - (0.0, 0.1) 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 Myanmar Rural - - (0.3, 5.7) - (0.0, 0.3) - - - Contraceptive implants

www.FPwatch.info Page 42

www.FPwatch.info Page 43

Table B4: Availability of modern contraceptive method diversity, among outlets screened, by outlet type – Myanmar Strata, 2016 Community Private Not-For- Private For-Profit Private Medical Itinerant Drug Private Other Pharmacy General Retailer Health Worker Profit Health Facility Total* Vendor Total* % % % % % % % %

(95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) Proportion of outlets Metro N=63 Metro N=1 Metro N=522 Metro N=657 Metro N=1,243 Metro N=6,136 Metro N=1 Metro N=6,137 screened, currently Urban N=357 Urban N=2 Urban N=626 Urban N=767 Urban N=1,752 Urban N=12,627 Urban N=58 Urban N=12,685 stocking / providing†: Rural N=1,478 Rural N=4 Rural N=163 Rural N=237 Rural N=1,882 Rural N=12,605 Rural N=419 Rural N=13,024 3+ methods‡ 6.0 100.0 19.9 37.2 27.6 0.2 0.0 0.2 Myanmar Metropolitan (2.0, 16.6) - (14.7, 26.3) (32.3, 42.5) (23.8, 31.7) (0.1, 0.4) - (0.1, 0.4) 10.8 69.0 18.9 56.4 34.3 0.2 0.0 0.2 Myanmar Urban (7.1, 16.0) (13.8, 96.9) (15.8, 22.3) (51.5, 61.1) (30.4, 38.3) (0.1, 0.4) - (0.1, 0.4) 9.1 0.0 15.3 35.0 11.3 0.2 0.5 0.2 Myanmar Rural (7.3, 11.1) - (9.8, 23.2) (27.0, 43.9) (9.6, 13.4) (0.1, 0.3) (0.2, 1.3) (0.2, 0.3) 3+ methods with LARC 2.7 100.0 2.4 0.1 1.5 0.0 0.0 0.0 Myanmar Metropolitan (0.4, 16.6) - (1.3, 4.5) (0.0, 0.9) (0.8, 2.8) - - - 2.0 69.0 4.9 1.1 2.6 0.0 0.0 0.0 Myanmar Urban (0.9, 4.4) (13.8, 96.9) (3.3, 7.4) (0.5, 2.7) (1.9, 3.7) (0.0, 0.1) - (0.0, 0.1) 1.4 0.0 4.7 0.3 1.5 0.0 0.0 0.0 Myanmar Rural (0.9, 2.3) - (1.7, 12.5) (0.0, 1.6) (1.0, 2.3) (0.0, 0.1) - (0.0, 0.1) 3+ methods with LA/PM 2.7 100.0 2.5 0.1 1.5 0.0 0.0 0.0 Myanmar Metropolitan (0.4, 16.7) - (1.4, 4.6) (0.0, 0.9) (0.8, 2.8) - - - 2.1 69.0 6.0 1.1 3.0 0.0 0.0 0.0 Myanmar Urban (1.0, 4.5) (13.8, 96.9) (4.1, 8.6) (0.5, 2.7) (2.1, 4.2) (0.0, 0.1) - (0.0, 0.1) 1.4 0.0 4.8 0.3 1.5 0.0 0.0 0.0 Myanmar Rural (0.9, 2.3) - (1.7, 12.6) (0.0, 1.6) (1.0, 2.3) (0.0, 0.1) - (0.0, 0.1) 5+ methods§ 0.0 100.0 1.0 0.1 0.6 0.0 0.0 0.0 Myanmar Metropolitan - - (0.4, 2.5) (0.0, 0.5) (0.3, 1.5) - - - 0.0 69.0 2.4 0.8 1.2 0.0 0.0 0.0 Myanmar Urban - (13.8, 96.9) (1.2, 4.7) (0.3, 2.0) (0.7, 2.1) (0.0, 0.1) - (0.0, 0.1) 0.3 0.0 0.5 0.0 0.3 0.0 0.0 0.0 Myanmar Rural (0.1, 0.6) - (0.1, 2.0) - (0.1, 0.5) - - - * Private Medical Total category = community health worker + private not-for-profit + private for-profit health facility + pharmacy categories; Private Other Total category = general retailer + itinerant drug vendor categories † There were 19 family planning commodity-stocking outlets in Myanmar with partially completed interviews, which were excluded from the denominator (12 from metro stratum, 2 from urban stratum and 5 from rural stratum). ‡ 3 or more among: male condom, female condom, oral contraceptive, emergency contraceptive, contraceptive injectable, contraceptive implant, IUD commodities and/or male sterilization, female sterilization services. No other modern contraceptive methods were found in sampled outlets. § 5 or more among: male condom, female condom, oral contraceptive, emergency contraceptive, contraceptive injectable, contraceptive implant, IUD commodities and/or male sterilization, female sterilization services. No

www.FPwatch.info Page 44

www.FPwatch.info Page 45

Table B5: Current stock out of selected modern contraceptive commodities on day of survey, among outlets reportedly stocking method in previous 3 months, by outlet type – Myanmar Strata, 2016 Community Private Not-For- Private For-Profit Private Medical Itinerant Drug Private Other Pharmacy General Retailer Health Worker Profit Health Facility Total* Vendor Total* Proportion of outlets reportedly stocking % % % % % % % % method in previous 3 (95% CI) (n) (95% CI) (n) (95% CI) (n) (95% CI) (n) (95% CI) (n) (95% CI) (n) (95% CI) (n) (95% CI) (n) months, currently stocked out of†,‡: Oral contraceptives 4.3 0.0 7.2 2.4 3.8 10.5 - 10.5 Myanmar Metropolitan [1.0, 17.4] (19) (1) [4.4, 11.8] (215) [1.2, 4.7] (609) [2.4, 6.0] (844) [6.4, 16.8] (344) - [6.4, 16.8] (344) 18.6 0.0 14.2 5.1 8.6 10.9 0.0 10.8 Myanmar Urban [10.7, 30.2] (109) (1) [9.8, 20.2] (271) [3.1, 8.4] (709) [6.4, 11.5] (1,090) [8.9, 13.3] (1,113) [0.0, 0.0] (4) [8.8, 13.2] (1,117) 21.0 18.3 10.5 1.3 16.9 16.2 28.0 16.4 Myanmar Rural [16.4, 26.4] (479) [2.5, 66.2] (4) [4.8, 21.6] (62) [0.6, 3.1] (211) [13.3, 21.3] (756) [14.3, 18.2] (1,917) [14.9, 46.3] (39) [14.5, 18.4] (1,956) Emergency contraceptives 0.0 0.0 3.9 10.2 8.5 12.2 - 12.2 Myanmar Metropolitan (1) (1) [1.6, 9.2] (88) [6.8, 15.0] (276) [5.8, 12.3] (366) [5.7, 24.2] (50) - [5.7, 24.2] (50) 47.3 0.0 16.9 13.2 15.0 15.8 - 15.8 Myanmar Urban [23.6, 72.3] (18) (1) [10.2, 26.5] (95) [10.3, 16.8] (393) [12.0, 18.6] (507) [6.1, 35.1] (51) - [6.1, 35.1] (51) 14.1 - 14.3 4.6 11.1 28.8 46.0 33.4 Myanmar Rural [6.7, 27.1] (60) - [4.2, 38.7] (13) [1.8, 11.3] (64) [6.3, 19.0] (137) [10.3, 58.8] (18) [16.4, 78.7] (7) [16.2, 56.6] (25) Contraceptive injectables 5.8 0.0 2.1 9.1 4.3 3.0 0.0 2.9 Myanmar Metropolitan [1.3, 21.9] (34) (1) [1.0, 4.4] (376) [5.5, 14.9] (189) [2.7, 6.7] (600) [0.3, 25.6] (9) (1) [0.3, 24.4] (10) 10.7 0.0 7.4 9.0 8.7 6.8 21.0 10.1 Myanmar Urban [6.5, 17.1] (210) (1) [5.0, 10.7] (469) [6.7, 11.9] (495) [7.1, 10.7] (1,175) [2.5, 17.2] (48) [9.0, 41.7] (19) [5.1, 19.2] (67) 14.2 18.3 4.2 3.6 12.3 19.8 25.4 21.5 Myanmar Rural [11.6, 17.2] (798) [2.5, 66.2] (4) [1.6, 10.8] (139) [1.6, 7.9] (181) [10.2, 14.8] (1,122) [14.5, 26.5] (382) [12.8, 44.0] (128) [16.4, 27.7] (510) Contraceptive implants ------Myanmar Metropolitan ------0.0 25.7 - 21.7 - - - Myanmar Urban - (1) [8.1, 57.7] (14) - [7.0, 50.3] (15) ------Myanmar Rural ------IUDs 0.0 0.0 6.2 0.0 4.7 - - - Myanmar Metropolitan [0.0, 0.0] (2) (1) [0.9, 31.9] (16) (1) [0.7, 26.0] (20) - - - Myanmar Urban 37.3 0.0 4.8 15.3 14.3 0.0 - 0.0

www.FPwatch.info Page 46

Table B5: Current stock out of selected modern contraceptive commodities on day of survey, among outlets reportedly stocking method in previous 3 months, by outlet type – Myanmar Strata, 2016 Community Private Not-For- Private For-Profit Private Medical Itinerant Drug Private Other Pharmacy General Retailer Health Worker Profit Health Facility Total* Vendor Total* Proportion of outlets reportedly stocking % % % % % % % % method in previous 3 (95% CI) (n) (95% CI) (n) (95% CI) (n) (95% CI) (n) (95% CI) (n) (95% CI) (n) (95% CI) (n) (95% CI) (n) months, currently stocked out of†,‡: [14.0, 68.6] (13) (1) [1.5, 13.9] (40) [4.2, 42.4] (9) [6.6, 28.3] (63) (1) - (1) 6.9 - 0.0 45.2 6.7 0.0 - 0.0 Myanmar Rural [1.4, 28.3] (29) - [0.0, 0.0] (7) [6.0, 91.5] (2) [1.6, 23.5] (38) (1) - (1) * Private Medical Total category = community health worker + private not-for-profit + private for-profit health facility + pharmacy categories; Private Other Total category = general retailer + itinerant drug vendor categories † This indicator is among all screened outlets that reportedly stocked the method in the previous 3 months. It does not account for whether the outlet is expected to provide the commodity according to national regulations. It is a point-in-time stock out indicator from https://www.rhsupplies.org/fileadmin/uploads/rhsc/Issues/Addressing_Stockouts/Takestock/Documents/Using_the_Power_of_Partnership_to_Speak_the_Same_Language_on_Stockouts.pdf. It is defined as the percentage of facilities reporting that they have stocked the method in the previous 3 months but were stocked out on the day of the assessment. ‡ There were 19 family planning commodity-stocking outlets in Myanmar with partially completed interviews, which were excluded from the denominator (12 from metro stratum, 2 from urban stratum and 5 from rural stratum). Source: FPwatch Outlet Survey, Myanmar, 2016

www.FPwatch.info Page 47

Table B6: Median price of selected modern contraceptive methods in Myanmar Kyat , USD and USD per CYP, by private outlet type, Myanmar Strata – 2016 Community Health Private For-Profit Private Medical Itinerant Drug Private Other Pharmacy General Retailer Worker Health Facility Total* Vendor Total*

Median price of method, with Median Median Median Median Median Median Median interquartile range†,‡: [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) Male condoms Myanmar Kyat 0 0 67 67 167 0 133 per condom [0, 0] (5) [0, 67] (40) [50, 67] (124) [33, 67] (169) [67, 267] (83) (1) [67, 267] (84) Myanmar 0.00 0.00 0.05 0.05 0.14 0.00 0.11 USD per condom§ Metropolitan [0.00, 0.00] (5) [0.00, 0.05] (40) [0.04, 0.05] (124) [0.03, 0.05] (169) [0.05, 0.22] (83) (1) [0.05, 0.22] (84) 0.00 0.00 6.60 6.60 16.50 0.00 13.20 USD per CYP∞ [0.00, 0.00] (5) [0.00, 6.60] (40) [4.95, 6.60] (124) [3.30, 6.60] (169) [6.60, 26.40] (83) (1) [6.60, 26.40] (84) Myanmar Kyat 0 0 67 67 67 0 67 per condom [0, 0] (29) [0, 50] (58) [50, 67] (143) [0, 67] (230) [50, 67] (93) (1) [50, 67] (94) Myanmar 0.00 0.00 0.05 0.05 0.05 0.00 0.05 USD per condom Urban [0.00, 0.00] (29) [0.00, 0.04] (58) [0.04, 0.05] (143) [0.00, 0.05] (230) [0.04, 0.05] (93) (1) [0.04, 0.05] (94) 0.00 0.00 6.60 6.60 6.60 0.00 6.60 USD per CYP [0.00, 0.00] (29) [0.00, 4.95] (58) [4.95, 6.60] (143) [0.00, 6.60] (230) [4.95, 6.60] (93) (1) [4.95, 6.60] (94) Myanmar Kyat 0 0 67 0 50 33 50 per condom [0, 0] (160) [0, 0] (11) [38, 67] (38) [0, 0] (209) [5, 67] (51) [0, 67] (10) [0, 67] (61) Myanmar 0.00 0.00 0.05 0.00 0.04 0.03 0.04 USD per condom Rural [0.00, 0.00] (160) [0.00, 0.00] (11) [0.03, 0.05] (38) [0.00, 0.00] (209) [0.00, 0.05] (51) [0.00, 0.05] (10) [0.00, 0.05] (61) 0.00 0.00 6.60 0.00 4.95 3.30 4.95 USD per CYP [0.00, 0.00] (160) [0.00, 0.00] (11) [3.71, 6.60] (38) [0.00, 0.00] (209) [0.50, 6.60] (51) [0.00, 6.60] (10) [0.00, 6.60] (61) Female condoms

Myanmar Kyat - 0 0 0 - - - per condom - (1) (1) [0, 0] (2) - - - Myanmar - 0.00 0.00 0.00 - - - USD per condom Metropolitan - (1) (1) [0.00, 0.00] (2) - - - - 0.00 0.00 0.00 - - - USD per CYP - (1) (1) [0.00, 0.00] (2) - - - Myanmar Kyat 0 0 300 0 - - - per condom (1) [0, 0] (3) [200, 300] (2) [0, 0] (6) - - - Myanmar 0.00 0.00 0.25 0.00 - - - USD per condom Urban (1) [0.00, 0.00] (3) [0.17, 0.25] (2) [0.00, 0.00] (6) - - - 0.00 0.00 29.70 0.00 - - - USD per CYP (1) [0.00, 0.00] (3) [19.80, 29.70] (2) [0.00, 0.00] (6) - - - Myanmar Myanmar Kyat 0 0 - 0 - - - Rural per condom [0, 0] (6) (1) - [0, 0] (7) - - -

www.FPwatch.info Page 48

Median price of method, with Median Median Median Median Median Median Median interquartile range†,‡: [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) 0.00 0.00 - 0.00 - - - USD per condom [0.00, 0.00] (6) (1) - [0.00, 0.00] (7) - - - 0.00 0.00 - 0.00 - - - USD per CYP [0.00, 0.00] (6) (1) - [0.00, 0.00] (7) - - - Oral contraceptives Myanmar Kyat 0 500 600 600 500 - 500 per cycle [0, 500] (29) [500, 1000] (337) [450, 1500] (1,739) [450, 1000] (2,107) [200, 600] (544) - [200, 600] (544) Myanmar 0.00 0.41 0.50 0.50 0.41 - 0.41 USD per cycle Metropolitan [0.00, 0.41] (29) [0.41, 0.82] (337) [0.37, 1.24] (1,739) [0.37, 0.82] (2,107) [0.17, 0.50] (544) - [0.17, 0.50] (544) 0.00 6.19 7.43 7.43 6.19 - 6.19 USD per CYP [0.00, 6.19] (29) [6.19, 12.38] (337) [5.57, 18.56] (1,739) [5.57, 12.38] (2,107) [2.48, 7.43] (544) - [2.48, 7.43] (544) Myanmar Kyat 400 500 500 500 300 450 300 per cycle [0, 500] (125) [500, 900] (366) [400, 800] (1,722) [400, 700] (2,215) [200, 500] (1,517) [150, 600] (6) [200, 500] (1,523) Myanmar 0.33 0.41 0.41 0.41 0.25 0.37 0.25 USD per cycle Urban [0.00, 0.41] (125) [0.41, 0.74] (366) [0.33, 0.66] (1,722) [0.33, 0.58] (2,215) [0.17, 0.41] (1,517) [0.12, 0.50] (6) [0.17, 0.41] (1,523) 4.95 6.19 6.19 6.19 3.71 5.57 3.71 USD per CYP [0.00, 6.19] (125) [6.19, 11.14] (366) [4.95, 9.90] (1,722) [4.95, 8.66] (2,215) [2.48, 6.19] (1,517) [1.86, 7.43] (6) [2.48, 6.19] (1,523) Myanmar Kyat 200 500 500 300 250 400 250 per cycle [0, 500] (517) [250, 500] (75) [250, 600] (492) [0, 500] (1,089) [200, 500] (2,230) [200, 500] (39) [200, 500] (2,269) Myanmar 0.17 0.41 0.41 0.25 0.21 0.33 0.21 USD per cycle Rural [0.00, 0.41] (517) [0.21, 0.41] (75) [0.21, 0.50] (492) [0.00, 0.41] (1,089) [0.17, 0.41] (2,230) [0.17, 0.41] (39) [0.17, 0.41] (2,269) 2.48 6.19 6.19 3.71 3.09 4.95 3.09 USD per CYP [0.00, 6.19] (517) [3.09, 6.19] (75) [3.09, 7.43] (492) [0.00, 6.19] (1,089) [2.48, 6.19] (2,230) [2.48, 6.19] (39) [2.48, 6.19] (2,269) Combined oral contraceptives Myanmar Kyat 0 600 600 600 550 - 550 per cycle [0, 500] (25) [500, 1500] (293) [500, 2100] (1,472) [500, 1600] (1,792) [500, 700] (334) - [500, 700] (334) Myanmar 0.00 0.50 0.50 0.50 0.45 - 0.45 USD per cycle Metropolitan [0.00, 0.41] (25) [0.41, 1.24] (293) [0.41, 1.73] (1,472) [0.41, 1.32] (1,792) [0.41, 0.58] (334) - [0.41, 0.58] (334) 0.00 7.43 7.43 7.43 6.81 - 6.81 USD per CYP [0.00, 6.19] (25) [6.19, 18.56] (293) [6.19, 25.99] (1,472) [6.19, 19.80] (1,792) [6.19, 8.66] (334) - [6.19, 8.66] (334) Myanmar Kyat 500 500 500 500 500 450 500 Myanmar per cycle [0, 500] (111) [500, 900] (335) [450, 950] (1,461) [450, 800] (1,909) [450, 600] (841) [450, 600] (4) [450, 600] (845) Urban 0.41 0.41 0.41 0.41 0.41 0.37 0.41 USD per cycle [0.00, 0.41] (111) [0.41, 0.74] (335) [0.37, 0.78] (1,461) [0.37, 0.66] (1,909) [0.37, 0.50] (841) [0.37, 0.50] (4) [0.37, 0.50] (845)

www.FPwatch.info Page 49

Median price of method, with Median Median Median Median Median Median Median interquartile range†,‡: [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) 6.19 6.19 6.19 6.19 6.19 5.57 6.19 USD per CYP [0.00, 6.19] (111) [6.19, 11.14] (335) [5.57, 11.76] (1,461) [5.57, 9.90] (1,909) [5.57, 7.43] (841) [5.57, 7.43] (4) [5.57, 7.43] (845) Myanmar Kyat 0 500 500 400 500 500 500 per cycle [0, 500] (455) [450, 600] (64) [500, 700] (385) [0, 500] (909) [450, 600] (955) [300, 600] (27) [450, 600] (982) Myanmar 0.00 0.41 0.41 0.33 0.41 0.41 0.41 USD per cycle Rural [0.00, 0.41] (455) [0.37, 0.50] (64) [0.41, 0.58] (385) [0.00, 0.41] (909) [0.37, 0.50] (955) [0.25, 0.50] (27) [0.37, 0.50] (982) 0.00 6.19 6.19 4.95 6.19 6.19 6.19 USD per CYP [0.00, 6.19] (455) [5.57, 7.43] (64) [6.19, 8.66] (385) [0.00, 6.19] (909) [5.57, 7.43] (955) [3.71, 7.43] (27) [5.57, 7.43] (982) Progestin, only pills Myanmar Kyat 250 200 200 200 200 - 200 per cycle [150, 300] (4) [150, 500] (44) [150, 300] (267) [150, 300] (315) [150, 250] (210) - [150, 250] (210) Myanmar 0.21 0.17 0.17 0.17 0.17 - 0.17 USD per cycle Metropolitan [0.12, 0.25] (4) [0.12, 0.41] (44) [0.12, 0.25] (267) [0.12, 0.25] (315) [0.12, 0.21] (210) - [0.12, 0.21] (210) 3.09 2.48 2.48 2.48 2.48 - 2.48 USD per CYP [1.86, 3.71] (4) [1.86, 6.19] (44) [1.86, 3.71] (267) [1.86, 3.71] (315) [1.86, 3.09] (210) - [1.86, 3.09] (210) Myanmar Kyat 200 200 200 200 200 150 200 per cycle [150, 200] (14) [200, 1000] (31) [150, 200] (261) [150, 200] (306) [150, 200] (676) [150, 150] (2) [150, 200] (678) Myanmar 0.17 0.17 0.17 0.17 0.17 0.12 0.17 USD per cycle Urban [0.12, 0.17] (14) [0.17, 0.82] (31) [0.12, 0.17] (261) [0.12, 0.17] (306) [0.12, 0.17] (676) [0.12, 0.12] (2) [0.12, 0.17] (678) 2.48 2.48 2.48 2.48 2.48 1.86 2.48 USD per CYP [1.86, 2.48] (14) [2.48, 12.38] (31) [1.86, 2.48] (261) [1.86, 2.48] (306) [1.86, 2.48] (676) [1.86, 1.86] (2) [1.86, 2.48] (678) Myanmar Kyat 200 200 200 200 200 200 200 per cycle [200, 300] (58) [150, 250] (11) [150, 250] (107) [150, 250] (176) [150, 250] (1,275) [200, 200] (12) [150, 250] (1,287) Myanmar 0.17 0.17 0.17 0.17 0.17 0.17 0.17 USD per cycle Rural [0.17, 0.25] (58) [0.12, 0.21] (11) [0.12, 0.21] (107) [0.12, 0.21] (176) [0.12, 0.21] (1,275) [0.17, 0.17] (12) [0.12, 0.21] (1,287) 2.48 2.48 2.48 2.48 2.48 2.48 2.48 USD per CYP [2.48, 3.71] (58) [1.86, 3.09] (11) [1.86, 3.09] (107) [1.86, 3.09] (176) [1.86, 3.09] (1,275) [2.48, 2.48] (12) [1.86, 3.09] (1,287) Emergency contraceptives Myanmar Kyat 1000 1000 900 900 1000 - 1000 per dose (1) [800, 1000] (85) [800, 1000] (311) [800, 1000] (398) [1000, 1050] (42) - [1000, 1050] (42) Myanmar 0.82 0.82 0.74 0.74 0.82 - 0.82 USD per dose Metropolitan (1) [0.66, 0.82] (85) [0.66, 0.82] (311) [0.66, 0.82] (398) [0.82, 0.87] (42) - [0.82, 0.87] (42) 16.50 16.50 14.85 14.85 16.50 - 16.50 USD per CYP (1) [13.20, 16.50] (85) [13.20, 16.50] (311) [13.20, 16.50] (398) [16.50, 17.32] (42) - [16.50, 17.32] (42)

www.FPwatch.info Page 50

Median price of method, with Median Median Median Median Median Median Median interquartile range†,‡: [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) Myanmar Kyat 0 850 900 900 1000 - 1000 per dose [0, 1000] (11) [500, 1000] (83) [700, 1000] (449) [700, 1000] (544) [850, 1000] (47) - [850, 1000] (47) Myanmar 0.00 0.70 0.74 0.74 0.82 - 0.82 USD per dose Urban [0.00, 0.82] (11) [0.41, 0.82] (83) [0.58, 0.82] (449) [0.58, 0.82] (544) [0.70, 0.82] (47) - [0.70, 0.82] (47) 0.00 14.03 14.85 14.85 16.50 - 16.50 USD per CYP [0.00, 16.50] (11) [8.25, 16.50] (83) [11.55, 16.50] (449) [11.55, 16.50] (544) [14.03, 16.50] (47) - [14.03, 16.50] (47) Myanmar Kyat 0 900 1000 650 1000 700 1000 per dose [0, 500] (51) [650, 1000] (10) [950, 1000] (61) [0, 1000] (122) [1000, 1200] (12) [0, 1500] (3) [1000, 1200] (15) Myanmar 0.00 0.74 0.82 0.54 0.82 0.58 0.82 USD per dose Rural [0.00, 0.41] (51) [0.54, 0.82] (10) [0.78, 0.82] (61) [0.00, 0.82] (122) [0.82, 0.99] (12) [0.00, 1.24] (3) [0.82, 0.99] (15) 0.00 14.85 16.50 10.73 16.50 11.55 16.50 USD per CYP [0.00, 8.25] (51) [10.73, 16.50] (10) [15.68, 16.50] (61) [0.00, 16.50] (122) [16.50, 19.80] (12) [0.00, 24.75] (3) [16.50, 19.80] (15) Contraceptive injectables Myanmar Kyat 1000 1500 550 1500 500 1000 500 per dose [500, 1500] (31) [1300, 2000] (384) [500, 600] (188) [580, 1500] (604) [500, 500] (8) (1) [500, 500] (9) Myanmar 0.82 1.24 0.45 1.24 0.41 0.82 0.41 USD per dose Metropolitan [0.41, 1.24] (31) [1.07, 1.65] (384) [0.41, 0.50] (188) [0.48, 1.24] (604) [0.41, 0.41] (8) (1) [0.41, 0.41] (9) 3.30 4.95 1.82 4.95 1.65 3.30 1.65 USD per CYP [1.65, 4.95] (31) [4.29, 6.60] (384) [1.65, 1.98] (188) [1.91, 4.95] (604) [1.65, 1.65] (8) (1) [1.65, 1.65] (9) Myanmar Kyat 1000 1500 550 850 500 1000 550 per dose [600, 1200] (220) [1000, 1750] (462) [500, 700] (584) [540, 1500] (1,267) [450, 600] (49) [1000, 1500] (14) [450, 1000] (63) Myanmar 0.82 1.24 0.45 0.70 0.41 0.82 0.45 USD per dose Urban [0.50, 0.99] (220) [0.82, 1.44] (462) [0.41, 0.58] (584) [0.45, 1.24] (1,267) [0.37, 0.50] (49) [0.82, 1.24] (14) [0.37, 0.82] (63) 3.30 4.95 1.82 2.81 1.65 3.30 1.82 USD per CYP [1.98, 3.96] (220) [3.30, 6.60] (462) [1.65, 2.31] (584) [1.82, 4.95] (1,267) [1.49, 1.98] (49) [3.30, 4.95] (14) [1.49, 3.30] (63) Myanmar Kyat 1000 1500 700 1000 700 1000 900 per dose [1000, 1500] (812) [1000, 1500] (144) [550, 1000] (231) [1000, 1500] (1,190) [600, 1000] (368) [1000, 1500] (115) [600, 1000] (483) Myanmar 0.82 1.24 0.58 0.82 0.58 0.82 0.74 USD per dose Rural [0.82, 1.24] (812) [0.82, 1.24] (144) [0.45, 0.82] (231) [0.82, 1.24] (1,190) [0.50, 0.82] (368) [0.82, 1.24] (115) [0.50, 0.82] (483) 3.30 4.95 2.31 3.30 2.31 3.30 2.97 USD per CYP [3.30, 4.95] (812) [3.30, 4.95] (144) [1.82, 3.30] (231) [3.30, 4.95] (1,190) [1.98, 3.30] (368) [3.30, 4.95] (115) [1.98, 3.30] (483) 3 month injectables Myanmar Myanmar Kyat 1000 1500 550 1500 500 1000 500 Metropolitan per dose [500, 1500] (31) [1300, 2000] (383) [500, 600] (188) [580, 1500] (603) [500, 500] (8) (1) [500, 500] (9)

www.FPwatch.info Page 51

Median price of method, with Median Median Median Median Median Median Median interquartile range†,‡: [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) 0.82 1.24 0.45 1.24 0.41 0.82 0.41 USD per dose [0.41, 1.24] (31) [1.07, 1.65] (383) [0.41, 0.50] (188) [0.48, 1.24] (603) [0.41, 0.41] (8) (1) [0.41, 0.41] (9) 3.30 4.95 1.82 4.95 1.65 3.30 1.65 USD per CYP [1.65, 4.95] (31) [4.29, 6.60] (383) [1.65, 1.98] (188) [1.91, 4.95] (603) [1.65, 1.65] (8) (1) [1.65, 1.65] (9) Myanmar Kyat 1000 1500 550 850 500 1000 550 per dose [600, 1200] (220) [1000, 2000] (460) [500, 700] (584) [550, 1500] (1,265) [450, 600] (49) [1000, 1500] (14) [450, 1000] (63) Myanmar 0.82 1.24 0.45 0.70 0.41 0.82 0.45 USD per dose Urban [0.50, 0.99] (220) [0.82, 1.65] (460) [0.41, 0.58] (584) [0.45, 1.24] (1,265) [0.37, 0.50] (49) [0.82, 1.24] (14) [0.37, 0.82] (63) 3.30 4.95 1.82 2.81 1.65 3.30 1.82 USD per CYP [1.98, 3.96] (220) [3.30, 6.60] (460) [1.65, 2.31] (584) [1.82, 4.95] (1,265) [1.49, 1.98] (49) [3.30, 4.95] (14) [1.49, 3.30] (63) Myanmar Kyat 1000 1500 700 1000 700 1000 900 per dose [1000, 1500] (812) [1000, 1500] (143) [550, 1000] (231) [1000, 1500] (1,189) [600, 1000] (368) [1000, 1500] (115) [600, 1000] (483) Myanmar 0.82 1.24 0.58 0.82 0.58 0.82 0.74 USD per dose Rural [0.82, 1.24] (812) [0.82, 1.24] (143) [0.45, 0.82] (231) [0.82, 1.24] (1,189) [0.50, 0.82] (368) [0.82, 1.24] (115) [0.50, 0.82] (483) 3.30 4.95 2.31 3.30 2.31 3.30 2.97 USD per CYP [3.30, 4.95] (812) [3.30, 4.95] (143) [1.82, 3.30] (231) [3.30, 4.95] (1,189) [1.98, 3.30] (368) [3.30, 4.95] (115) [1.98, 3.30] (483) 1 month injectables Myanmar Kyat - 1500 - 1500 - - - per dose - (1) - (1) - - - Myanmar - 1.24 - 1.24 - - - USD per dose Metropolitan - (1) - (1) - - - - 16.09 - 16.09 - - - USD per CYP - (1) - (1) - - - Myanmar Kyat - 1000 - 1000 - - - per dose - [400, 1000] (2) - [400, 1000] (2) - - - Myanmar - 0.82 - 0.82 - - - USD per dose Urban - [0.33, 0.82] (2) - [0.33, 0.82] (2) - - - - 10.72 - 10.72 - - - USD per CYP - [4.29, 10.72] (2) - [4.29, 10.72] (2) - - - Myanmar Kyat - 400 - 400 - - - per dose - (1) - (1) - - - Myanmar - 0.33 - 0.33 - - - Rural USD per dose - (1) - (1) - - - USD per CYP - 4.29 - 4.29 - - -

www.FPwatch.info Page 52

Median price of method, with Median Median Median Median Median Median Median interquartile range†,‡: [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) - (1) - (1) - - - Contraceptive implants Myanmar Kyat ------per dose ------Myanmar ------USD per dose Metropolitan ------USD per CYP ------Myanmar Kyat - 15000 - 15000 - - - per dose - [15000, 18000] (11) - [15000, 18000] (13) - - - Myanmar - 12.38 - 12.38 - - - USD per dose Urban - [12.38, 14.85] (11) - [12.38, 14.85] (13) - - - - 4.95 - 4.95 - - - USD per CYP - [3.26, 4.95] (5) - [3.26, 4.95] (7) - - - Myanmar Kyat ------per dose ------Myanmar ------USD per dose Rural ------USD per CYP ------Implanon implants Myanmar Kyat ------per dose ------Myanmar ------USD per dose Metropolitan ------USD per CYP ------Myanmar Kyat - 15000 - 15000 - - - per dose - [15000, 15000] (3) - [15000, 15000] (4) - - - Myanmar - 12.38 - 12.38 - - - USD per dose Urban - [12.38, 12.38] (3) - [12.38, 12.38] (4) - - - - 4.95 - 4.95 - - - USD per CYP - [4.95, 4.95] (3) - [4.95, 4.95] (4) - - - Myanmar Myanmar Kyat ------

www.FPwatch.info Page 53

Median price of method, with Median Median Median Median Median Median Median interquartile range†,‡: [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) Rural per dose ------

------USD per dose ------USD per CYP ------Jadelle implants Myanmar Kyat ------per dose ------Myanmar ------USD per dose Metropolitan ------USD per CYP ------Myanmar Kyat - 15000 - 15000 - - - per dose - [15000, 15000] (2) - [15000, 15000] (3) - - - Myanmar - 12.38 - 12.38 - - - USD per dose Urban - [12.38, 12.38] (2) - [12.38, 12.38] (3) - - - - 3.26 - 3.26 - - - USD per CYP - [3.26, 3.26] (2) - [3.26, 3.26] (3) - - - Myanmar Kyat ------per dose ------Myanmar ------USD per dose Rural ------USD per CYP ------IUDs Myanmar Kyat 5000 10000 550 5000 - - - per IUD [5000, 5000] (2) [1450, 12500] (13) (1) [1450, 11000] (17) - - - Myanmar 4.13 8.25 0.45 4.13 - - - USD per IUD Metropolitan [4.13, 4.13] (2) [1.20, 10.31] (13) (1) [1.20, 9.07] (17) - - - 0.90 1.79 0.10 0.90 - - - USD per CYP [0.90, 0.90] (2) [0.26, 2.24] (13) (1) [0.26, 1.97] (17) - - - Myanmar Myanmar Kyat 5000 6000 600 5000 0 - 0 Urban per IUD [0, 5000] (8) [3500, 10000] (38) [500, 700] (5) [1000, 7000] (52) (1) - (1)

www.FPwatch.info Page 54

Median price of method, with Median Median Median Median Median Median Median interquartile range†,‡: [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) 4.13 4.95 0.50 4.13 0.00 - 0.00 USD per IUD [0.00, 4.13] (8) [2.89, 8.25] (38) [0.41, 0.58] (5) [0.82, 5.78] (52) (1) - (1) 0.90 1.08 0.11 0.90 0.00 - 0.00 USD per CYP [0.00, 0.90] (8) [0.63, 1.79] (38) [0.09, 0.13] (5) [0.18, 1.26] (52) (1) - (1) Myanmar Kyat 2000 6000 450 3000 800 - 800 per IUD [0, 4000] (19) [3000, 10000] (6) (1) [0, 6000] (26) (1) - (1) Myanmar 1.65 4.95 0.37 2.47 0.66 - 0.66 USD per IUD Rural [0.00, 3.30] (19) [2.47, 8.25] (6) (1) [0.00, 4.95] (26) (1) - (1) 0.36 1.08 0.08 0.54 0.14 - 0.14 USD per CYP [0.00, 0.72] (19) [0.54, 1.79] (6) (1) [0.00, 1.08] (26) (1) - (1) Female sterilization|| ------Myanmar Kyat ------Myanmar ------USD Metropolitan ------USD per CYP ------400000 - 400000 - - - Myanmar Kyat - [200000, 400000] (5) - [200000, 400000] (5) - - - Myanmar - 330.00 - 330.00 - - - USD Urban - [165.00, 330.00] (5) - [165.00, 330.00] (5) - - - - 32.04 - 32.04 - - - USD per CYP - [16.02, 32.04] (5) - [16.02, 32.04] (5) - - - - 0 - 0 - - - Myanmar Kyat - (1) - (1) - - - Myanmar - 0.00 - 0.00 - - - USD Rural - (1) - (1) - - - - 0.00 - 0.00 - - - USD per CYP - (1) - (1) - - - * Private Medical Total category = community health worker + private not-for-profit + private for-profit health facility + pharmacy categories; Private Other Total category = general retailer + itinerant drug vendor categories † Price for all commodities with provider-dependent service (injectables, IUDs) may include a service charge. ‡ The number of family planning products captured in audits sheets with missing price information are as follows: 1,008 male condoms (346 metro, 462 urban, 200 rural), 14 female condoms (6 metro, 4 urban, 4 rural), 152 oral contraceptives(63 metro, 54 urban, 35 rural), 33 emergency contraceptives (13 metro, 10 urban, 10 rural), 47 injectables (17 metro, 19 urban, 11 rural), 0 implants, 32 IUDs (10 metro, 12 urban, 10 rural), 1 male sterilization (1 urban) and 19 female sterilizations (3 metro, 16 urban). § Based on the average rate of exchange from February 26th to May 19th, 2016 of 1,212.121 Myanmar Kyat per 1 USD.

www.FPwatch.info Page 55

Median price of method, with Median Median Median Median Median Median Median interquartile range†,‡: [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) [IQR] (n) ∞ This price is determined for the unit used in CYP conversion factors: condoms: 1 condom; cyclebeads: 1 product/string; vaginal pessaries: 1 tablet; oral contraceptives: 1 cycle or blister package; emergency contraceptives: 1 dose; injectables: 1 dose/injection; IUDs: 1 IUD. CYP – Couple Year Protection is the estimated protection provided by contraceptive methods during a one-year period, based upon the volume of all contraceptives sold or distributed free of charge to clients during that period (see Annex 11).‖ || Male sterilizations are illegal in Myanmar. A small number of outlets did report offering male sterilization services. However, no prices were reported for the procedure. Source: FPwatch Outlet Survey, Myanmar, 2016

www.FPwatch.info Page 56

Table B7: Median markup percentage for selected modern contraceptive commodities with interquartile range, by private outlet type – Myanmar Strata, 2016 Community Health Private For-Profit Private Medical Itinerant Drug Pharmacy General Retailer Private Other Total* Worker Health Facility Total* Vendor Median markup percentage of commodity, with interquartile Median % Median % Median % Median % Median % Median % Median % (n) (n) (n) (n) (n) (n) (n) range†,‡,§: [IQR] [IQR] [IQR] [IQR] [IQR] [IQR] [IQR] Oral contraceptives 0.0 16.1 11.1 11.1 18.4 - 18.4 Myanmar Metropolitan [0.0, 10.0] (28) [8.7, 27.3] (274) [7.7, 20.0] (1,573) [7.7, 20.0] (1,876) [11.1, 33.3] (454) - [11.1, 33.3] (454) 14.3 16.7 12.5 12.5 20.0 7.1 20.0 Myanmar Urban [0.0, 42.9] (109) [8.1, 33.3] (286) [8.7, 25.0] (1,529) [8.3, 25.0] (1,925) [11.1, 33.3] (1,302) [4.7, 9.1] (6) [11.1, 33.3] (1,308) 0.0 20.0 22.2 11.1 25.0 33.3 25.0 Myanmar Rural [0.0, 25.0] (441) [11.1, 36.4] (69) [11.1, 33.3] (461) [0.0, 31.6] (976) [16.3, 38.9] (1,972) [11.1, 40.0] (37) [16.3, 38.9] (2,009) Emergency contraceptives 11.1 17.6 13.2 14.3 11.1 - 11.1 Myanmar Metropolitan (1) [11.1, 33.3] (56) [8.7, 20.0] (275) [9.1, 23.1] (332) [5.9, 18.2] (17) - [5.9, 18.2] (17) 0.0 17.6 12.5 12.5 11.1 - 11.1 Myanmar Urban [0.0, 17.6] (11) [5.9, 33.3] (61) [7.7, 20.5] (397) [7.1, 23.1] (469) [6.7, 17.6] (36) - [6.7, 17.6] (36) 0.0 8.3 17.6 5.9 17.6 40.0 25.0 Myanmar Rural [0.0-11.1] (47) [3.4, 11.1] (9) [11.1, 25.0] (55) [0.0, 16.7] (111) [17.6, 33.3] (10) [0.0, 50.0] (3) [17.6, 33.3] (13) Contraceptive injectables 100.0 200.0 11.1 143.9 0.0 - 0.0 Myanmar Metropolitan [42.9, 140.0] (30) [122.2, 263.6] (306) [10.0, 20.0] (169) [20.0, 212.5] (505) [0.0, 0.0] (8) - [0.0, 0.0] (8) 81.8 172.7 11.1 22.4 11.1 81.8 11.1 Myanmar Urban [33.3, 130.8] (189) [100.0, 233.3] (358) [9.1, 16.7] (529) [10.0, 150.0] (1,076) [7.7, 14.3] (44) [66.7, 172.7] (13) [9.1, 45.5] (57) 100.0 172.7 20.0 100.0 25.0 100.0 33.3 Myanmar Rural [66.7, 166.7] (674) [108.3, 212.5] (129) [11.1, 53.8] (226) [50.0, 163.2] (1,032) [15.4, 42.9] (334) [66.7, 150.0] (111) [18.2, 81.8] (445) Contraceptive implants ------Myanmar Metropolitan ------20.0 - 20.0 - - - Myanmar Urban - [20.0, 140.0] (6) - [20.0, 140.0] (6) ------Myanmar Rural ------IUDs - 20.8 10.0 20.8 - - - Myanmar Metropolitan - [20.8, 657.6] (9) (1) [20.8, 657.6] (10) - - - 233.3 733.3 11.1 400.0 0.0 - 0.0 Myanmar Urban [0.0, 400.0] (6) [257.1, 1100.0] (29) [11.1, 27.3] (3) [36.4, 900.0] (38) (1) - (1) Myanmar Rural 0.0 233.3 12.5 233.3 33.3 - 33.3

www.FPwatch.info Page 57

Table B7: Median markup percentage for selected modern contraceptive commodities with interquartile range, by private outlet type – Myanmar Strata, 2016 Community Health Private For-Profit Private Medical Itinerant Drug Pharmacy General Retailer Private Other Total* Worker Health Facility Total* Vendor Median markup percentage of commodity, with interquartile Median % Median % Median % Median % Median % Median % Median % (n) (n) (n) (n) (n) (n) (n) range†,‡,§: [IQR] [IQR] [IQR] [IQR] [IQR] [IQR] [IQR] [0.0, 300.0] (12) [233.3, 233.3] (4) (1) [0.0, 300.0] (17) (1) - (1) * Private Medical Total category = community health worker + private not-for-profit + private for-profit health facility + pharmacy categories; Private Other Total category = general retailer + itinerant drug vendor categories † Price for all commodities with provider-dependent service (injectables, IUDs) may include a service charge. ‡ The number of family planning products captured in audits sheets with missing price information are as follows: 1,008 male condoms (346 metro, 462 urban, 200 rural), 14 female condoms (6 metro, 4 urban, 4 rural), 152 oral contraceptives(63 metro, 54 urban, 35 rural), 33 emergency contraceptives (13 metro, 10 urban, 10 rural), 47 injectables (17 metro, 19 urban, 11 rural), 0 implants, 32 IUDs (10 metro, 12 urban, 10 rural), 1 male sterilization (1 urban) and 19 female sterilizations (3 metro, 16 urban). § Based on the average rate of exchange from February 26th to May 19th, 2016 of 1,212.121 Myanmar Kyat per 1 USD. ∞ This price is determined for the unit used in CYP conversion factors: condoms: 1 condom; cyclebeads: 1 product/string; vaginal pessaries: 1 tablet; oral contraceptives: 1 cycle or blister package; emergency contraceptives: 1 dose; injectables: 1 dose/injection; IUDs: 1 IUD. CYP – Couple Year Protection is the estimated protection provided by contraceptive methods during a one-year period, based upon the volume of all contraceptives sold or distributed free of charge to clients during that period (see Annex 11).‖ Source: FPwatch Outlet Survey, Myanmar, 2016

www.FPwatch.info Page 58

Table B8: Contraceptive method market share: Relative proportion of total CYP sold/distributed, by method and outlet type – Myanmar Strata, 2016 CYPs sold or distributed in Private For- previous 1 month by outlet type Community Private Not- Private General Itinerant Drug Private Other Method Profit Health Pharmacy and contraceptive method type as Health Worker For-Profit Medical Total* Retailer Vendor Total* Total∞ Facility a % of total CYPs sold / distributed†,‡: % % % % % % % % % 1. Male condoms Myanmar Metropolitan 0.1 0.0 0.1 1.8 2.0 1.7 0.0 1.7 3.6 Myanmar Urban 0.0 0.0 0.1 1.1 1.3 0.3 0.0 0.3 1.6 Myanmar Rural 0.5 0.0 0.0 0.1 0.6 0.2 0.0 0.2 0.8 2. Female condoms Myanmar Metropolitan 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Myanmar Urban 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Myanmar Rural 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3. Oral contraceptives Myanmar Metropolitan 0.7 0.3 5.6 24.7 31.3 4.5 0.0 4.5 35.9 Myanmar Urban 1.0 0.1 1.8 18.8 21.7 5.1 0.0 5.1 26.7 Myanmar Rural 5.7 0.1 0.6 4.4 10.8 15.7 0.2 15.9 26.7 Combined oral contraceptives Myanmar Metropolitan 0.6 0.3 5.1 20.7 26.7 2.6 0.0 2.6 29.3 Myanmar Urban 0.9 0.1 1.7 14.2 16.9 2.3 0.0 2.3 19.2 Myanmar Rural 5.2 0.1 0.4 2.8 8.5 6.0 0.1 6.2 14.7 Progestin-only pills Myanmar Metropolitan 0.1 0.0 0.5 4.0 4.6 1.9 0.0 1.9 6.5 Myanmar Urban 0.1 0.0 0.1 4.6 4.8 2.8 0.0 2.8 7.6 Myanmar Rural 0.5 0.0 0.1 1.6 2.2 9.7 0.1 9.7 12.0 4. Emergency contraceptives Myanmar Metropolitan 0.0 0.0 0.5 3.6 4.2 0.5 0.0 0.5 4.7 Myanmar Urban 0.0 0.0 0.1 2.9 3.0 0.1 0.0 0.1 3.1 Myanmar Rural 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 5. Contraceptive injectables Myanmar Metropolitan 2.4 2.4 32.3 10.0 47.2 0.6 0.0 0.6 47.8 Myanmar Urban 5.1 0.6 12.1 42.2 60.0 1.4 0.2 1.6 61.5 Myanmar Rural 38.9 0.2 5.1 14.3 58.5 10.0 2.7 12.8 71.2 3 month injectables Myanmar Metropolitan 2.4 2.4 32.3 10.0 47.2 0.6 0.0 0.6 47.8 Myanmar Urban 5.1 0.6 12.1 42.2 60.0 1.4 0.2 1.6 61.5 Myanmar Rural 38.9 0.2 5.1 14.3 58.5 10.0 2.7 12.8 71.2 1 month injetables Myanmar Metropolitan 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

www.FPwatch.info Page 59

Table B8: Contraceptive method market share: Relative proportion of total CYP sold/distributed, by method and outlet type – Myanmar Strata, 2016 CYPs sold or distributed in Private For- previous 1 month by outlet type Community Private Not- Private General Itinerant Drug Private Other Method Profit Health Pharmacy and contraceptive method type as Health Worker For-Profit Medical Total* Retailer Vendor Total* Total∞ Facility a % of total CYPs sold / distributed†,‡: % % % % % % % % % Myanmar Urban 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Myanmar Rural 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6. Contraceptive implants Myanmar Metropolitan 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Myanmar Urban 0.0 0.8 0.2 0.0 0.9 0.0 0.0 0.0 0.9 Myanmar Rural 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Implanon implants Myanmar Metropolitan 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Myanmar Urban 0.0 0.3 0.2 0.0 0.5 0.0 0.0 0.0 0.5 Myanmar Rural 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Jadelle implants Myanmar Metropolitan 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Myanmar Urban 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.5 Myanmar Rural 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7. IUDs Myanmar Metropolitan 1.2 5.1 1.7 0.0 8.0 0.0 0.0 0.0 8.0 Myanmar Urban 0.1 1.7 3.0 0.8 5.5 0.0 0.0 0.0 5.5 Myanmar Rural 0.6 0.0 0.2 0.1 0.8 0.0 0.0 0.0 0.8 8. Male sterilization Myanmar Metropolitan 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Myanmar Urban 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Myanmar Rural 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 9. Female sterilization Myanmar Metropolitan 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Myanmar Urban 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.7 Myanmar Rural 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OUTLET TYPE TOTAL∞ Myanmar Metropolitan 4.4 7.9 40.2 40.2 92.7 7.3 0.0 7.3 100.0 Myanmar Urban 6.2 3.1 17.9 65.8 93.0 6.8 0.2 7.0 100.0 Myanmar Rural 45.8 0.3 5.8 19.1 71.0 26.0 3.0 29.0 100.0 * Private Medical Total category = community health worker + private not-for-profit + private for-profit health facility + pharmacy categories; Private Other Total category = general retailer + itinerant drug vendor categories † A total of 162,938 CYPs (weighted) were reportedly distributed in the previous 1 month in Myanmar (34,176 in metro, 10,4611 in urban, and 24,151 in rural Myanmar). This is based on the number of commodities reportedly sold for categories 1-7 (not number of services performed for categories 5-7) and number of sterilizations reportedly performed for categories 8-9. ‡ In metropolitan Myanmar, 3,907 FP products were audited, not including condoms (2,714 oral contraceptives, 453 emergency contraceptives, 630 injectables, 0 implants, 27 IUDs). In addition, 70 outlets were audited for male condoms, 0 outlets for female condoms, and 0 outlets for female sterilization services. Volume information was excluded due to missing information or as a volume outlier for: 110 male condoms, 3 female condoms,

www.FPwatch.info Page 60

Table B8: Contraceptive method market share: Relative proportion of total CYP sold/distributed, by method and outlet type – Myanmar Strata, 2016 CYPs sold or distributed in Private For- previous 1 month by outlet type Community Private Not- Private General Itinerant Drug Private Other Method Profit Health Pharmacy and contraceptive method type as Health Worker For-Profit Medical Total* Retailer Vendor Total* Total∞ Facility a % of total CYPs sold / distributed†,‡: % % % % % % % % % 150 oral contraceptive tablets, 32 emergency contraceptive tablets, 1 injectable, 0 implants, no IUD products, no male sterilizations and 0 female sterilizations. In urban Myanmar, 5,920 FP products were audited, not including condoms (3,790 oral contraceptives, 601 emergency contraceptives, 1,348 injectables, 13 implants, 65 IUDs). In addition, 70 outlets were audited for male condoms, 0 outlets for female condoms, and 1 outlet for female sterilization services. Volume information was excluded due to missing information or as a volume outlier for: 104 male condoms, 4 female condoms, 226 oral contraceptive tablets, 63 emergency contraceptive tablets, 2 injectables, 6 implants, no IUD products, no male sterilizations and 4 female sterilizations. In rural Myanmar, 5,394 FP products were audited, not including condoms (3,393 oral contraceptives, 147 emergency contraceptives, 1,684 injectables, 0 implants, 37 IUDs). In addition, 88 outlets were audited for male condoms, 3 outlets for female condoms, and 0 outlets for female sterilization services. Volume information was excluded due to missing information or as a volume outlier for: 73 male condoms, 3 female condoms, 182 oral contraceptive tablets, 10 emergency contraceptive tablets, 0 injectables, 0 implants, no IUD products, no male sterilizations and 0 female sterilizations. ∞ Row total: CYP volume for the specified contraceptive method type. Column total: market share for the specified outlet type method categories 1-9. || Male sterilizations are illegal in Myanmar. A small number of outlets did report offering male sterilization services. However, no volumes were reported for the procedure. Source: FPwatch Outlet Survey, Myanmar, 2016

www.FPwatch.info Page 61

www.FPwatch.info Page 62

Table B9: Contraceptive method market share within outlet type: Relative proportion of total CYP sold/distributed within outlet type, by method – Myanmar Strata, 2016 CYPs sold or distributed in previous 1 month by outlet type Community Private Not-For- Private For-Profit Private Medical Itinerant Drug Private Other Pharmacy General Retailer and contraceptive method type as Health Worker Profit Total Health Facility Total* Vendor Total* a % of total CYPs sold / distributed†,‡: % % % % % % % % Myanmar Urban 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Myanmar Rural 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6. Contraceptive implants Myanmar Metropolitan 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Myanmar Urban 0.0 24.4 0.8 0.0 1.0 0.0 0.0 0.0 Myanmar Rural 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Implanon implants Myanmar Metropolitan 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Myanmar Urban 0.0 9.7 0.8 0.0 0.5 0.0 0.0 0.0 Myanmar Rural 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Jadelle implants Myanmar Metropolitan 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Myanmar Urban 0.0 14.7 0.0 0.0 0.5 0.0 0.0 0.0 Myanmar Rural 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7. IUDs Myanmar Metropolitan 27.0 64.9 4.2 0.0 8.6 0.0 0.0 0.0 Myanmar Urban 0.8 53.5 16.5 1.2 5.9 0.0 0.0 0.0 Myanmar Rural 1.3 0.0 2.9 0.3 1.1 0.0 0.0 0.0 8. Male sterilization∞ Myanmar Metropolitan 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Myanmar Urban 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Myanmar Rural 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9. Female sterilization Myanmar Metropolitan 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Myanmar Urban 0.0 0.0 3.8 0.0 0.7 0.0 0.0 0.0 Myanmar Rural 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 * Private Medical Total category = community health worker + private not-for-profit + private for-profit health facility + pharmacy categories; Private Other Total category = general retailer + itinerant drug vendor categories † A total of 162,938 CYPs (weighted) were reportedly distributed in the previous 1 month in Myanmar (34,176 in metro, 10,4611 in urban, and 24,151 in rural Myanmar). This is based on the number of commodities reportedly sold for categories 1-7 (not number of services performed for categories 5-7) and number of sterilizations reportedly performed for categories 8-9. ‡ In metropolitan Myanmar, 3,907 FP products were audited, not including condoms (2,714 oral contraceptives, 453 emergency contraceptives, 630 injectables, 0 implants, 27 IUDs). In addition, 70 outlets were audited for male condoms, 0 outlets for female condoms, and 0 outlets for female sterilization services. Volume information was excluded due to missing information or as a volume outlier for: 110 male condoms, 3 female condoms, 150 oral contraceptive tablets, 32 emergency contraceptive tablets, 1 injectable, 0 implants, no IUD products, no male sterilizations and 0 female sterilizations. In urban Myanmar, 5,920 FP products were audited, not including condoms (3,790 oral contraceptives, 601 emergency contraceptives, 1,348 injectables, 13 implants, 65 IUDs). In addition, 70 outlets were audited for male condoms, 0 outlets for female condoms, and 1 outlet for female sterilization services. Volume information was excluded due to missing information or as a volume outlier for: 104 male condoms, 4 female condoms, 226 oral contraceptive tablets, 63 emergency contraceptive tablets, 2 injectables, 6 implants, no IUD products, no male sterilizations and 4 female sterilizations. In rural Myanmar, 5,394 FP products were audited, not including condoms (3,393 oral contraceptives, 147 emergency contraceptives, 1,684 injectables, 0 implants, 37 IUDs). In addition, 88 outlets were audited for male

www.FPwatch.info Page 63

www.FPwatch.info Page 64

Table B10: Availability of selected contraceptive services, among outlets screened, by outlet type – Myanmar Strata, 2016 Community Private Not-For- Private For-Profit Private Medical Itinerant Drug Private Other Pharmacy General Retailer Health Worker Profit Health Facility Total* Vendor Total* % % % % % % % %

(95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) Metro N=63 Metro N=1 Metro N=522 Metro N=657 Metro N=1,243 Metro N=6,136 Metro N=1 Metro N=6,137 Proportion of outlets Urban N=357 Urban N=2 Urban N=626 Urban N=767 Urban N=1,752 Urban N=12,627 Urban N=58 Urban N=12,685 screened, providing†: Rural N=1,478 Rural N=4 Rural N=163 Rural N=237 Rural N=1,882 Rural N=12,605 Rural N=419 Rural N=13,024 Contraceptive injection service 62.6 100.0 69.8 4.8 37.5 0.0 100.0 0.0 Myanmar Metropolitan (52.3, 71.8) - (61.0, 77.4) (3.3, 6.9) (33.7, 41.6) (0.0, 0.1) - (0.0, 0.1) 74.7 69.0 78.1 9.4 45.9 0.2 8.3 0.4 Myanmar Urban (66.4, 81.4) (13.8, 96.9) (73.9, 81.8) (6.2, 14.1) (40.7, 51.2) (0.1, 0.5) (1.6, 33.1) (0.2, 0.7) 68.1 81.7 87.3 21.2 65.5 0.5 63.2 3.1 Myanmar Rural (64.3, 71.6) (33.8, 97.5) (80.8, 91.8) (15.2, 28.9) (62.1, 68.8) (0.3, 0.9) (54.3, 71.3) (2.3, 4.1) Implant insertion service 0.0 100.0 3.1 0.1 1.6 0.0 0.0 0.0 Myanmar Metropolitan - - (1.0, 9.1) (0.0, 0.7) (0.6, 4.2) - - - 0.0 69.0 4.4 0.0 1.5 0.0 0.0 0.0 Myanmar Urban - (13.8, 96.9) (2.7, 7.2) - (0.9, 2.6) (0.0, 0.1) - (0.0, 0.1) 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 Myanmar Rural (0.0, 0.1) - (0.1, 2.4) - (0.0, 0.1) - - - IUD insertion service 4.0 100.0 5.3 0.1 2.8 0.0 0.0 0.0 Myanmar Metropolitan (1.0, 15.2) - (3.3, 8.4) (0.0, 0.5) (1.8, 4.5) - - - 4.0 69.0 10.0 0.0 4.2 0.0 0.0 0.0 Myanmar Urban (2.2, 7.1) (13.8, 96.9) (7.5, 13.3) - (3.0, 5.7) (0.0, 0.0) - (0.0, 0.0) 1.5 30.4 5.9 0.2 1.8 0.0 0.0 0.0 Myanmar Rural (1.0, 2.4) (4.6, 79.8) (2.5, 13.1) (0.0, 1.3) (1.2, 2.5) - - - Male sterilization service‡ 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Myanmar Metropolitan ------0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 Myanmar Urban (0.0, 0.0) - (0.0, 1.0) - (0.0, 0.3) - - - 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Myanmar Rural (0.0, 0.0) - - - (0.0, 0.1) - - - Female sterilization service 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 Myanmar Metropolitan - - (0.2, 1.9) - (0.1, 0.8) - - - Myanmar Urban 0.0 0.0 3.6 0.0 1.1 0.0 0.0 0.0

www.FPwatch.info Page 65

www.FPwatch.info Page 66

Table B11: Service readiness to provide provider-dependent contraceptive services, among outlets reportedly offering the procedure, by outlet type – Myanmar Metropolitan/Urban/Rural, 2016 Private For- Community Private Not-For- Private Medical Itinerant Drug Private Other Profit Health Pharmacy General Retailer Health Worker Profit Total* Vendor Total* Facility Proportion of outlets offering service, % % % % % % % % with†,‡: [95%] (n) [95%] (n) [95%] (n) [95%] (n) [95%] (n) [95%] (n) [95%] (n) [95%] (n) Contraceptive injection service Availability of 67.3 100.0 92.9 70.4 88.7 51.6 100.0 62.8 commodity [42.2, 85.3] (44) (1) [86.0, 96.6] (384) [52.6, 83.6] (39) [82.3, 93.0] (468) [9.3, 91.7] (3) (1) [16.0, 93.7] (4) Availability of 78.9 100.0 99.3 85.0 96.2 100.0 0.0 76.7 Myanmar credentials [60.2, 90.2] (44) (1) [97.7, 99.8] (384) [71.4, 92.8] (39) [93.1, 97.9] (468) [100.0, 100.0] (3) (1) [26.7, 96.7] (4) Metropolitan Availability of 64.6 100.0 87.9 76.3 84.7 51.6 100.0 62.8 equipment [43.2, 81.4] (44) (1) [83.2, 91.4] (384) [57.6, 88.5] (37) [80.0, 88.4] (466) [9.3, 91.7] (3) (1) [16.0, 93.7] (4) 29.5 100.0 81.8 61.1 74.8 51.6 0.0 39.5 Service readiness [13.8, 52.4] (44) (1) [75.1, 87.0] (384) [42.1, 77.3] (37) [68.0, 80.6] (466) [9.3, 91.7] (3) (1) [8.5, 82.1] (4) Availability of 67.7 100.0 86.7 96.0 80.6 86.6 55.6 72.9 commodity [60.0, 74.5] (274) (1) [83.0, 89.7] (489) [89.9, 98.5] (87) [77.0, 83.7] (851) [61.0, 96.4] (18) [36.2, 73.4] (28) [55.1, 85.5] (46) Availability of 75.1 100.0 98.4 73.5 87.5 84.9 13.2 53.3 Myanmar Urban credentials [68.7, 80.6] (274) (1) [96.7, 99.3] (489) [58.2, 84.7] (87) [83.9, 90.3] (851) [58.8, 95.7] (18) [3.3, 40.1] (28) [32.1, 73.5] (46) Availability of 78.2 100.0 85.3 85.5 82.7 77.9 82.7 80.0 equipment [72.0, 83.4] (274) (1) [80.3, 89.2] (489) [74.2, 92.3] (86) [78.9, 86.0] (850) [49.2, 92.8] (18) [67.0, 91.8] (28) [63.5, 90.2] (46) 48.4 100.0 75.9 58.3 64.1 64.0 13.2 41.6 Service readiness [41.4, 55.4] (274) (1) [71.1, 80.1] (489) [43.1, 72.0] (86) [59.8, 68.2] (850) [32.5, 86.7] (18) [3.3, 40.1] (28) [20.1, 66.8] (46) Availability of 65.8 100.0 92.9 90.9 68.5 71.9 35.3 41.1 commodity [62.0, 69.5] (1,046) [100.0, 100.0] (3) [86.1, 96.6] (141) [77.4, 96.7] (50) [64.9, 71.9] (1,240) [46.4, 88.4] (37) [26.8, 44.8] (256) [33.0, 49.6] (293) Availability of 33.8 100.0 93.0 49.2 38.5 10.0 2.1 3.4 credentials [30.2, 37.5] (1,046) [100.0, 100.0] (3) [86.1, 96.6] (141) [31.7, 66.8] (50) [34.7, 42.5] (1,240) [3.6, 24.7] (37) [1.0, 4.4] (256) [1.8, 6.3] (293) Myanmar Rural Availability of 66.4 90.0 77.0 94.0 67.9 84.4 50.8 56.1 equipment [62.5, 70.0] (1,045) [49.0, 98.8] (3) [66.5, 85.0] (140) [86.4, 97.4] (50) [64.3, 71.2] (1,238) [66.2, 93.7] (37) [37.2, 64.4] (255) [41.8, 69.5] (292) 23.3 90.0 68.9 47.7 27.3 2.8 1.4 1.6 Service readiness [20.2, 26.7] (1,045) [49.0, 98.8] (3) [58.6, 77.6] (140) [30.3, 65.6] (50) [24.0, 30.8] (1,238) [0.6, 12.1] (37) [0.6, 3.2] (255) [0.8, 3.5] (292) Contraceptive implant insertion service Availability of - 0.0 0.0 0.0 0.0 - - - commodity - (1) [0.0, 0.0] (12) (1) [0.0, 0.0] (14) - - - Availability of - 100.0 12.8 0.0 23.6 - - - Myanmar credentials - (1) [2.2, 48.8] (9) (1) [4.8, 65.4] (11) - - - Metropolitan Availability of - 100.0 71.3 0.0 72.3 - - - equipment - (1) [43.0, 89.1] (12) (1) [45.5, 89.1] (14) - - - - 0.0 0.0 0.0 0.0 - - - Service readiness - (1) [0.0, 0.0] (9) (1) [0.0, 0.0] (11) - - - Myanmar Urban Availability of - 100.0 34.2 - 39.4 0.0 - 0.0

www.FPwatch.info Page 67

Table B11: Service readiness to provide provider-dependent contraceptive services, among outlets reportedly offering the procedure, by outlet type – Myanmar Metropolitan/Urban/Rural, 2016 Private For- Community Private Not-For- Private Medical Itinerant Drug Private Other Profit Health Pharmacy General Retailer Health Worker Profit Total* Vendor Total* Facility Proportion of outlets offering service, % % % % % % % % with†,‡: [95%] (n) [95%] (n) [95%] (n) [95%] (n) [95%] (n) [95%] (n) [95%] (n) [95%] (n) commodity - (1) [14.3, 61.8] (29) - [20.0, 62.9] (30) [0.0, 0.0] (2) - [0.0, 0.0] (2) Availability of - 100.0 57.9 - 62.4 16.7 - 16.7 credentials - (1) [30.6, 81.2] (21) - [39.6, 80.8] (22) [1.4, 73.5] (2) - [1.4, 73.5] (2) Availability of - 100.0 95.3 - 95.7 100.0 - 100.0 equipment - (1) [81.0, 99.0] (29) - [82.2, 99.1] (30) [100.0, 100.0] (2) - [100.0, 100.0] (2) - 100.0 39.3 - 45.7 0.0 - 0.0 Service readiness - (1) [15.2, 70.1] (21) - [23.6, 69.7] (22) [0.0, 0.0] (2) - [0.0, 0.0] (2) Availability of 0.0 - 0.0 - 0.0 - - - commodity (1) - (1) - [0.0, 0.0] (2) - - - Availability of 0.0 - - - 0.0 - - - credentials (1) - - - (1) - - - Myanmar Rural Availability of 0.0 - 100.0 - 65.0 - - - equipment (1) - (1) - [12.5, 96.0] (2) - - - 0.0 - - - 0.0 - - - Service readiness (1) - - - (1) - - - IUD insertion service Availability of 79.1 100.0 55.3 0.0 59.6 - - - commodity [23.9, 97.9] (3) (1) [32.0, 76.4] (23) (1) [36.5, 79.1] (28) - - - Availability of 89.5 100.0 22.6 0.0 36.0 - - - Myanmar credentials [43.7, 98.9] (3) (1) [8.6, 47.8] (17) (1) [14.8, 64.6] (22) - - - Metropolitan Availability of 100.0 100.0 79.0 0.0 81.3 - - - equipment [100.0, 100.0] (3) (1) [41.1, 95.3] (22) (1) [47.6, 95.4] (27) - - - 68.6 100.0 11.4 0.0 24.7 - - - Service readiness [17.5, 95.7] (3) (1) [2.6, 38.6] (17) (1) [7.2, 58.2] (22) - - - Availability of 42.4 100.0 60.0 - 57.3 83.3 - 83.3 commodity [19.0, 69.9] (15) (1) [42.0, 75.6] (55) - [43.2, 70.3] (71) [26.5, 98.6] (2) - [26.5, 98.6] (2) Availability of 16.7 100.0 54.4 - 46.6 16.7 - 16.7 Myanmar Urban credentials [4.9, 43.6] (15) (1) [36.1, 71.6] (47) - [32.3, 61.5] (63) [1.4, 73.5] (2) - [1.4, 73.5] (2) Availability of 60.3 100.0 97.8 - 89.7 100.0 - 100.0 equipment [30.5, 83.9] (15) (1) [88.1, 99.6] (55) - [76.8, 95.8] (71) [100.0, 100.0] (2) - [100.0, 100.0] (2) 6.8 100.0 39.7 - 33.6 0.0 - 0.0 Service readiness [1.0, 34.1] (15) (1) [23.0, 59.1] (47) - [20.7, 49.5] (63) [0.0, 0.0] (2) - [0.0, 0.0] (2) Availability of 60.0 0.0 83.0 0.0 60.7 - - - commodity [37.3, 79.0] (26) (1) [48.1, 96.3] (8) (1) [41.1, 77.3] (36) - - - Myanmar Rural Availability of 29.4 0.0 50.1 100.0 32.5 - - - credentials [14.7, 50.1] (25) (1) [14.9, 85.2] (8) (1) [17.9, 51.5] (35) - - -

www.FPwatch.info Page 68

Table B11: Service readiness to provide provider-dependent contraceptive services, among outlets reportedly offering the procedure, by outlet type – Myanmar Metropolitan/Urban/Rural, 2016 Private For- Community Private Not-For- Private Medical Itinerant Drug Private Other Profit Health Pharmacy General Retailer Health Worker Profit Total* Vendor Total* Facility Proportion of outlets offering service, % % % % % % % % with†,‡: [95%] (n) [95%] (n) [95%] (n) [95%] (n) [95%] (n) [95%] (n) [95%] (n) [95%] (n) Availability of 41.3 0.0 100.0 100.0 50.9 - - - equipment [23.8, 61.4] (25) (1) [100.0, 100.0] (8) (1) [33.0, 68.5] (35) - - - 16.6 0.0 43.4 0.0 20.7 - - - Service readiness [6.2, 37.4] (24) (1) [10.4, 83.6] (8) (1) [8.8, 41.4] (34) - - - Female sterilization service∞ Availability of - - 100.0 - 100.0 - - - credentials - - [100.0, 100.0] (3) - [100.0, 100.0] (3) - - - Myanmar Availability of - - 71.4 - 71.4 - - - Metrpolitan equipment - - [18.1, 96.6] (3) - [18.1, 96.6] (3) - - - - - 71.4 - 71.4 - - - Service readiness - - [18.1, 96.6] (3) - [18.1, 96.6] (3) - - - Availability of - - 100.0 - 100.0 - - - credentials - - [100.0, 100.0] (23) - [100.0, 100.0] (23) - - - - - 96.9 - 96.9 - - - Myanmar Urban Availability of equipment - - [88.3, 99.2] (23) - [88.3, 99.2] (23) - - - - - 96.9 - 96.9 - - - Service readiness - - [88.3, 99.2] (23) - [88.3, 99.2] (23) - - - Availability of - - 100.0 - 100.0 - - - credentials - - (1) - (1) - - - Availability of - - 0.0 - 0.0 - - - Myanmar Rural equipment - - (1) - (1) - - - - - 0.0 - 0.0 - - - Service readiness - - (1) - (1) - - - * Private Medical Total category = community health worker + private not-for-profit + private for-profit health facility + pharmacy categories; Private Other Total category = general retailer + itinerant drug vendor categories † Full service readiness is defined as having available: 1. The commodity (not applicable for male/female sterilization); 2. A provider with credentials meeting the guidelines to perform the service (per correspondence with Myanmar Government Ministry of Health and Sports); and 3. A minimum set of sentinel equipment (http://www.cpc.unc.edu/measure/prh/rh_indicators/specific/long-acting-permanent-methods/percent-of-facilities-with- appropriate) for providing the service. Observations that are missing information for commodity availability, provider credentials, or equipment are excluded from the ‘service readiness’ denominator. ‡ The denominator includes 19 outlets that met screening criteria for a full interview but did not complete the interview (were not interviewed or completed a partial interview). The list of family planning services with incomplete survey information are as follows: 31 IUD insertions (17 urban, 14 rural), 29 implant insertions (18 urban, 11 rural), 36 contraceptive injections (22 urban, 14 rural), 1 male sterilization (1 urban) and 18 female (10 urban, 8 rural) sterilizations. ∞ Male sterilizations are illegal in Myanmar. A small number of outlets did report offering male sterilization services. However, no further information was collected for this procedure. Source: FPwatch Outlet Survey, Myanmar, 2016

www.FPwatch.info Page 69

Figure B1. Modern contraceptive method market composition – Myanmar Strata, 2016 Among all outlets stocking at least 1 modern contraceptive or providing at least 1 contraceptive service, excluding condoms only outlets, by outlet type

Metropolitan Urban Rural Community Health Worker 3% 5% Not- For-Profit 10% 27% Private For-Profit 29% Health Facility 37% 18% Pharmacy 41% 29% 58% General Retailer 34% 5%

Itinerant Drug Vendor 3%

N = 1,368 N = 2,382 N = 2,930 In the Myanmar private sector across strata, some significant differences were seen in market composition. In metropolitan and urban Myanmar, pharmacies comprised a considerably higher proportion of the private market with at least one contraceptive method available (excluding those with only male condoms) at approximately one-third of market composition compared to 5% of rural market composition. Facilities were a slightly larger share of the metropolitan market composition (about one-third) compared to urban Myanmar (about one-fifth), and both was a considerably larger proportion of the market compared to rural Myanmar (3%). In rural Myanmar, most of the private market composition was accounted for by general retailers (58%) compared to only about one-third in urban and one-quarter in metropolitan Myanmar. CHWs’ share of the market composition was also higher in rural Myanmar (29%) compared to urban (18%) and metropolitan (3%) Myanmar. Finally, IDVs were only a sizeable proportion of market composition in rural Myanmar (5%).

www.FPwatch.info Page 70

Figure B2. Percentage of modern contraceptive commodity-stocking outlets with selected contraceptives available – Myanmar Strata, 2016 Among all screened outlets, by private sector type

Metropolitan Urban Rural

100

0 Private Medical Total Private Other Total Private Medical Total Private Other Total Private Medical Total Private Other Total Male condoms Female condoms Oral contraceptives Combined oral contraceptives Progestin-only pills Emergency contraceptives Contraceptive injectables Implants IUDs

Comparing availability of short-acting methods between metro, urban, and rural areas across broad outlet types (private medical total = CHWs + non-profits + facilities + pharmacies; and private other total = general retailers + IDVs) of Myanmar among those screened, there was a trend for slightly higher availability of male condoms in metropolitan and urban areas as compared to rural areas when looking at private medical outlets. In addition, there was higher availability in metropolitan and urban areas of oral and emergency contraceptives compared to rural areas when looking at private medical outlets. For injectables, about 60% of urban private medical outlets screened stocked injectables compared to about half in rural areas and about 40% in metropolitan areas. In rural areas, slightly more private other outlets screened stocked all methods. Comparing LARC methods, there were not large differences seen as availability was generally low across strata and outlet types.

www.FPwatch.info Page 71

Figure B3. Percentage of outlets with selected method mixes available – Myanmar Strata, 2016 Among all screened outlets, by private sector type

Metropolitan Urban Rural

100

0 Private Medical Total Private Other Total Private Medical Total Private Other Total Private Medical Total Private Other Total Any modern method 3+ methods 3+ methods with LARC/PM 5+ methods

Looking, in particular, at availability of three or more methods as a standard of method diversity available, the proportion of private medical outlets having three or more methods available was highest in urban Myanmar (about one-third of screened facilities) compared to metropolitan areas (about one-quarter) and significantly higher compared to rural areas, about 10%.

www.FPwatch.info Page 72

Figure B4. Percentage of outlets with stock outs of selected contraceptive methods – Myanmar Strata, 2016 Among all outlets reportedly stocking the method at any time in the previous three months, by private sector type

Metropolitan Urban Rural

Comparing stock outs for contraceptive methods in outlets reportedly carrying them in the previous three months between metropolitan, urban, and rural Myanmar, there was a trend for slightly lower levels of stock outs of all methods in metropolitan areas (3 – 8%) compared to urban areas (10 – 15%) and rural areas (12 – 18%).

www.FPwatch.info Page 73

Figure B5. Price of contraceptive methods in the private sector – Myanmar Metropolitan, 2016 Median price in USD and USD/CYP with interquartile range, by contraceptive method

There was a trend for slightly higher prices per CYP in metro Myanmar as compared with rural or urban areas across contraceptive methods.

www.FPwatch.info Page 74

Figure B6. Price of contraceptive methods in the private sector – Myanmar Urban, 2016 Median price in USD and USD/CYP with interquartile range, by contraceptive method

There was a trend for slightly higher prices per CYP in metro Myanmar as compared with rural or urban areas across contraceptive methods.

www.FPwatch.info Page 75

Figure B7. Price of contraceptive methods in the private sector – Myanmar Rural, 2016 Median price in USD and USD/CYP with interquartile range, by contraceptive method

There was a trend for slightly higher prices per CYP in metro Myanmar as compared with rural or urban areas across contraceptive methods.

www.FPwatch.info Page 76

Figure B8. Percentage market share for contraceptives methods – Myanmar Strata, 2016 As a % of total CYPs sold/distributed, by private sector type

Metropolitan Rural Urban

Female sterilization Male sterilization IUDs Implants Contraceptive injectables Emergency contraceptives Oral contraceptives Female condoms Male condoms 100

0 Private Medical Total Private Other Total Private Medical Total Private Other Total Private Medical Total Private Other Total

In metropolitan and urban areas of Myanmar 80% or greater of total CYPs distributed were in the private medical sector with other private facilities comprising about 10% of market share. Rural areas in Myanmar had a higher share of CYPs coming from other private outlets (nearly 30%) compared to private medical outlets (about 70%). By method share, the proportion of CYPs from metropolitan areas was slightly larger for oral contraceptives (about one-third) compared to urban areas (about one-quarter), while urban areas had a higher proportion of CYPs from injectables (about two-thirds) compared to urban areas (about half). In rural areas, most of the market share was from injectables (about two-thirds) with most of the rest from oral contraceptives. LARCs, particularly IUDs, comprised about 8% of the share in metropolitan Myanmar compared to about 5% in urban Myanmar and less than 1% in rural Myanmar.

www.FPwatch.info Page 77

Figure B9. Within outlet market share for contraceptive methods – Myanmar Strata, 2016 As a % of total CYPs sold/distributed within outlet type and sector, by private sector type

Metropolitan Rural Urban

100

Female sterilization 80 Male sterilization

IUDs

Implants 60

Contraceptive injectables

Emergency contraceptives 40

Oral contraceptives

Female condoms 20 Male condoms

0 Private Medical Private Other Private Medical Private Other Private Medical Private Other Total Total Total Total Total Total

Comparing within outlet market share between metropolitan, urban, and rural Myanmar, looking at private medical outlets, injectables followed by oral contraceptives were the main contributors to within sector market share. In urban and metropolitan areas, there was slightly more diversity with small amounts of within market share for IUDs followed by emergency contraceptives and male condoms.

www.FPwatch.info Page 78

Figure B10. Percentage of outlets with selected contraceptive services available – Myanmar Strata, 2016 Among all screened outlets, among outlets screened, by private sector type

Urban Rural Metropolitan

100

0 Private Medical Total Private Other Total Private Medical Total Private Other Total Private Medical Total Private Other Total Contraceptive injection service Implant insertion service IUD insertion service Male sterilization service Female sterilization service

There was higher availability of contraceptive injections in rural areas among private medical outlets screened compared to urban and metropolitan areas. There was relatively low availability (<3%) of other services in both metropolitan and urban Myanmar and especially in rural areas.

www.FPwatch.info Page 79

Figure B11. Service readiness to offer provider-dependent contraceptive services – Myanmar Strata, 2016 Among outlets reportedly offering the service, by private sector type \

Urban Rural Metropolitan

Comparing service readiness between metropolitan, urban, and rural Myanmar outlets, there was a considerably higher proportion of outlets in metropolitan and urban areas found to meet the criteria for service readiness compared to rural areas, among those outlets reportedly offering injection services. For other services, low service readiness was found across strata (except for high service readiness for female sterilizations in urban areas) due to deficiencies across the three criteria. There was a considerable amount of missing data for these services and this indicator making assessment and comparisons difficult.

www.FPwatch.info Page 80

Annexes Annex 1: FPwatch Background FPwatch is a multi-country research project implemented by PSI (www.psi.org). Standardized tools and approaches are employed to provide comparable data across countries and over time. Project countries include: Ethiopia, the DRC, India, Nigeria and Myanmar. The project was launched in 2014 with funding from the BMGF for four project countries, and is currently funded through 2016 by the BMGF. Funding for Myanmar was secured through the 3MDG Fund in 2015.

FPwatch is designed to provide timely, relevant and high-quality modern contraceptives and associated services market evidence. The goal of providing this market evidence is to inform and monitor national and global policy, strategy and funding decisions for understanding FP markets. FPwatch is monitoring family planning markets in the context of increased investments in family planning as part of the FP2020 Initiative, a partnership aiming to expand access to family planning information, services and supplies to an additional 120 million women and girls in 69 of the world’s poorest countries by 2020.

The project implements a set of research tools designed to:

1) Provide a picture of the total market for distribution of modern family planning methods including: all providers carrying condoms, oral contraceptives, emergency contraceptives, injectables, contraceptive implants or IUDs or providing provider-dependent contraceptive services including: injections, implant insertions, IUD insertions or male or female sterilizations; the relative modern contraceptive market share for each provider type; stock outs; and price markups.

2) Monitor the readiness of market components for distribution of modern family planning methods, including: availability of modern contraceptives and services; and provider qualifications, training and essential equipment for providing services.

3) Monitor the performance of market components for distribution of modern family planning methods, including: the relative market share for each method and for short-acting relative to long-acting methods; consumer price; quality-assurance indicators for contraceptives.

FPwatch research tools for FP market monitoring include:

1. Outlet surveys

Outlet surveys entail collecting quantitative data from all outlets and providers with the potential to sell or distribute modern contraceptives and/or provide provider-dependent contraceptive services. These outlets include health facilities, community health workers, pharmacies, drug stores, retail outlets, market stalls and mobile providers. Information on male and female condoms is collected from all enumerated outlets including brand, price of most popular condom and volume of all condoms sold. A screening process identifies outlets that provide modern contraceptives above the level of oral contraceptives and/or provide provider-dependent family planning services. Among these eligible outlets, service providers are interviewed and all modern contraceptives are audited. The audit collects information about each modern contraceptive in stock (e.g. brand name, drug active ingredients and strengths, manufacturer, etc.) and the retailer reports on consumer price and sale/distribution volumes for each product. A provider interview is conducted among those outlets where services including contraceptive injections, implant and IUD insertions and male and female sterilizations are available. The provider interview on services collects information on price and volume of services, provider qualifications available at the outlet and the availability of a minimum set of equipment needed to provide the service. A representative sample of outlets is identified within target study domains such that findings from the outlet survey provide estimates of contraceptive availability, price and relative market share across the entire market as well as within key market segments.

www.FPwatch.info Page 81

2. Key informant interviews

The outlet survey was complemented by in-depth interviews conducted with key informants at the national and state levels. The interviews provided context for national family planning trends, policies and strategy for interpreting the data.

www.FPwatch.info Page 82

Annex 2: Myanmar Background Myanmar is the 26th most populous country in the world and harbours 0.73% of the world’s population. In 2015, it was reported that maternal mortality ratio (MMR) is 178/100,000 live births in Myanmar. To reduce MMR, family planning has proven to be one of the most cost-effective in developing countries. The Maternal and Reproductive Health Division of the Ministry of Health and Sports (MOHS) is the key player for the health of women for reproductive age (WRA). Moreover, specific objectives regarding family planning includes 1) reduce unmet need for contraception and unplanned births; and 2) reduce socio-economic disparities in access to and use of contraception.

Important gains have been made in availability and access to modern contraceptive methods in Myanmar in recent years. The modern contraceptive prevalence rate (mCPR) has increased from 32.8% in 2001 to 52% in the most recent 2015-2016 Demographic and Health Survey (DHS). However, unmet need for modern family planning methods remains high at 16% and regional disparities and inequities in access between urban and rural and rich and poor populations persist. In 2013, the Government of Myanmar committed the nation to the FP2020 Initiative goal to enable 120 million additional women and girls to have informed choice and access to family planning information and a range of modern contraceptive methods. The FP2020 commitments include national efforts to:

 Increase mCPR from 41% to 50% by 2015 and over 60% by 2020.  In fiscal year 2011-2012, Myanmar committed USD $1.29million for the purchase of contraceptives during the 2012-2013 financial period and pledges to increase the health budget to cover nearly 30 million couples by 2020.  Boost partnership with the private sector, civil society organizations, and other development partners for expanded service delivery. They will continue to strengthen logistics management information system to ensure reproductive health commodity security through improved projection, forecasting, procurement, supply, storage, systematic distribution, and inventory control.  Improve the method mix with an increased use of long acting permanent methods of birth control.  Implement a monitoring system to strengthen quality of care and ensure women have a full range of contraceptive options.  Address regional disparities and inequalities.  Review and develop a five-year strategic plan for reproductive health through a consultative progress.  Strengthen the policies on clinical contraceptive methods through increased collaboration with stakeholders within the context of the Nay Pyi Taw Accord.  Expand the forum of family planning under the umbrella of the Health Sector Coordinating Committee and create an Executive Working Group on Family Planning as a branch of the Maternal Newborn and Child Health Technical Strategic Group.  Achieve universal access to sexual and reproductive health and promote reproductive rights, and to reduce maternal mortality.

From 2014 to 2016, an annual health facility survey looking at the availability of family planning and reproductive health commodities in the public sector was completed. However, high-quality evidence related to the private- sector provision of modern family planning methods remains limited leaving a critical gap in monitoring efforts to track progress on the FP2020 indicators. The Maternal and Reproductive Health Unit of the Department of Public Health, with the support of United Nations Population Fund (UNFPA), is leading coordination of the public, NGO and private health sectors to generate and share information on progress toward FP2020 commitments.

www.FPwatch.info Page 83

Figure X1. Map of Myanmar

Healthcare system In Myanmar, the Department of Health under the MOHS is responsible for providing comprehensive health care services to the entire population in the country. The following divisions are in operation; Administration, Planning, Public Health, Medical Care, Disease Control, Epidemiology, Law and Legislation, National Health Laboratory, Occupational Health, Nursing and Budget. The public health division is responsible for primary health care and basic health services, nutrition promotion and research, environmental sanitation, maternal and child health services, school health services and health education. The State/Regional Health Department is responsible for state and regional planning, coordination, training and technical support, close supervision, monitoring and evaluation of health services. At the peripheral level, i.e. the township level, actual provision of health services to the community is undertaken.

www.FPwatch.info Page 84

Basic health staff are responsible for providing the majority of comprehensive health care services. In Rural Health Centers (RHCs), one health assistant (HA), one lady health visitor (LHV), five midwives and five Public Health Supervisors Grade II must be present. Supervisors are responsible for disease control activities and environmental sanitation, but due to the shortage of supervisors, midwives carry out all health care activities especially in rural areas. Midwives must responsibility for maternal and child health care as well as for immunization, nutrition promotion and disease control activities. Family planning services in Myanmar are provided through both public and private sectors.

In the private sector, private hospitals and clinics (some socially franchised such as PSI’s Sun Quality Trust Clinics (SQTs) and poly-clinics), private doctors, private (community) health workers and pharmacists provide FP commodities and services. Doctors and health workers typically have credentials and training to provide a range of services and pharmacies may be staffed with providers trained in specific FP services. There are not currently standardized regulations for provision of FP commodities and services in the private sector. There are also general retailers and itinerant drug vendors (IDVs) that provide FP commodities and services. Provision of FP services is largely unregulated among these outlets and providers.

FP2020 and Family Planning Policy Myanmar has taken several steps to achieve its policy, financial, and program goals to meet it’s FP2020 commitments. As of 2016, Myanmar committed to task-shifting oral contraceptive and condom method provision to Auxillary Midwives (AMW) under the supervision of Midwives. Training on long-term family planning methods (particularly, implants) was provided for the public sector with the support of UNFPA, PSI, Jhpiego and ObGy Society/ MMA. Myanmar held health care provider trainings on how best to provide services to the peri-urban poor in the Yangon region (reaching 34 townships), Mandalay region (23 townships), and Magway region (25 townships), where maternal mortality is high and unmet need is high.

Myanmar also developed a five-year strategic plan for reproductive health as well as a Costed Implementation Plan in 2014 to meet its FP2020 commitments. During the 2015-2016 budget year, the Ministry of Health and Sports spent US $2.8 million for all logistics of maternal and reproductive health (records, registers, and maternal medicines). The MOHS is working continuously on strengthening its logistics management information system to ensure reproductive health commodity security. Capacity building of M&E officers was carried with the support of Track20 team and consensus building workshops were conducted with all FP stakeholders. Since 2014, the Reproductive Health Commodity Logistic System was implemented in 212 townships. In 2016, with technical support from JSI and financial support from UNFPA, 55 townships under Shan (South) and Mandalay regions worked to expand the monitoring system.

Nationwide implant training was conducted for health care providers in the public sector in 2016 through a public-private partnership approach. To monitor the effectiveness of implant training, the lead FP working committee agreed to use a post training assessment form and quality control checklist with technical support from JHPIEGO and PSI. The funding gap to cover all other states and regions is under the negotiation of the MOHS and the 3MDG Fund.

Modern contraceptive methods usage In Myanmar, 51% of currently married women use some modern contraceptive method. Commonly used methods include injectables (28%), pills (14%) and female sterilization (5%), according to Demographic and Health Survey 2015-2016. Traditionally FP efforts have focused on female sterilizations as a contraceptive method, however, with the introduction of long acting reversible contraceptive methods and an improvement in the knowledge and choices of other available contraceptive options, it is expected that use of this preferred method will decline. In an effort to expand the basket of choices for contraceptive methods for women and increase uptake of family planning methods, the government of Myanmar allowed the introduction of the implants and IUDs through the private sector. Generally, there has been an increase in uptake of injectable methods prompting an increase in the number of distributors for the product. While significant improvements have been made there are still significant challenges and barriers to methods uptake, mainly provider biases and the reluctance by physicians to prescrible or recommend specific methods. Discontinuation of use among women initiating injectable methods due to concerns about changes in menstruation is another challenge including community myths and perceptions as well as safety concerns about invasive methods such as IUDs and implants.

www.FPwatch.info Page 85

Efforts have been made through various agencies partnering with the state government to reduce barriers through advocacy, community and provider outreach and education, as well as the provision of counselling and follow-up services to clients.

www.FPwatch.info Page 86

Annex 3: Outlet Survey Methods Design and Study Population

FPwatch implements cross-sectional outlet surveys in project countries. The study population is defined as all outlets with the potential to sell or distribute modern contraceptives and/or provide associated contraceptive services. In Myanmar this includes the following outlet types:

Private not-for-profit Private not-for-profit facilities include NGO hospitals, health centers, facilities clinics and health posts. Private for-profit facilities Private for-profit facilities include private hospitals, clinics and poly- clinics including Sun-Quality Health (SQH) clinics and Sun Primary Health (SPH) providers. Pharmacies/drug shops Pharmacies and drug shops sell all classes of medicines including prescription-only medicines; this includes outlets that are mainly retail and outlets that are mainly wholesale but do some retail sales. General retailers General retailers are grocery stores and village shops that sell fast- moving consumer goods, food and provisions. Itinerant drug vendors Mobile providers selling medicines and other goods; they are not registered with any national regulatory authority and have no formal training. (Community) health General practitioners offering non-facility-based (home-based or mobile workers provision) community-based services. These providers may practice within government health facilities and see patients outside of regular working hours (midwife, malaria inspector, health assistant, nurse, auxiliary nurse midwife, village malaria volunteer). This also includes PSI- M community health services provider (CHSP).

Stratification The outlet survey used explicit stratification to provide estimates within three study domains: 1) Rural (village tracts): This research domain was drawn from all areas designated as village tracts within townships as designated by the Myanmar government for administrative purposes. This covers approximately 67% of the total population of Myanmar. 2) Urban (wards): This research domain was drawn from all areas designated as urban wards within townships, other than for the metropolitan areas of Yangon and Mandalay, as designated by the Myanmar government for administrative purposes. This covers approximately 20% of the total population of Myanmar. 3) Metropolitan (wards): This research domain was drawn from urban wards in Yangon and Mandalay metropolitan areas. This covers approximately 13% of the total population of Myanmar.

Eligibility Criteria 1. Private sector outlets with potential to sell/distribute modern contraceptives or provide family planning services will be included in the census screening. 2. Outlets are eligible for a provider interview and family planning product audit if they meet at least one of three study criteria: o One or more modern contraceptives (including oral contraceptives, emergency contraceptives, contraceptive injections, contraceptive implants or IUDs) reportedly in stock on the day of the survey; o One or more of these modern contraceptives reportedly in stock within the past 3 months; or o Family planning services available (including injection of contraceptive injections, insertion of contraceptive implants or IUDs or provision of male/female sterilizations).

Sampling The outlet survey used a census approach for selecting outlets into the study. All outlets that are potentially eligible for the study were approached within a sampled administrative unit using a full census approach. The primary sampling approach taken for outlet surveys entails sampling a set of administrative units (geographic clusters) with a corresponding population of approximately 10,000 to 15,000 inhabitants. The appropriate

www.FPwatch.info Page 87 administrative unit in Myanmar corresponding to this desired population size is village tract (a cluster of villages) in rural areas and urban ward in urban areas. There are over 3,000 wards and over 13,000 village tracts in Myanmar. The next administrative unit above this level is township and there are 330 townships nationwide. Out of 330 townships 18 are self-administered and 41 townships were not accessible due to security reason and political issues. Therefore, these townships were excluded from the sampling frame. A sampling frame with population sizes was used for selecting the sample because accurate estimates on the total number of outlets per geographic/administrative unit that may be eligible do not exist. The major assumption in using population figures for sampling is that distribution of outlets and/or distribution of medicines moving through outlets in a given cluster is correlated with population size. Township, village tract and urban ward population estimates were obtained from the 2014 Myanmar Department of Population based on the Myanmar Population and Housing Census.

A representative sample of village tracts/ wards were selected in each research domain.  Rural domain: two-stage systematic random cluster sampling was used to select village tracts. At first- stage, townships were selected using probability proportionate to population size (PPS) sampling. Within selected townships, rural village tracts were sampled from a list of all village tracts using PPS.  Urban domain: two-stage systematic random cluster sampling was used to select urban wards. At first- stage, townships were selected using PPS sampling. Within selected townships, urban wards were sampled from a list of all village tracts using PPS.  Metropolitan domain: single-stage systematic random cluster sampling will be used to select metropolitan urban wards. Each cluster was sampled from a list of all wards within the Yangon and Mandalay metropolitan areas using PPS.

Within each cluster, a census of all outlets with the potential to sell/distribute modern contraceptives or provide family planning services was conducted. The census approach taken within 705 clusters yielded sufficient sample size for estimating key indicators among most outlet types.

Key Informant Interviews Purposive sampling was used to select key informants for in-depth interviews. KIIs stated with key persons within the MOHS and NGOs identified by PSI-M and then will snowball to select individuals from the government family planning and reproductive health programs, donor organizations, and other implementing partners.

Sample Size A sample size calculation was completed to identify minimum sample size requirements to estimate with precision (+/-5 percentage points) the proportion of outlets with three or more modern methods of contraception available on the day of the survey, among private outlets with at least one modern contraceptive method available, in each of the three selected strata. This indicator was chosen because it is highly relevant for FP2020 goals for women and girls to have informed choice and access to family planning information and a range of modern contraceptive methods.

The required sample size for each research domain was calculated in three steps: 1) determine the required number of modern family planning method stocking outlets; 2) determine the number of enumerated outlets to arrive at the required number of modern family planning method stocking outlets; and 3) determine the number of clusters for the census to arrive at this number of outlets. The study was powered based on estimated numbers of private sector outlets per village tract/ward in study areas based on findings from previous ACTwatch outlet surveys conducted in Myanmar and PSI-M reproductive health surveys.

The following sample sizes met requirements for the FPwatch estimations for each research domain:  Rural domain: 55 townships, 6 clusters per township: 320 clusters  Urban domain: 55 townships, 5-6 clusters per township: 290 clusters  Metropolitan domain: 95 clusters

This is a total of 705 study clusters (wards/village tracts) across 3 survey domains.

www.FPwatch.info Page 88

Data Collection Interviewers, supervisors, and quality controllers received training that included an orientation to the study, questionnaire, and classroom training on completing contraceptive product audits, and a field exercise. Following training, data collection was implemented from February 29th and May 20th 2016.

A structured questionnaire was used for all interviews (see Annex 7). A series of screening questions was administered at all outlets to determine eligibility for the survey. Outlets where contraceptives were reportedly sold and/or services was reportedly provided were invited to participate in the full survey. Following verbal informed consent procedures, an audit of all available contraceptive commodities was conducted. Contraceptive audit information included formulation, package size, brand name, active ingredients and strengths, manufacturer, country of manufacture, reported sale/distribution in the week preceding the survey, retail price, and wholesale price. Detailed descriptions of contraceptives audited are provided in Annex 8. In addition to the product audit, a series of questions was administered to the senior-most provider on contraceptive services as well as provider training and qualifications.).

The interview was conducted using paper questionnaires and entered with Census and Survey Processing System (CSPro) software. The questionnaire, including the information sheet and informed consent, were translated and back-translated to confirm valid translations in Myanmar language. The database were also programmed with automated skips and range checks to prevent missing data and/or entering impossible or implausible information.

Up to three visits were made to all outlets to complete the screening process, audit, and provider interview as needed (e.g. where outlets were closed or providers were not available Geo-coordinates were collected for each outlet using Garmin Etrex ® GPS devices.

Protection of Human Subjects The outlet survey protocol was submitted to and approved by the PSI Research Ethics Board as well as Ethical Review Committee of Department of Medical Research. Provider interviews and product audits were completed only after administration of a standard informed consent form and provider consent to participate in the study.

Timeframe Data collection occurred between February 29th and May 20th 2016 following a 10-day fieldworker training and took up to ten weeks to complete data collection.

www.FPwatch.info Page 89

Annex 4: Sampled Clusters

Division Metro/ Urban/ Ward Township name Ward name Name Rural population Mandalay Aungmyaythazan U Poke Htaw(W) Metro 27574 Mandalay Aungmyaythazan Daw Na Bwar(W) Metro 24258 Mandalay Aungmyaythazan Aung Myay Thar Zan(W) Metro 17251 Mandalay Aungmyaythazan Ah Hneik Taw(W) Metro 12665 Mandalay Aungmyaythazan Ah Ma Ra Htar Ni (West)(W) Metro 5706 Mandalay Chanayethazan Pyi Gyi Pyawbwe (West)(W) Metro 18078 Mandalay Chanayethazan Maw Ra Gi War(W) Metro 13292 Mandalay Chanmyathazi Aung Pin Lel(W) Metro 25061 Mandalay Chanmyathazi Mya Yi Nan Dar(W) Metro 20622 Mandalay Chanmyathazi Kyung Lone U Shaung(W) Metro 19337 Mandalay Chanmyathazi Aung Thar Yar(W) Metro 17701 Mandalay Chanmyathazi Myo Thit No (1)(W) Metro 15550 Mandalay Mahaaungmyay Than Hlet Maw (West)(W) Metro 31333 Mandalay Mahaaungmyay Sein Pan(W) Metro 21767 Mandalay Mahaaungmyay Ye Mun (South)(W) Metro 16500 Mandalay Mahaaungmyay Hay Ma Mar Lar (South)(W) Metro 6471 Mandalay Pyigyitagon Thin Pan Kone(W) Metro 32174 Mandalay Pyigyitagon (Sa Lone)(W) Metro 26062 Mandalay Pyigyitagon Ngwe Taw Kyi Kone(W) Metro 20141 Mandalay Pyigyitagon (Za Gwe)(W) Metro 13944 Yangon Ahlone Ga Lon(W) Metro 4336 Yangon Ahlone Saw Ran Paing(East)/Sayar Hmat Gyi (East)(W) Metro 4171 Yangon Bahan Shwe Taung Kyar No(1)(W) Metro 3814 Yangon Dagon York Lan(W) Metro 7336 Yangon Dagon Myothit (East) No(5)(W) Metro 8168 Yangon Dagon Myothit (East) No(2)(W) Metro 3374 Yangon Dagon Myothit (North) No(51)(W) Metro 11110 Yangon Dagon Myothit (North) No(34)(W) Metro 6790 Yangon Dagon Myothit (North) No(36)(W) Metro 4936 Yangon Dagon Myothit (Seikkan) No(88)(W) Metro 15382 Yangon Dagon Myothit (South) No(70)(W) Metro 18275 Yangon Dagon Myothit (South) No(19)(W) Metro 16777 Yangon Dagon Myothit (South) No(54)(W) Metro 16240 Yangon Dagon Myothit (South) No(56)(W) Metro 15868 Yangon Dagon Myothit (South) No(17)(South)/ No (17)(W) Metro 13668 Yangon Dagon Myothit (South) No(106)(W) Metro 11374 Yangon Dagon Myothit (South) No(24)(W) Metro 9211 Yangon Dagon Myothit (South) No(64)(W) Metro 4655 Yangon Dala Htaw (Lower)(VT) Metro 2365 Yangon Dala Rakhine Chaung (North)(VT) Metro 1911 Yangon Dawbon Ya Mon Nar(2)(W) Metro 7689 Yangon Hlaing No(13)(W) Metro 21015 Yangon Hlaingtharya No(5)(W) Metro 48386 Yangon Hlaingtharya No(7)(W) Metro 46988

www.FPwatch.info Page 90

Yangon Hlaingtharya Oke Kan Thaung Kyar (Yae Oke Kan)(VT) Metro 42201 Yangon Hlaingtharya No(3)(W) Metro 28790 Yangon Hlaingtharya No(18)(W) Metro 23773 Yangon Hlaingtharya No(16)(W) Metro 23372 Yangon Hlaingtharya Ku Lar Gyi Su(VT) Metro 14818 Yangon Hlaingtharya No(13)(W) Metro 11631 Yangon Insein Sint Ngu(W) Metro 22861 Yangon Insein Aung San(W) Metro 18555 Yangon Kamaryut No(3)(W) Metro 17021 Yangon Kamaryut No(7)(W) Metro 6907 Yangon Lanmadaw No(7)(W) Metro 7626 Yangon Mayangone No(5)(Sein Pan Myaing/9 Miles)(W) Metro 38672 Yangon Mayangone No(2)(Tha Maing Myo)(W) Metro 34588 Yangon Mayangone No(6)(Nyar Na Sar Gi)(W) Metro 9387 Yangon Mingaladon Thin Gan Kyun Gyi(VT) Metro 42350 Yangon Mingaladon Shwe Nant Thar(VT) Metro 39989 Yangon Mingaladon Pauk Kone(W) Metro 29829 Yangon Mingaladon Nwe Khway(VT) Metro 14159 Yangon Mingaladon San Gyi Wa(W) Metro 9764 Yangon Mingaladon Htauk Kyant (Myauk Paing)(W) Metro 7935 Yangon Mingalartaungnyunt Yae Twin Kone(W) Metro 12102 Yangon Mingalartaungnyunt Kan Taw Ka Lay (South)(W) Metro 10684 Yangon Mingalartaungnyunt Lut Lat Yay(W) Metro 4038 Yangon North Okkalapa Shwe Pauk Kan Myo Thit(W) Metro 66531 Yangon North Okkalapa (Hta Won Bei)(W) Metro 48446 Yangon North Okkalapa No(2)(W) Metro 28571 Yangon North Okkalapa (Kha)(W) Metro 8329 Yangon North Okkalapa (Ga)(W) Metro 7139 Yangon North Okkalapa Ta Dar Gyi Ward(W) Metro 5413 Yangon Pazundaung SubNo(8)(W) Metro 3568 Yangon Sanchaung Kyun Taw (North)(W) Metro 2975 Yangon Shwepyithar No(10)(W) Metro 27053 Yangon Shwepyithar Oke Hpo(VT) Metro 17812 Yangon Shwepyithar No(13)(W) Metro 12486 Yangon Shwepyithar No(20)(W) Metro 8961 Yangon South Okkalapa No(10)(W) Metro 13147 Yangon South Okkalapa No(15)(W) Metro 8476 Yangon Tamwe Ma Au Kone(W) Metro 12977 Yangon Tamwe Kyar Kwet Thit(W) Metro 10016 Yangon Thaketa No(10)(South)(W) Metro 36384 Yangon Thaketa No(1) Htu Par Yon(W) Metro 11887 Yangon Thanlyin Let Yet San(VT) Metro 26742 Yangon Thanlyin Bo Gyoke(VT) Metro 21239 Yangon Thanlyin Aung Chan Thar(W) Metro 10403 Yangon Thanlyin Myo Ma (South)(W) Metro 5244 Yangon Thanlyin Nga/Pa(VT) Metro 2687 Yangon Thanlyin Win Kha Nee(VT) Metro 1179 Yangon Thingangyun San Pya(W) Metro 10848 www.FPwatch.info Page 91

Yangon Thingangyun Ga Ward(W) Metro 6160 Yangon Yankin No(11)(W) Metro 8651 Yangon Yankin No(5)(W) Metro 5930 Ayeyarwady Bogale No (6)(W) Urban 7591 Ayeyarwady Bogale No (10)(W) Urban 4564 Ayeyarwady Bogale No (2)(W) Urban 3313 Ayeyarwady Bogale No (7)(W) Urban 6018 Ayeyarwady Bogale No (8)(W) Urban 4982 Ayeyarwady Einme Ah Htet Paing(W) Urban 4666 Ayeyarwady Einme Chaung Wa Paing(W) Urban 3350 Ayeyarwady Kyonpyaw Aung San(W) Urban 7355 Ayeyarwady Kyonpyaw Mya Wa Di(W) Urban 1948 Ayeyarwady Kyonpyaw Tay Za(W) Urban 2947 Ayeyarwady Kyonpyaw Pin Lon(W) Urban 4295 Ayeyarwady Maubin Ma Har Baw Di Ward(W) Urban 2647 Ayeyarwady Maubin Say Yon(W) Urban 2518 Ayeyarwady Maubin Sar Yay Kone(W) Urban 5432 Ayeyarwady Maubin Aung Myay Thar Zi(W) Urban 3798 Ayeyarwady Maubin Hlay Seik Myauk Paing(W) Urban 3291 Ayeyarwady Myaungmya Mya Sandar(W) Urban 5262 Ayeyarwady Myaungmya Mya Hay Mar(W) Urban 3558 Ayeyarwady Myaungmya Ma Yan Gone(W) Urban 7840 Ayeyarwady Myaungmya Mya Yadanar(W) Urban 5928 Ayeyarwady Nyaungdon No (10)(W) Urban 2224 Ayeyarwady Nyaungdon No (8)(W) Urban 3707 Ayeyarwady Pyapon No (18) (Kan Taw Min Ga Lar )(W) Urban 3666 Ayeyarwady Pyapon No (1)(W) Urban 1379 Ayeyarwady Pyapon No (17) (Leik U Kone Kwet Thit)(W) Urban 4357 Ayeyarwady Pyapon No (15) (Bo Chyoke Kwet Thit)(W) Urban 6620 Ayeyarwady Pyapon No (8) (Ah Pyaung )(W) Urban 1226 Ayeyarwady Pyapon No (9) (Kwet Thit (North) )(W) Urban 1100 Ayeyarwady Pyapon No (4) (Ma Gyi Tan)(W) Urban 1812 Ayeyarwady Pyapon No (14) (Sit Kwet Thit)(W) Urban 3599 Ayeyarwady Yegyi Thaung Tan (Aung San)(W) Urban 2854 Ayeyarwady Yegyi Aung San(W) Urban 1764 Ayeyarwady Yegyi Shwe Bo(W) Urban 3780 Bago (E) Bago Zyaing Ga Naing (South)(W) Urban 7410 Bago (E) Bago Hin Thar Kone(W) Urban 8148 Bago (E) Bago Pon Nar Su(W) Urban 12285 Bago (E) Bago No (8) OueThar 8(W) Urban 12641 Bago (E) Bago No (7) OueThar 7(W) Urban 10550 Bago (E) Bago Han Thar Wa Di(W) Urban 5041 Bago (E) Bago No (1) OueThar 1(W) Urban 10705 Bago (E) Bago No (2) OueThar 2(W) Urban 6517 Bago (E) Bago Myo Twin West (Kha Gway)(W) Urban 11142 Bago (E) Bago Myo Thit(W) Urban 10537 Bago (E) Bago Bo Kone(W) Urban 5566 Bago (E) Bago Ma Zin (Kka Gway)(W) Urban 10579 www.FPwatch.info Page 92

Bago (E) Bago Leik Pyar Kan(W) Urban 5358 Bago (E) Bago Ma Zin( Ga Nge)(W) Urban 11891 Bago (E) Bago Myo Twin (East-Kha Gway)(W) Urban 31389 Bago (E) Bago Phyar Gyi (1)(W) Urban 5758 Bago (E) Bago No (4) OueThar 4(W) Urban 3445 Bago (E) Bago Zyaing Ga Naing (North)(W) Urban 8570 Bago (E) Bago No (6) OueThar 6(W) Urban 4279 Bago (E) Bago Kyauk Gyi Su(W) Urban 7867 Bago (E) Bago Ma Zin(Ka Gyi)(W) Urban 19954 Bago (E) Bago Myo Twin (East-Ka Gyi)(W) Urban 9091 Bago (E) Kyauktaga Kwin (North)(W) Urban 3023 Bago (E) Kyauktaga Zay Paing(W) Urban 2531 Bago (E) Phyu No (4)(W) Urban 4011 Bago (E) Phyu Zay(W) Urban 1656 Bago (E) Phyu Ka Nyut Kwin (West 1)(W) Urban 5100 Bago (E) Phyu No (1)(W) Urban 7433 Bago (E) Phyu No (2)(W) Urban 5393 Bago (E) Phyu Ka Nyut Kwin (East 1)(W) Urban 4594 Bago (E) Phyu Ka Nyut Kwin (East 2)(W) Urban 4526 Bago (E) Waw Waw Ah Shey Bet Kan(W) Urban 10262 Bago (W) Monyo Shwe U Daung(W) Urban 2303 Bago (W) Monyo Zaw Ti Ka(W) Urban 1867 Bago (W) Paungde Min Kwet No (1)(W) Urban 1990 Bago (W) Paungde Nwe Cho (1)(W) Urban 2629 Bago (W) Paungde Min Kwet No (3)(W) Urban 4092 Bago (W) Paungde Oke Hpo (1) east(W) Urban 2362 Bago (W) Paungde Nwe Cho (2)(W) Urban 1734 Bago (W) Thegon Kan Taw Min Ga Lar(W) Urban 2331 Bago (W) Thegon Chan Myae Tharyar(W) Urban 4739 Kachin Mohnyin Mya Thi Dar(W) Urban 5887 Kachin Mohnyin Oke Kyin(W) Urban 4677 Kachin Mohnyin Myo Ma(North)(W) Urban 5820 Kachin Mohnyin Aung Tha Pyay(W) Urban 6665 Kachin Mohnyin Nam Khar(W) Urban 7721 Kachin Mohnyin Myo Ma(South)(W) Urban 5297 Kachin Mohnyin Ah Shey Su(W) Urban 7154 Kayin Hlaingbwe No (4)(W) Urban 22 Kayin Hlaingbwe No (4)(W) Urban 897 Kayin Hlaingbwe (Ka Gyi)(W) Urban 4432 Magway Aunglan Ywa htaung(W) Urban 10067 Magway Aunglan San Chaung(W) Urban 7728 Magway Aunglan Zay Kone(W) Urban 3266 Magway Aunglan Set Yon(W) Urban 10963 Magway Magway Aung Myit Tar(W) Urban 10793 Magway Magway Min Kan Gyi(W) Urban 10419 Magway Magway Ywar Thit Pwe Kyo(W) Urban 6219 Magway Magway Sar Shwe Kin(W) Urban 5953 Magway Magway Pyi Taw Thar(W) Urban 5602 www.FPwatch.info Page 93

Magway Magway Thein Gar Gi(W) Urban 9560 Magway Magway Aung Ya Ta Nar(W) Urban 8036 Magway Magway Aung Min Ga Lar(W) Urban 8290 Magway Magway Kan Thar(W) Urban 7409 Magway Magway Myin Thar(W) Urban 6332 Magway Natmauk Myo Ma Kwet Thit(W) Urban 1704 Magway Natmauk Kan Gyi(W) Urban 1573 Magway Pauk Aung Chan Thar(W) Urban 1436 Magway Yesagyo No (8)(W) Urban 5036 Magway Yesagyo No (6)(W) Urban 2698 Magway Yesagyo No (1)(W) Urban 4379 Mandalay Kyaukse Sue Kone(W) Urban 4631 Mandalay Kyaukse Hpaung Ywar(W) Urban 3907 Mandalay Kyaukse Aye Mya Kyi Lin(W) Urban 6073 Mandalay Kyaukse Baw Ga Wa Di(W) Urban 5460 Mandalay Kyaukse Ye Su(W) Urban 4440 Mandalay Kyaukse Min Yat(W) Urban 5942 Mandalay Meiktila Thiri Mingalar(W) Urban 2843 Mandalay Meiktila Wun Zin(W) Urban 12315 Mandalay Meiktila Yan Myo Aung(W) Urban 14807 Mandalay Meiktila Ya Da Nar Man Aung(W) Urban 10476 Mandalay Meiktila Myo Ma(W) Urban 2747 Mandalay Meiktila Aung San(W) Urban 16341 Mandalay Meiktila Kyi Taw Kone(W) Urban 8678 Mandalay Meiktila Aung Zaya(W) Urban 11179 Mandalay Meiktila Pyi Thar Yar (North)(W) Urban 5117 Mandalay Meiktila Pauk Chaung(W) Urban 6413 Mandalay Myittha Myo Ma (East)(W) Urban 4411 Mandalay Patheingyi Myo Ma(W) Urban 13082 Mandalay Pyinoolwin Yat Kwet Gyi (4)(W) Urban 4792 Mandalay Pyinoolwin Yat Kwet Gyi (6)(W) Urban 9252 Mandalay Pyinoolwin Yat Kwet Gyi (19)(W) Urban 3501 Mandalay Pyinoolwin Pa Day Thar(W) Urban 10387 Mandalay Pyinoolwin Yat Kwet Gyi (2)(W) Urban 9184 Mandalay Pyinoolwin Yat Kwet Gyi (7)(W) Urban 15783 Mandalay Pyinoolwin Yat Kwet Gyi (1)(W) Urban 17094 Mandalay Pyinoolwin Yat Kwet Gyi (20)(W) Urban 3990 Mandalay Pyinoolwin Yat Kwet Gyi (14)(W) Urban 2056 Mandalay Pyinoolwin Yat Kwet Gyi (21)(W) Urban 9800 Mandalay Pyinoolwin Yat Kwet Gyi (18)(W) Urban 2729 Mandalay Pyinoolwin Yat Kwet Gyi (3)(W) Urban 15389 Mandalay Pyinoolwin Yat Kwet Gyi (17)(W) Urban 10309 Mandalay Pyinoolwin Yat Kwet Gyi (5)(W) Urban 14533 Mandalay Pyinoolwin Yat Kwet Gyi (10)(W) Urban 8756 Mandalay Pyinoolwin Yat Kwet Gyi (12)(W) Urban 5640 Mandalay Pyinoolwin Nan Da Wun(W) Urban 8010 Mandalay Pyinoolwin Yat Kwet Gyi (16)(W) Urban 2463 Mandalay Yamethin War Toe(W) Urban 7130 www.FPwatch.info Page 94

Mandalay Yamethin Aung Min Ga Lar(W) Urban 8894 Mon Kyaikto Kant Kaw (W) Urban 8995 Mon Kyaikto Kawt San Naing (W) Urban 7546 Mon Kyaikto Taung Thu Su (W) Urban 7019 Mon Kyaikto Myauk Paing (W) Urban 2893 Mon Paung Ka Dar (W) Urban 10735 Mon Paung Paung (W) Urban 6934 Naypyitaw Det Khi Na Thi Ri Det Khi Na Thi Ri(W) Urban 20528 Naypyitaw Det Khi Na Thi Ri Shwe In Kyinn (W) Urban 2666 Naypyitaw Tatkon Bo Min Yaung(W) Urban 5909 Naypyitaw Tatkon Ah Naw Ra Htar (W) Urban 8335 Naypyitaw Tatkon Sa Yar San(W) Urban 8145 Rakhine Kyaukpyu Ah Yar Shi(W) Urban 4665 Rakhine Myebon Myay Pon Myauk Paing(W) Urban 1286 Rakhine Myebon Thea Tan(W) Urban 2124 Rakhine Myebon Ku Lar Taung(W) Urban 3161 Rakhine Thandwe No(5)(W) Urban 1918 Rakhine Thandwe No(4)(W) Urban 3109 Rakhine Thandwe No(6)(W) Urban 2278 Sagaing Kale Hlaing Thar Yar(W) Urban 5523 Sagaing Kale Taung Zalat(W) Urban 10949 Sagaing Kale San Myo(W) Urban 8121 Sagaing Kale Myo Hla(W) Urban 4703 Sagaing Kale Gyo Thone Pin(W) Urban 7540 Sagaing Kale Tat U Thida(W) Urban 8984 Sagaing Kale Thazin(W) Urban 6598 Sagaing Kale Mingalar U Yin(W) Urban 5141 Sagaing Kale Aung Thit Sar(W) Urban 7278 Sagaing Kale Tar Han(W) Urban 14876 Sagaing Kale Chan Myayt Aung Si(W) Urban 12538 Sagaing Kale Nyaung Pin Thar(W) Urban 4845 Sagaing Kale Aung Myay Man(W) Urban 5116 Sagaing Katha Hlyat Sit Kone(W) Urban 2417 Sagaing Katha Zay Yar Chaung(W) Urban 4491 Sagaing Monywa Kwayt Gyi(W) Urban 7710 Sagaing Monywa Hpa Yar Gyi(W) Urban 3634 Sagaing Monywa Sit Pin(W) Urban 6351 Sagaing Monywa Thar Lar(W) Urban 21192 Sagaing Monywa Yone Gyi(W) Urban 9722 Sagaing Monywa Aung Chan Thar(W) Urban 9868 Sagaing Monywa Aung Min Ga Lar(W) Urban 2983 Sagaing Monywa Myo Thit(W) Urban 6826 Sagaing Monywa Monywa (South)(W) Urban 6275 Sagaing Monywa Oe Bo(South)(W) Urban 6137 Sagaing Monywa Nan Da Wun(W) Urban 15516 Sagaing Monywa Mya Wa Di(W) Urban 16753 Sagaing Monywa Inn Ywar Thit(W) Urban 5780 Sagaing Monywa Nat Lu Hteik Pan(W) Urban 8831 www.FPwatch.info Page 95

Sagaing Monywa Ah Lone(W) Urban 7546 Sagaing Monywa Htan Taw(W) Urban 15538 Sagaing Monywa Hpone Soe(W) Urban 5887 Sagaing Monywa Set Hmu Zon(W) Urban 11912 Sagaing Monywa Lel Di(W) Urban 3834 Sagaing Pinlebu Moe Kaung(W) Urban 3648 Sagaing Shwebo No (7)(W) Urban 7237 Sagaing Shwebo No(2)(W) Urban 3068 Sagaing Shwebo No (10)(W) Urban 15861 Sagaing Shwebo No (2)(W) Urban 5722 Sagaing Shwebo No (1)(W) Urban 9581 Sagaing Shwebo No(1)(W) Urban 2007 Sagaing Shwebo No (4)(W) Urban 6555 Sagaing Shwebo No (3)(W) Urban 4275 Sagaing Wetlet No (1)(W) Urban 4121 Shan (East) Tachileik Ma Ka Ho Hkam(W) Urban 7937 Shan (East) Tachileik Wan Kaung(W) Urban 9998 Shan (East) Tachileik No(1)(W) Urban 1018 Shan (East) Tachileik Pone Tun(W) Urban 9048 Shan (East) Tachileik Sang Hseng(W) Urban 16787 Shan (East) Tachileik No(1)(W) Urban 919 Shan (East) Tachileik Mae Khawng(W) Urban 6246 Shan (North) Lashio No(7)/Than Lwin(W) Urban 23076 Shan (North) Lashio No(8)/Aung Thi Dar(W) Urban 9782 Shan (North) Lashio No(4)/Ahr Yon Taw(W) Urban 10435 Shan (North) Lashio No(1)/Thi Ri Ma Har(W) Urban 28097 Shan (North) Lashio No(5)/Aung Min Ga Lar(W) Urban 20667 Shan (North) Lashio No(9)/Myanmar Khar Yoe Yar(W) Urban 17080 Shan (North) Lashio No(12)/Lashio Gyi(W) Urban 40079 Shan (North) Lashio No(10)/Myo Wan(W) Urban 11309 Shan (North) Lashio No(2)/Aung Myit Tar(W) Urban 3689 Shan (North) Nawnghkio Zay(W) Urban 3737 Shan (North) Nawnghkio Bu Tar(W) Urban 6801 Shan (South) Nyaungshwe Nan Da Wun(W) Urban 6953 Shan (South) Nyaungshwe Min Ga Lar(W) Urban 766 Shan (South) Taunggyi No(3)(W) Urban 4038 Shan (South) Taunggyi Zay Paing(W) Urban 1508 Shan (South) Taunggyi Kyaung Gyi Su(W) Urban 29344 Shan (South) Taunggyi No(9)(W) Urban 6869 Shan (South) Taunggyi Chan Mya Thar Zi(W) Urban 6380 Shan (South) Taunggyi Sao San Tun(W) Urban 11984 Shan (South) Taunggyi Ya Da Nar Thi Ri(W) Urban 8969 Shan (South) Taunggyi Min Ga Lar Shwe Baho(W) Urban 3530 Shan (South) Taunggyi No(8)(W) Urban 6456 Shan (South) Taunggyi Sint Hal(W) Urban 4957 Shan (South) Taunggyi Nyaung Hpyu Sa Khan(W) Urban 16839 Shan (South) Taunggyi Min Ga Lar U(W) Urban 6397 Shan (South) Taunggyi Thit Taw(W) Urban 7306 www.FPwatch.info Page 96

Shan (South) Taunggyi Shwe Bon Thar(W) Urban 5000 Shan (South) Taunggyi Dana Thei Di(W) Urban 2172 Shan (South) Taunggyi No(6)(W) Urban 8364 Shan (South) Taunggyi Yae Aye Kwin(W) Urban 10504 Shan (South) Taunggyi Kan (East)(W) Urban 3141 Shan (South) Taunggyi Hpa Yar Phyu(W) Urban 17763 Shan (South) Taunggyi Shwe Taung(W) Urban 9607 Shan (South) Taunggyi Kan Thar(W) Urban 7190 Shan (South) Taunggyi Kan Gyi(W) Urban 4144 Shan (South) Taunggyi Ming Ga Lar Aung Myay(W) Urban 5024 Shan (South) Taunggyi No(12)(W) Urban 6338 Tanintharyi Yebyu No(3)(W) Urban 1339 Tanintharyi Yebyu No(1)(W) Urban 538 Yangon Hmawbi No(4)(W) Urban 9483 Yangon Hmawbi No(1)(W) Urban 5107 Yangon Hmawbi No(3)(W) Urban 2588 Yangon Hmawbi No(2)(W) Urban 8782 Yangon Twantay Kyun Taw(W) Urban 5558 Yangon Twantay Min Paing(W) Urban 7143 Yangon Twantay Oe Bo (West)(W) Urban 5238 Yangon Twantay Kun Chan(W) Urban 9618 Ayeyarwady Bogale Aye Yar Rural 9126 Ayeyarwady Bogale Daunt Gyi Rural 16706 Ayeyarwady Bogale Hay Man Rural 12245 Ayeyarwady Bogale Ka Don Ka Ni Rural 14715 Ayeyarwady Bogale Ku Lar Ohn Pin Su Rural 1567 Ayeyarwady Bogale Kwin Pone Gyi Rural 1776 Ayeyarwady Bogale Kyun Thar Yar Rural 10648 Ayeyarwady Bogale Ma Yeit Ywar Thit Rural 2461 Ayeyarwady Bogale Nga Pi Chaung Rural 3833 Ayeyarwady Bogale Nyi Naung Wa Rural 3062 Ayeyarwady Bogale Tha Kan Wa Rural 3206 Ayeyarwady Bogale Thit Hpyu Chaung (Kan Su) Rural 4646 Ayeyarwady Bogale Ywar Thit Rural 2126 Ayeyarwady Einme Ah Su Gyi Rural 2547 Ayeyarwady Einme Ga Yet Gyi Rural 1498 Ayeyarwady Einme Hpa Yar Gyi Kone Rural 4385 Ayeyarwady Einme Htan Lay Pin Rural 3047 Ayeyarwady Einme Inn Ma Rural 1869 Ayeyarwady Einme Kyon Sein Gyi Rural 1975 Ayeyarwady Einme Tha Yet Kone Rural 2001 Ayeyarwady Einme Yae Thoe (Nyaung Waing) Rural 3452 Ayeyarwady Kangyidaunt Ah Htet Ta Khun Taing Rural 2204 Ayeyarwady Kangyidaunt Kyun Hlyar Shey Rural 2902 Ayeyarwady Kangyidaunt Kyun Taw Kone Rural 2583 Ayeyarwady Kangyidaunt Ma Ka Kyun Rural 2915 Ayeyarwady Kangyidaunt Pauk Kyun Rural 1938 Ayeyarwady Kangyidaunt Shan Rural 3028 www.FPwatch.info Page 97

Ayeyarwady Kangyidaunt Shan Ngu Rural 1617 Ayeyarwady Kangyidaunt Yae Twin Seik Rural 3291 Ayeyarwady Kyonpyaw Inn Ta Yaw Rural 3988 Ayeyarwady Kyonpyaw Kwin Thar Rural 2475 Ayeyarwady Kyonpyaw Man Kyar Rural 2805 Ayeyarwady Kyonpyaw Paik Taw Rural 2933 Ayeyarwady Kyonpyaw Thit Ma Thi Rural 2323 Ayeyarwady Maubin Auk Htone Rural 5683 Ayeyarwady Maubin Aung Bon Rural 4947 Ayeyarwady Maubin Hta Nee Rural 13747 Ayeyarwady Maubin Htan Pin Kwayt (East) Rural 4267 Ayeyarwady Maubin Kywe Done Rural 4606 Ayeyarwady Maubin Ma Let To Rural 19894 Ayeyarwady Maubin Mee Thway Chaung Rural 4779 Ayeyarwady Maubin Taw Ta Loke Rural 8167 Ayeyarwady Maubin Yae Le Gyi Rural 1385 Ayeyarwady Myaungmya Ah Twin Lay Bet Twar Rural 1955 Ayeyarwady Myaungmya Ba Maw Kun Thee Pin Rural 1744 Ayeyarwady Myaungmya Kone Thar Rural 5231 Ayeyarwady Myaungmya Kun Chan Rural 3022 Ayeyarwady Myaungmya Kyon Tar Moke Soe Ma Rural 2107 Ayeyarwady Myaungmya Moke Soe Kwin Rural 8335 Ayeyarwady Myaungmya Poe Laung Rural 3745 Ayeyarwady Myaungmya Put Kha Yaing Rural 2955 Ayeyarwady Myaungmya Pyin Pon Rural 4289 Ayeyarwady Myaungmya Sin Ku Kone Hteik Pyaung Rural 3189 Ayeyarwady Nyaungdon Gan Chaung Rural 3394 Ayeyarwady Nyaungdon Hnget Pyaw Kyun Rural 6905 Ayeyarwady Nyaungdon Hteik Wa Gyi Rural 3892 Ayeyarwady Nyaungdon Ka Nyin Kauk Gyi Rural 9765 Ayeyarwady Nyaungdon Moe Hoke Rural 2970 Ayeyarwady Nyaungdon Nat Pay Rural 6751 Ayeyarwady Nyaungdon Nyaung Rural 2886 Ayeyarwady Nyaungdon Set Kawt Yae Lel Kyun Rural 3954 Ayeyarwady Nyaungdon Tha Pyay Chaung Rural 4188 Ayeyarwady Nyaungdon Wea Daunt-Ah Twin Rural 3117 Ayeyarwady Pyapon Auk Kwin Gyi Rural 5090 Ayeyarwady Pyapon Ba Wa Thit Rural 22518 Ayeyarwady Pyapon Chaung Twin Rural 7445 Ayeyarwady Pyapon Daw Nyein Rural 26061 Ayeyarwady Pyapon Day Da Lu Rural 23165 Ayeyarwady Pyapon Gyo War Kyan Khin Su Rural 3725 Ayeyarwady Pyapon Kyon Ku Rural 8674 Ayeyarwady Pyapon Kyon Tar Shan Kwin Rural 4163 www.FPwatch.info Page 98

Ayeyarwady Pyapon Pyapon Ta Man Rural 3675 Ayeyarwady Pyapon Seik Ma Rural 6665 Ayeyarwady Pyapon Tei Pin Seik Rural 17415 Ayeyarwady Pyapon Tha Leik Gyi Rural 4204 Ayeyarwady Yegyi Inn Hlyar Kone Rural 1631 Ayeyarwady Yegyi Let Pan Pin Rural 3174 Ayeyarwady Yegyi Taung Lel Rural 1033 Ayeyarwady Yegyi Tha Khut Kone Rural 1137 Bago (East) Bago Inn Ta Kaw Rural 15504 Bago (East) Bago Kin Paing Chon Rural 3307 Bago (East) Bago Pyin Pon Gyi Rural 9821 Bago (East) Bago Ta Mar Pin Rural 2277 Bago (East) Bago Tat Ka Lay Rural 5727 Bago (East) Bago Win Ga Baw Rural 4754 Bago (East) Kyauktaga Khin Gyi(Shan Su) Rural 4260 Bago (East) Kyauktaga Khin Inn Gyi Rural 3157 Bago (East) Kyauktaga Kin Rural 6137 Bago (East) Kyauktaga Kyaung Soe Rural 4804 Bago (East) Kyauktaga Sin Za Loke Rural 4501 Bago (East) Kyauktaga Tha Min Inn Kone Rural 7079 Bago (East) Kyauktaga Tu Maung Rural 2051 Bago (East) Kyauktaga Waing Gyi Rural 1325 Bago (East) Phyu Hpyu Ah Shey Rural 9469 Bago (East) Phyu Ka Nyin Daing Rural 3813 Bago (East) Phyu Nyaung Pin Thar Rural 13028 Bago (East) Phyu Saik Tan Khin Rural 2027 Bago (East) Waw Hpa Yar Pyo Rural 2777 Bago (East) Waw Htein Ta Pin Rural 3615 Bago (East) Waw Kyon Eik Rural 2703 Bago (East) Waw Nyaung Kaing Rural 3132 Bago (East) Waw Oke Hpo Rural 3383 Bago (East) Waw Thu Ye Thu Mein Rural 7497 Bago (West) Monyo Htein Taw Rural 8070 Bago (West) Paungde Khay Man Rural 2528 Bago (West) Paungde Kyaung Taw Yar Rural 1070 Bago (West) Paungde Ma Gyi Kone Rural 1685 Bago (West) Paungde Ma Gyi Pin Rural 2173 Bago (West) Paungde Taung Boet Hla Rural 3085 Bago (West) Thegon Chaung Kan Gyi Rural 1554 Bago (West) Thegon Paik Chin Kone Rural 857 Bago (West) Thegon Yin Taik Hmaw Rural 4678 Kachin Mohnyin He Pu Rural 5036 Kachin Mohnyin Lel Mee Rural 5288

www.FPwatch.info Page 99

Kachin Mohnyin Nam Mar Rural 11086 Kachin Mohnyin Nam Mun Rural 12884 Kayin Hlaingbwe Ah Htet Yae Pu Rural 3777 Kayin Hlaingbwe Auk Yae Pu Rural 5939 Kayin Hlaingbwe Ka Mawt Le (Kyaung) Rural 3429 Kayin Hlaingbwe Ko Maung Rural 5187 Kayin Hlaingbwe Kun Tar Rural 5992 Kayin Hlaingbwe Kyet Tu Yway Rural 2604 Kayin Hlaingbwe Ta Wun Hpan Ya Rural 2357 Kayin Hlaingbwe Tar Paung Rural 5506 Kayin Hlaingbwe U Daung Rural 2836 Kayin Hlaingbwe Yin Baing Rural 1820 Magway Aunglan Du Yin Ga Bo Rural 3918 Magway Aunglan Ma Gyi Zin Rural 959 Magway Aunglan Ta Loke Pin Rural 4405 Magway Aunglan Tei Pin Rural 4068 Magway Aunglan Tha Hpan San Rural 1265 Magway Magway Let Pu To Rural 794 Magway Magway Lint Myint Rural 3797 Magway Magway Ngar Saung Rural 3765 Magway Natmauk Kyauk Tan Rural 5786 Magway Natmauk Le Bu Rural 6401 Magway Natmauk Tha Yet Chin Rural 4226 Magway Natmauk Thar Hmyar Rural 4021 Magway Natmauk Twin Gyi Rural 4137 Magway Natmauk Ywar Taw Rural 1450 Magway Pauk Chaing Zauk Rural 2485 Magway Pauk Chaung Nar Rural 1103 Magway Pauk Inn Tein Rural 527 Magway Pauk Kyauk Taing Khin Rural 6088 Magway Pauk Tha Mar Taw Rural 9568 Magway Sidoktaya Khway Ma Laung Rural 914 Magway Sidoktaya Myay Ni Kone Rural 1236 Magway Sidoktaya Nat Gyi Rural 1726 Magway Yesagyo Ah Lel Thaung Rural 3098 Magway Yesagyo Htan Se Pin Rural 1658 Magway Yesagyo Kan Thit Rural 2085 Magway Yesagyo Kan U Rural 1357 Magway Yesagyo Nan U Rural 2765 Magway Yesagyo Nyaung Taw Rural 2288 Magway Yesagyo Sin Ma Ye Rural 1806 Magway Yesagyo Zee Kone Rural 1592 Magway Yesagyo Zee Taw Rural 2190

www.FPwatch.info Page 100

Mandalay Kyaukse Dan Taing Rural 3633 Mandalay Kyaukse Hpyauk Seik Pin Rural 8991 Mandalay Kyaukse Ka Laing Kyaw Rural 2142 Mandalay Kyaukse Kyaung Rural 2558 Mandalay Kyaukse Myaung U Rural 1298 Mandalay Kyaukse Myay So Moe Kaung Rural 4008 Mandalay Kyaukse Ohn Kyaw Rural 990 Mandalay Kyaukse Pat Tar Rural 9227 Mandalay Kyaukse Shar Pin Rural 1406 Mandalay Kyaukse Thin Pyo Rural 638 Mandalay Kyaukse Ye Baw Gyi Rural 7317 Mandalay Meiktila Ga Lon Kone Rural 1988 Mandalay Meiktila Kan Thar Rural 10453 Mandalay Meiktila Khin Te Rural 3544 Mandalay Meiktila Kyaung Rural 4319 Mandalay Meiktila Taw Ma Rural 7873 Mandalay Meiktila Thee Kone Rural 2014 Mandalay Meiktila Yae Wai Rural 5647 Mandalay Meiktila Yae Wai Rural 3689 Mandalay Myittha Ku Me Rural 12144 Mandalay Myittha Myin Ywar Gyi Rural 1474 Mandalay Myittha Tha Pyay Taung Rural 7985 Mandalay Patheingyi Aing Gyi Rural 3875 Mandalay Patheingyi Nan Dar Rural 4877 Mandalay Patheingyi Nan U Lwin Rural 15746 Mandalay Patheingyi Ohn Chaw Rural 28689 Mandalay Patheingyi Shin Taw Kone Rural 6860 Mandalay Patheingyi Zee Oke Rural 7819 Mandalay Pyinoolwin Htone Bo Rural 3347 Mandalay Thabeikkyin Chaung Gyi Rural 16953 Mandalay Thabeikkyin Khun Hnit Maing Chan Thar Rural 11355 Mandalay Thabeikkyin Kyar Hnyat Rural 14993 Mandalay Thabeikkyin Kyauk Aing Rural 3269 Mandalay Thabeikkyin Ohn Zone Rural 34047 Mandalay Thabeikkyin Sa Bai Na Go Rural 4906 Mandalay Yamethin Ah Lel Kone Rural 3252 Mandalay Yamethin Kyauk Hpu Rural 3688 Mandalay Yamethin Kywe Tat Rural 2335 Mandalay Yamethin Oke Shit Kone Rural 2391 Mandalay Yamethin Se Gyi Rural 3470 Mandalay Yamethin Shwe Dar Thar Si Rural 4976 Mandalay Yamethin War Hpyu Taung Rural 16689 Mandalay Yamethin War Yon Taw Rural 1536

www.FPwatch.info Page 101

Mon Kyaikto Hpet Ka Leik Rural 7714 Mon Kyaikto Kin Mun Chaung Rural 20647 Mon Kyaikto Kyaik Ka Thar Rural 6275 Mon Kyaikto Kyun Taw Rural 3149 Mon Kyaikto Moke Pa Lin Rural 6434 Mon Kyaikto Thein Za Yat Rural 22853 Mon Paung Ah Hlat Rural 8228 Mon Paung Moke Ta Ma Rural 22355 Mon Paung Zin Kyaik Rural 20888 Nay Pyi Taw Tatkon Ah Lel Kyun Rural 2449 Nay Pyi Taw Tatkon Htan Taw Gyi Rural 5391 Nay Pyi Taw Tatkon Kin Mun Tan Rural 4734 Nay Pyi Taw Tatkon Tha Pyay Chaung Rural 4333 Rakhine Kyaukpyu Gant Gar Rural 2790 Rakhine Kyaukpyu Gyin Gyi Rural 4850 Rakhine Kyaukpyu Nga Seint Pyin Rural 2512 Rakhine Kyaukpyu Ohn Taw Rural 2657 Rakhine Myebon Hpa Lar Kya Rural 1674 Rakhine Myebon Kyauk Hpya Lar Rural 1211 Rakhine Myebon Sat Tet Rural 284 Rakhine Myebon Thin Ga Net Rural 735 Rakhine Myebon Yae Ni Gyi Rural 2628 Rakhine Myebon Yoe Sa Nwin Rural 5568 Rakhine Thandwe Gwayt Chaung Rural 2311 Rakhine Thandwe Kyauk Ka Lat Rural 6371 Rakhine Thandwe Pein Taw Gyi Rural 1176 Rakhine Thandwe Yae Kauk Rural 3221 Sagaing Chaung-U Khin Mun Rural 8450 Sagaing Chaung-U Su Lay Kone Rural 1896 Sagaing Chaung-U Taw Kyaung Gyi Rural 4464 Sagaing Chaung-U Taw Kyaung Lay Rural 4353 Sagaing Kale Mauk Lin Rural 19442 Sagaing Kale Nat Myaung Rural 2990 Sagaing Kale Pauk Taw Rural 1918 Sagaing Kale Pyin Taw U Rural 15147 Sagaing Kale Sa Khan Gyi Rural 8148 Sagaing Kale Thar Si Rural 11247 Sagaing Kale Tin Thar Rural 13347 Sagaing Kale Yae Shin Rural 2824 Sagaing Katha Bwet Rural 4488 Sagaing Katha Ka Lon Rural 3585 Sagaing Katha Sa Kar Kone Rural 8410 Sagaing Katha Than Pu Yar Rural 4574

www.FPwatch.info Page 102

Sagaing Monywa Kaw La Pya Rural 5809 Sagaing Monywa Kha Wea Kyin Rural 7949 Sagaing Monywa Kyay Mon Rural 3007 Sagaing Monywa Kyee Oke Rural 2442 Sagaing Monywa Min Rural 3368 Sagaing Monywa Myay Ne Rural 2750 Sagaing Monywa Pauk Pin Rural 3404 Sagaing Monywa Thet Kei Kyin Rural 3442 Sagaing Monywa Yaung Taw Tone Rural 2257 Sagaing Pinlebu Kha Ket Rural 1841 Sagaing Pinlebu Naung Mu Rural 6532 Sagaing Pinlebu Naung Taw Rural 2415 Sagaing Pinlebu Pin Maung Rural 2379 Sagaing Pinlebu War Yu Thar Rural 2678 Sagaing Shwebo Ma Khauk Rural 1518 Sagaing Shwebo Myin Chin Rural 3655 Sagaing Shwebo Myin See Rural 3502 Sagaing Shwebo Pa Laing Rural 6246 Sagaing Shwebo Tei Pin Rural 2801 Sagaing Shwebo Tei Pin Rural 6940 Sagaing Shwebo Ywar Taw Rural 2157 Sagaing Wetlet Hpa Yar Pyan Rural 2720 Sagaing Wetlet Ku Kaung Rural 3037 Sagaing Wetlet Kywe Zin Rural 2064 Sagaing Wetlet Ta Kaung Min Rural 2646 Sagaing Wetlet Tha Yet Gyi Rural 3527 Shan (East) Tachileik Hawng Leik/Wan Long Rural 33339 Shan (East) Tachileik Hpan Min Rural 9713 Shan (East) Tachileik Mong He Rural 5462 Shan (North) Lashio Mae Han Rural 6568 Shan (North) Lashio Man Pwe Long Rural 2862 Shan (North) Lashio Nam Pawng Rural 7245 Shan (North) Lashio Sum Kwei Rural 2597 Shan (North) Nawnghkio Doe Pin Rural 4431 Shan (North) Nawnghkio Hsam Ma Hse Rural 7105 Shan (North) Nawnghkio Kone Gyi Ywar Ma Rural 4547 Shan (North) Nawnghkio Long Yone Rural 7057 Shan (North) Nawnghkio Ong Ma Hkar Rural 4093 Shan (South) Laihka Nam Toke Rural 2240 Shan (South) Laihka Pong Taik Rural 2222 Shan (South) Laihka Wan Lay Rural 1705 Shan (South) Nyaungshwe He Yar Ywar Ma Rural 4528 Shan (South) Nyaungshwe Inn Tein Rural 3555 Shan (South) Nyaungshwe Kyun Gyi Rural 3603 Shan (South) Nyaungshwe Let Maung Kway Rural 2737 Shan (South) Nyaungshwe Lin Kin Rural 4822

www.FPwatch.info Page 103

Shan (South) Nyaungshwe Min Chaung Rural 8869 Shan (South) Nyaungshwe Sam Kar Rural 3927 Shan (South) Nyaungshwe Taung To Rural 4695 Shan (South) Nyaungshwe Tha Le U Rural 6998 Shan (South) Nyaungshwe Tha Pyay Pin Rural 5356 Shan (South) Taunggyi Ban Kway Rural 4659 Shan (South) Taunggyi Mong Thaw (East) Rural 14429 Shan (South) Taunggyi Nam See Rural 8576 Shan (South) Taunggyi Nawng Hke Rural 7598 Shan (South) Taunggyi Than Te Rural 5874 Tanintharyi Kyunsu Ma Aing Rural 10126 Tanintharyi Kyunsu Me Taw Rural 12050 Tanintharyi Kyunsu Taw Pyar Rural 8804 Tanintharyi Kyunsu Yae Kan Taung Rural 18087 Tanintharyi Yebyu Ein Da Rar Zar Rural 2621 Tanintharyi Yebyu Kan Pauk Rural 11531 Tanintharyi Yebyu Pa Ra Dat Rural 5146 Yangon Hmawbi Auk War Net Chaung Rural 6820 Yangon Hmawbi Bwet Gyi Rural 11727 Yangon Hmawbi Hle Ngoke Chaung Rural 8297 Yangon Hmawbi Hnaw Kone Rural 4107 Yangon Hmawbi Kan Ka Lay (M) Rural 1790 Yangon Hmawbi Let Pan Tan Su Rural 4367 Yangon Hmawbi Myo Chaung Rural 3853 Yangon Hmawbi Shwe Hlay Gyi Rural 1426 Yangon Hmawbi Tat Gyi Kone Rural 14265 Yangon Hmawbi Than Day Pin Rural 23825 Yangon Hmawbi Yin Taik Pin Rural 5612 Yangon Twantay Ah Ka la Rural 1761 Yangon Twantay Hpa Yar Gyi Rural 6349 Yangon Twantay Tha Wun Taw Rural 7422 Yangon Twantay Wet Chaung Rural 3330 Yangon Twantay Yae Kyaw Rural 3237

www.FPwatch.info Page 104

Annex 5: Map of Sampled Townships Figure X2. Map of Selected Townships

* All outlet types were screened for eligibility within selected clusters of the selected townships (green). The sampling frame (gray & green) included all townships that were not exclued for security/military reasons (white). Government supported health facilities were also not included in the sample.

www.FPwatch.info Page 105

Annex 6: Detailed Sample Descriptions Table X1: Myanmar Sample Description Community Private For- Private Not- Private General Itinerant Private Other Health Profit Health Pharmacy Total For-Profit Medical Total Retailer Drug Vendor Total Workers Facility Number of outlets screened (Figure 1 Box B) 1,898 7 1,311 1,661 4,877 31,368 478 31,846 36,723 Number of outlets eligible and interviewed (Figure 1 Box D) 1,407 6 1,051 1,560 4,024 3,469 298 3,767 7,791 Number of outlets eligible but not interviewed (interview non-participation) 2 0 10 4 16 2 1 3 19 Number of interviewed outlets with at least one modern contraceptive (excluding condoms) on the day of the survey (Figure 1, Box D1) 987 5 993 1,528 3,513 3,039 132 3,171 6,684 Number of interviewed outlets that provide associated FP services, but do not stock modern contraceptives (excluding condoms) (Figure 1 Box D3) 306 0 32 2 340 6 136 142 482

www.FPwatch.info Page 106

Table X2: Myanmar Metropolitan/Urban/Rural Sample Description Community Private For- Private Not- Private General Itinerant Private Other Health Profit Health Pharmacy Total For-Profit Medical Total Retailer Drug Vendor Total Workers Facility Number of outlets screened (Figure 1 Box B) Metropolitan 63 1 522 657 1,243 6,136 1 6,137 7,380 Urban 357 2 626 767 1,752 12,627 58 12,685 14,437 Rural 1,478 4 163 237 1,882 12,605 419 13,024 14,906 Number of outlets eligible and interviewed (Figure 1 Box D) Metropolitan 47 1 405 615 1,068 367 1 368 1,436 Urban 280 1 502 721 1,504 1,120 28 1,148 2,652 Rural 1,080 4 144 224 1,452 1,982 269 2,251 3,703 Number of outlets eligible but not interviewed (interview non-participation) Metropolitan 1 0 9 2 12 0 0 0 12 Urban 0 0 1 1 2 0 0 0 2 Rural 1 0 0 1 2 2 1 3 5 Number of interviewed outlets with at least one modern contraceptive (excluding condoms) on the day of the survey (Figure 1, Box D1) Metropolitan 35 1 392 603 1,031 337 1 338 1,369 Urban 194 1 464 704 1,363 1,004 15 1,019 2,382 Rural 758 3 137 221 1,119 1,698 116 1,814 2,933 Number of interviewed outlets that provide associated FP services, but do not stock modern contraceptives (excluding condoms) (Figure 1 Box D3) Metropolitan 9 0 9 1 19 1 0 1 20 Urban 65 0 20 0 85 1 8 9 94 Rural 232 0 3 1 236 4 128 132 368

www.FPwatch.info Page 107

Annex 7: Questionnaire

FPwatch Outlet Survey MYANMAR 2016

Section 1: CENSUS INFORMATION: Interviewer completes this section for ALL OUTLETS! Outlet ID (Interviewer-State/Region-Township-Ward/Village Tract-Outlet ID) [___|___]-[___|___]-[___|___]-[___|___|___|___]-[___|___|___]

C1. Today’s date (dd/mm/yyyy) [___|___]-[___|___]-[ 2| 0 | 1 | 6 ] C2. Interviewer’s name C2a. Interviewer’s code

[______] [___|___] C3. States/ Region C3a. Region code [___|___]

C 4. Township C4a. Township code

[______] [___|___] C5. Ward/Village Tract C5a. Ward/Village Tract code

[______] [___|___|___|___] C6. Village C6a. Township code

[______] [___|___] C7. Name of outlet ( If no name, record “no name.”) C7a. Outlet code

[______] [___|___|___] C8. Type of Outlet

01 Private Hospital 07 Informal Provider (Quack) 02 Poly Clinic 08 Village Health Volunteer/ Community Health Worker 03 Non-SQH Clinic (GP) 09 Pharmacy/drug shop-mainly whole sale 04 SQH Clinic 10 Pharmacy/drug shop-mainly retail [___|___] 05 SPH provider (CHSP) 11 General Store/convenience store 06 Government Health Staff /Government basic 12 Village Shop/ Betel shop health staff 96 Other (specify):[______] (specify):[______]

Hello, my name is ______, I work on behalf of PSI-Myanmar. We are conducting a study on the availability of family planning products and services. The results will be used to improve the availability of family planning services for Myanmar families. I would like to ask you a few questions to see if you could be part of the survey.

108 | P a g e

OUTLET ID: [___|___]-[___|___]-[___|___]-[___|___|___|___]-[___|___|___]

Section 2: SCREENING CONDOMS: Interviewer completes this section for ALL OUTLETS! Read to the provider: I have just a few questions for you about availability of condoms. CO1. Do you have any MALE condoms available at this location today?

1 = Yes 0 = No Verify with prompt card. Go to CO6. [___] CO2. What brands of MALE condoms do you have in stock today? (Show Prompt Card)

[______] [______] [______] [______] [______] [______] [______] [______] [______] [______] CO3. What is the MOST COMMON BRAND of MALE condom you sell/distribute to individual consumers? (Include brand and type).

[______] CO4. What is the price for this MOST COMMON BRAND of MALE condom (in CO3) you sell to individual consumers? (If condoms are sold individually, record ‘01’ for package size.)

This outlet sells a package of [___|___] condom(s) for [___|___|___|___] KYATS 98 = Don’t know 9998 = Don’t know 97 = Refused 9997 = Refused 0000 = Free CO5. How many MALE condoms OF ALL BRANDS total have you sold/distributed to individual consumers at this location in the LAST 7 DAYS?

This outlet sold/distributed [___|___|___|___|___] single condoms in the LAST 7 DAYS. 99998 = Don’t know 99997 = Refused CO6. Do you have any FEMALE condoms available at this location today?

1 = Yes 0 = No Verify with prompt card. Go to SCREENING Section 3. [___] CO7. What brands of FEMALE condoms do you have in stock today? (Show Prompt Card)

[______] [______] [______] [______] [______] [______] CO8. What is the MOST COMMON BRAND of FEMALE condom you sell/distribute to individual consumers? (Include brand and type).

[______] CO9. What is the price for this MOST COMMON BRAND of FEMALE condom (in CO8) you sell to individual consumers? (If condoms are sold individually, record ‘01’ for package size.)

This outlet sells a package of [___|___] condom(s) for [___|___|___|___] KYATS 98 = Don’t know 9998 = Don’t know 97 = Refused 9997 = Refused 0000 = Free CO10. How many FEMALE condoms OF ALL BRANDS total have you sold/distributed to individual consumers at this location in the LAST 7 DAYS?

This outlet sold/distributed [___|___|___|___|___] single condoms in the LAST 7 DAYS. 99998 = Don’t know 99997 = Refused

INTERVIEWER: GO TO SECTION 3

109 | P a g e

OUTLET ID: [___|___]-[___|___]-[___|___]-[___|___|___|___]-[___|___|___]

Section 3: SCREENING & ELIGIBILIY: Interviewer completes this section for ALL OUTLETS! Read to the provider: I have just a few questions about the availability of family planning products and services . S1. Do you have any of the following family planning products available at this 1 = Yes (IF AT LEAST ONE AVAILABLE)  location TODAY? (Read all options and show PROMPT CARDS for each.) PROVIDE INFORMATION SHEET & GAIN CONSENT. RECORD START TIME IN C9. A. Oral contraceptive tablets GO TO SECTION 4: FAMILY PLANNING B. Emergency contraceptive tablets PRODUCT AUDIT. C. Injectable contraceptives 0 = No (NONE AVAILABLE)

D. Contraceptive implants [___] E. Contraceptive IUDs S2. Are there any of the following family planning products that are out of stock 1 = Yes (IF AT LEAST ONE OUT OF today, but that you stocked in the PAST 3 MONTHS at this location? (Read all STOCK)  PROVIDE INFORMATION options and show PROMPT CARDS for each.) SHEET & GAIN CONSENT. RECORD START TIME IN C9. GO TO SECTION 4, QUESTION A15. A. Oral contraceptive tablets 0 = No B. Emergency contraceptive tablets

C. Injectable contraceptives D. Contraceptive implants E. Contraceptive IUDs [___] S3. Do you provide any of the following family planning services at this location? 1 = Yes (IF AT LEAST ONE AVAILABLE)  (Read all options.) PROVIDE INFORMATION SHEET & GAIN CONSENT. RECORD START TIME IN C9. A. Injection of contraceptive injections GO TO SECTION 5: PROVIDER B. Insertion/removal of contraceptive implants INTERVIEW 0 = No  GO TO C9—RESULT OF VISIT C. Insertion/removal of contraceptive IUDs

D. Female sterilizations E. Male sterilizations [___]

110 | P a g e

OUTLET ID: [___|___]-[___|___]-[___|___]-[___|___|___|___]-[___|___|___]

C9. Result of visit(s). Date Visit 1 Visit 2 Visit 3 (did/mm/my) [___|___]-[___|___]-[ 1 | 6 ] [___|___]-[___|___]-[ 1 | 6 ] [___|___]-[___|___]-[ 1 | 6 ]

Time started [___|___]:[___|___] [___|___]:[___|___] [___|___]:[___|___]

Time completed [___|___]:[___|___] [___|___]:[___|___] [___|___]:[___|___] Result [___|___] [___|___] [___|___] 01 = Outlet eligible & survey completed GO TO E1 02 = Outlet ineligible: does not meet any screening criteria GO TO E1 03 = Interview interrupted GO TO C11 04 = Respondent not available/time not convenient GO TO C11 05 = Outlet not open at the time GO TO C11 06 = Outlet closed permanently GO TO E1 96 = Other (specify):[______] 97 = Refused GO TO C10 C10. If the provider refused, why?

1 = Customer load (Ask respondent for a time they would prefer to be interviewed and note in C11.) 2 = Thinks it’s an inspection / nervous about license GO TO E1 [___] 3 = Not interested 6 = Other (specify):[______] GO TO E1 9 = Refuses to give reason GO TO E1 C11. Use this space to record call back details. If it is not possible to complete the interview at another time, Go to E1.

INTERVIEWER: GO TO SECTION E: ENDING THE INTERVIEW

Section E: Ending the interview E1. Name of interviewee:

95 = Not applicable, no respondent; 97 = Refused [___] E2. Physical address or location identifiers of outlet (not PO box) E3. Telephone number (Give detailed description that will help supervisor to find the 99999999995 = Not applicable: no respondent outlet.) or has no telephone ______99999999997 = Refused ______[___|___|___|___|___|___|___|___|___|___|___]

E4.Latitude: [ N ]-[___|___|___]-[___|___|___|___|___] E5.Longitude: [ E ]-[___|___|___]-[___|___|___|___|___] E6. Additional observations by interviewer (if any)

THANK THE PROVIDER AND END INTERVIEW.

111 | P a g e

OUTLET ID: [___|___]-[___|___]-[___|___]-[___|___|___|___]-[___|___|___]

Section 4: FAMILY PLANNING PRODUCT AUDIT Module Before Going to the full interview ensure you have given the respondent a study information sheet, explained the study and obtained informed consent. Read to the provider: Can you please show us the full range of family planning products that you currently have in stock? Do you currently have any of the following? Prompt entire list using FAMILY PLANNING PROMPT CARDS; No response to be recorded.  Oral contraceptive tablets such as Forefinger, Sure, OK brands  Emergency contraceptive tablets such as Ecee2, Pill72 brands  Contraceptive injections such as Depo-M, Depo provera (Purple) brands  Contraceptive implants such as Implanon, Jadelle brands  Contraceptive IUDs such as Pregna brand  Misoprostol tablets  Birth control patches, vaginal birth control rings, vaginal foaming tablets

If the outlet has no family planning products in stock, check screening results then Go to Question A15. If additional audit sheets are used, add these sheets after the ones provided and staple the questionnaire again. All pages should be in order before you move onto the next outlet.

Number each family planning product by assigning a Product Number (starting from 1 Tablets, again from 1 for Injections, etc.)

Number each audit sheet used in the spaces provided at the bottom of the page.

Interviewer, if facility is hospital or multidepartment facility, ask: Where are the following products located in other departments at this outlet: oral contraceptive pills, emergency contraception, misoprostol, contraceptive injections, implants or IUDs? Read all. 1 = Yes 0 = No 95 = Not applicable Family planning clinic [__] Dispensary / Pharmacy / Outpatient [__] Antenatal / Maternity / MCH [__] Other department [__] If other, specify: [______]

Interviewer: Visit all departments indicated above to complete audit sheets.

In all outlets, complete the Sub-Outlet Code (as well as the Product Number) for each drug audited. These codes are listed below.

SUB-OUTLET CODES X ALL outlets that have only ONE dispensing/distribution point for medicines/diagnostics A Outpatient department B Antenatal / maternity clinic / MCH C ART / HIV/AIDS clinic D Private dispensing unit E Postnatal / F Maternity ward H Dispensary/ Main pharmacy (if used by all patients) I Family planning clinic Z Other (specify the type in the space for audit comments – TAB 12, INJ 14 or INS 15) ______

112 | P a g e

OUTLET ID: [___|___]-[___|___]-[___|___]-[___|___|___|___]-[___|___|___]

Sub- 1. Tablet type 2. Brand name 3a. Generic name 3b. Strength 3c. Units 4. Manufacturer outlet code 1 = contraceptive A. tablets [___|___] [___|___|___]. [___|___|___] [___|___] [_____] 2 = misoprostol tablets 3 = birth control patch B. ______4 = vaginal foaming [___|___] [___|___|___]. [___|___|___] [___|___] tablets Product C. number [___] [___|___] [___|___|___]. [___|___|___] [___|___]

Don’t know = 98 [__|__] 1 = mg Don’t know=999.998 2 = μg or mcg Don’t know = 98 [____|____] 98 = Don’t know Don’t know = 98 5. Country of manufacture 6. Package size 7a. Amount sold/distributed in the last 1 MONTH of brand to INDIVIDUAL CONSUMERS 8. Retail selling price of brand (BLISTER packages) (Record for # of TABLETS) This outlet sold/distributed [___|___|___|___] blister packages in the last 1 month. There are a total of [___|___|___] OR [___|___] individual tablets cost an This outlet sold [___|___|___|___] individual tablets in the last 1 month. individual customer tablets in each blister package. Not Applicable = 9995 Refused = 9997 [___|___|___|___] KYATS Don’t know = 9998 Free = 0000; Don’t know = 98 Refused =9997; 7b. Source of information for amount sold Don’t know = 9998

Don’t know = 98 0 = Provider recall 1 = Outlet records

[___|___|___] [___] 9. Wholesale purchase price of brand 10. Supplier of brand 11. Stocked out of brand at 12. Batch No./Lot. No. For the outlet’s MOST RECENT wholesale purchase (Record # of (Ask provider) From where do you get your supply for this brand for any point in the past 3 BLISTER packages) your most recent purchase? MONTHS? [______] 1 = Wholesale pharmacy Don’t know = 9998 [___|___|___] 2 = Retail pharmacy 1 = Yes 3 = Pharmaceutical company 0 = No blister packages cost 4 = Government medical stores 98 = Don’t know 5 = Private hospital [___|___|___|___|___|___] KYATS 6 = Poly clinic 13. Comments Free = 000000; 7 = Private clinic Refused = 99997; 8 = NGO (PSI, Marie Stopes) Don’t know = 999998 9 = Community-based health worker 10 = Agent 96 = Other: specify [______] 98 = Don’t know

FP Tablet Audit Sheet [__|__] of [___|___] 113 | P a g e

OUTLET ID: [___|___]-[___|___]-[___|___]-[___|___|___|___]-[___|___|___]

Sub-outlet 1. Brand name 2a. Generic name 2b. Strength per mL 3. Manufacturer 4. Country of manufacture code [__|__] A. [__|__|__].[__|__] mg / [__|__]. [__|__] mL [_____] ______[__|__] Product number B. [__|__|__].[__|__] mg / [__|__]. [__|__] mL Don’t know = 98 999.98 = Don’t know 99.98=Don’t know Don’t know = 98 [__|__]

Don’t know = 98 [__|__] Don’t know = 98 [___|___|___] 5. Package contents 6. Package size 7a. Do you, or other staff, perform injection services for 8a. How many injection 9a. Does this outlet/facility provide this Does package with this brand of injectable at this outlet/facility? procedures for this brand have brand of injectable for customers TO TAKE ampoule/vial contain There are a total of been conducted at this AWAY for injection procedures somewhere disposable needle for 1 = Yes outlet/facility in the LAST 1 else? injection? [___|___|___].[__|__] 0 = No Go to Q9a MONTH? 98 = Don’t know Go to Q9a 1 = Yes 1 = Yes mL in each ampoule/vial. 0 = No Go to Q11 0 = No 999.98 = Don’t know [___|___|___|___] 98 = Don’t know Go to Q11 7b. If yes, what is the TOTAL COST to have an injection for Refused = 9997 this brand, including PRODUCT COST AND SERVICE FEE? Don’t know = 9998 [___] [___] 9b. If yes, what is cost of 1 ampoule/vial for [___|___|___|___|___] KYATS 8b. Source of information for # this brand for an INDIVIDUAL CUSTOMER? Free = 00000 injections Refused = 99997 [___|___|___|___] KYATS Don’t know = 99998 0 = Provider recall Free = 0000 1 = Outlet records Refused = 9997 Don’t know = 9998

10a. How many injectables of this brand have 11. Wholesale purchase price of brand 12. Supplier of brand 13. Stocked out of 14. Batch No./Lot. No. been sold/distributed FOR TAKE AWAY at this (Ask provider) From where do you get your brand at any point outlet/facility in the LAST 1 MONTH? For the outlet’s MOST RECENT wholesale purchase supply for this brand for your most recent in the past 3 purchase? MONTHS? [______] [___|___|___|___] [___|___|___|___] 1 = Wholesale pharmacy Refused = 9997 2 = Retail pharmacy 1 = Yes Don’t know = 999998 Don’t know = 9998 ampoules/vials cost 3 = Pharmaceutical company 0 = No 4 = Government medical stores 98 = Don’t know 10b. Source of information for # take away [___|___|___|___|___|___] KYATS 5 = Private hospital 15. Comments Free = 000000 6 = Poly clinic

0 = Provider recall Refused = 999997 7 = Private clinic 1 = Outlet records Don’t know = 999998 8 = NGO (PSI, Marie Stopes) [___] 9 = Community-based health worker [___] 10 = Agent 96 = Other: specify [______] 98 = Don’t know

FP Injection Audit Sheet [__|__] of [___|___]

114 | P a g e

OUTLET ID: [___|___]-[___|___]-[___|___]-[___|___|___|___]-[___|___|___]

Sub-outlet 1. Type 2. Brand name (for copper IUD, 3a. Generic name 3b. Strength 4. Manufacturer 5. Country of code record brand + area of copper) (Leave blank for copper IUD) (Leave blank for copper manufacture 1 = Contraceptive IUD; For implants, give [_____] implant strength per 1 rod) ______2 = Vaginal birth

Product control ring [__|__]

number 3 = Hormonal-based [__|__|__].[__] mg / IUD [__|__] 4 = Copper-based IUD IUD or 1 rod Don’t know = 98 Don’t know = 98 [___]

Don’t know = 98 Don’t know = 98 [__|__] [___|___|___] 6. Package size 7a. Package contents 8a. Do you, or other staff, perform insertion services for 9a. How many insertion procedures for 10a. Does this outlet/facility provide this brand of Does package contain disposable this brand at this outlet/facility? this brand have been conducted at this implant/IUD for customers TO TAKE AWAY for In each package, there are a applicator or trocar? outlet/facility in the LAST 1 MONTH? insertion procedures somewhere else? total of 1 = Yes 1 = Yes Go to Q8a 0 = No Go to Q10a 1 = Yes [___|___] 0 = No 98 = Don’t know Go to Q10a [___|___|___|___] 0 = No Go to Q12 Refused = 9997 98 = Don’t know Go to Q12 number of [___] [___] Don’t know = 9998 [___] 1 = Rod(s)/Implants 7b. Package contents 8b. If yes, what is the TOTAL COST to have this brand 9b. Source of information for number of 2 = IUD(s) Go to Q8a (Ask provider) Is disposable applicator inserted, including PRODUCT COST AND SERVICE FEE? procedures 10b. If yes, what is cost of 1 implant/IUD for this 3 = Ring(s) Go to Q8a or trocar available for this product? brand to an individual customer? [___|___|___|___|___|___] KYATS 0 = Provider recall 1 = Yes Free = 00000 1 = Outlet records [___|___|___|___|___|___] KYATS 0 = No Refused = 99997 Free = 00000 [___] Don’t know = 99998 [___] Refused = 99997 Don’t know = 99998 11a. How many implants/IUDs of this 12. Wholesale purchase price of brand 13. Supplier of brand 14. Stocked out of 15. Batch No./Lot. No. brand have been sold/distributed FOR (Record # of packages described in Q6) (Ask provider) From where do you get your brand at any point in TAKE AWAY at this outlet/facility in the supply for this brand for your most recent the past 3 MONTHS? [______] LAST 1 MONTH? For the outlet’s MOST RECENT wholesale purchase? Don’t know = 999998 purchase 1 = Wholesale pharmacy 1 = Yes [___|___|___|___] 2 = Retail pharmacy 0 = No Refused = 9997 [___|___|___|___] 3 = Pharmaceutical company 98 = Don’t know Don’t know = 9998 4 = Government medical stores packages cost 5 = Private hospital [___] 16. Comments 11b. Source of information for number of 6 = Poly clinic take away [___|___|___|___|___|___] KYATS 7 = Private clinic Free = 000000 8 = NGO (PSI, Marie Stopes) 0 = Provider recall Refused = 999997 9 = Community-based health worker 1 = Outlet records Don’t know = 999998 10 = Agent 96 = Other: specify [______] 98 = Don’t know

FP Insertion Audit Sheet [_0_|_1_] of [___|___]

115 | P a g e

ID PDV: [___|___]-[___]-[___|___]-[___|___|___|___]-[___|___|___] A15. Are there any family planning products that are out of stock today, but that you stocked in the past 3 months?

1 = Yes [___] 0 = No Go to CD1 98 = Don’t know Go to CD1 A16. Do you know the names of the products that are out of stock? Will accept generic or brand names. Record one product per line.

1 = Yes, specify (brand and type of product, e.g. condoms, oral contraceptives, emergency contraceptives, injectables, implants, IUDs): [______] [______] [___] [______] [______] [______] [______] [______] [______] [______] [______] 0 = No A17. In the past 3 months, has this outlet/facility been out of stock, even for one day, of all brands of: READ LIST. Record 1 for yes, 0 for no A. Oral contraceptives [___] B. Emergency contraceptives [___] C. Contraceptive injections [___] D. Contraceptive implants [___] E. IUDs [___]

CYCLE BEADS AND DIAPHRAGMS MODULE: Read to the provider: First I have a few questions for you about specific family planning products. CD1: Does this outlet have cycle beads in stock? 1 = yes Ask to see the cycle beads [__] 0 = no Go to CD6 CD2: Record the brand names of cycle beads

[______] [______]

CD3: How many of these cycle beads did you sell/distribute to individual customers within the last 1 month? [___|___|___|___] Refused = 9997 Don’t know = 9998

CD4: What is the cost of 1 cycle beads pack for an individual customer?

Refused = 9997 ; Don’t know = 9998 ; Free=0000 [___|___|___|___] KYATS

CD5: From where did you get your most recent supply of cycle beads? 1 = Wholesale pharmacy 2 = Retail pharmacy 3 = Pharmaceutical company 4 = Government medical stores 5 = Private hospital 6 = Poly clinic [__|__] 7 = Private clinic 8 = NGO (PSI, Marie Stopes) 9 = Community-based health worker 10 = Agent 96 = Other: specify [______] 98 = Don’t know CD6: Does this outlet have diaphragms in stock? 1 = yes Ask to see the diaphragm [__] 0 = no Go to P1 CD7: Record the brand names of diaphragms.

116

[______] [______]

CD8: How many of these diaphragms did you sell/distribute to individual customers within the last 1 month? [___|___|___|___] KYATS Refused = 9997 Don’t know = 9998

CD9: What is the cost of 1 diaphragm for an individual customer? [___|___|___|___] Refused = 9997 ; Don’t know = 9998 ; Free=0000

CD10: From where did you get your most recent supply of diaphragms? 1 = Wholesale pharmacy 2 = Retail pharmacy 3 = Pharmaceutical company 4 = Government medical stores 5 = Private hospital 6 = Poly clinic [__|__] 7 = Private clinic 8 = NGO (PSI, Marie Stopes) 9 = Community-based health worker 10 = Agent 96 = Other: specify [______] 98 = Don’t know

Section 5: FAMILY PLANNING PROVIDER Module This section should be completed primarily by the provider who is responsible for providing family planning counseling and/or provider-dependent methods including IUD insertion and implants. Completing the questions may require speaking with more than 1 staff member at the outlet. If the respondent does not know the answer to a question in this section, ask to speak with another staff member who can provide the information.

Interviewer read: First I have some questions about family planning counseling. P1. Does this outlet refer clients for family planning counseling to help clients choose a family planning method?

[___] 1 = Yes 0 = No GO TO P3 P2. Where do you refer clients for family planning counseling?

Hospital/Clinic Individual Provider 1 = Hospital 8 = Doctor 2 = MCH clinic 9 = Nurse

3 = UHC/RHC 10 = Midwife 4 = Hospital 11 = Community Health Worker 5 = Poly clinic 96 = Other, specify: 6 = GP clinic (SUN/Non-SUN) [______] 7 = NGO clinics

P3. Does this outlet provide counseling to help clients choose a family planning method?

[___] 1 = Yes 0 = No GO TO P8 P4. If a client came in today, could s/he receive counseling on choosing a family planning method today?

[___] 1 = Yes 0 = No P5. Have you or any other current staff member at this outlet/facility received any training in the last 2 years on counseling clients on which type of family planning methods to use? (This includes pre-service training and stand-alone workshops). [___] 1 = Yes 0 = No GO TO P7 98 = Don’t know GO TO P7

117

P6. From which organization(s) did you, or staff from this outlet/facility, receive training on counseling clients on which types of family planning methods to use?

1 = Yes, specify: (name of organizations) [______] [______] [___] [______] [______] 0 = No 98 = Don’t know

P7. Does this outlet have any job aids for counseling clients on which type of family planning method to choose? (Ask to the respondent to see job aids.)

1 = Yes, observed [___] 2 = Yes, not observed 0 = No 98 = Don’t know P8. Have you or any other current staff member at this outlet/facility received any training in the last 2 years on the national guidelines for family planning? (This is the training conducted by the General Practitioners Society of the Myanmar Medical Association.) [___] 1 = Yes 0 = No 98 = Don’t know

P9. Do you have any of the following health qualifications? READ LIST.

Record 1 for yes, 0 for no A. Pharmacist (Degree in Pharmacy) [___] B. Medical Doctor [___] C. Health Assistant [___] D. Nurse / Midwife [___] E. Public Health Supervisor [___] F. Laboratory technician [___] G. Pharmacist trained by a private agency [___] H. Compounder [___] I. Village Health Volunteer / Community Health Worker/NGO/AMW/Nurse Aid/Military medical assistant [___] J. Others [___] Specify: [______]

P10. Is there any other staff in this outlet? 1=Yes 0=No Go to P12 P11. Not including yourself, do any other people working in this outlet/facility have the following health qualifications? READ LIST. Record 1 for yes, 0 for no, 8 for don’t know A. Pharmacist (Degree in Pharmacy) [___] B. Medical doctor [___] C. Health Assistant [___] D. Nurse / Midwife [___] E. Public Health Supervisor [___] F. Laboratory technician [___] G. Pharmacist trained by a private agency [___] H. Compounder [___] I. Village Health Volunteer / Community Health Worker/NGO/AMW/Nurse Aid/Military medical assistant [___] J. Others [___] Specify: [______]

Interviewer read: Now I have some questions about contraceptive injections. P12. Does this outlet/facility provide contraceptive injections? [___]

118

1 = Yes 0 = No GO TO P21

P13. If a client came in today, could she receive a contraceptive injection procedure today?

1 = Yes [___] 0 = No P14. Have you or any other current staff member at this outlet/facility received any training in the last 2 years on contraceptive injections? (This includes pre-service training and stand-alone workshops). (Don’t ask this question to Doctors, Nurses, Health Assitants, Midwives, LHV, Circle “95=Not relevant”)) [___] 1 = Yes 0 = No GO TO P16a 95 = Not relevant GO TO P16a 98 = Don’t know GO TO P16a P15. From which organization(s) did you, or staff from this facility, receive training on contraceptive injections?

1 = Yes, specify: (name of organizations): [___] [______] [______]

[______] [______] 0 = No 98 = Don’t know P16a. Does this facility perform injections for injectables P16b. What is the cost for injection for injectables received received from another outlet/facility? from another facility? 1 = Yes 0 = No GO TO P17 [___|___|___|___] KYATS

[___] Free = 0000; Refused = 9997; Don’t know = 9998 P17. How many total contraceptive injections for all brands have been performed at this facility in the previous 1 month? [___] [___|___|___|___] contraceptive injections Refused = 9997; Don’t know = 9998 P18. Does facility have a private area for contraceptive injecion? (Ask to observe.)

1 = Observed [___] 2 = Reported, not seen 0 = Not available 98 = Don’t know P19. Does this outlet/facility have disposable needles available for providing contraceptive injections?

1 = Observed [___] 2 = Reported, not seen

0 = Not available 98 = Don’t know P20. Which providers perform contraceptive injection procedures at this facility? Read all.

1 = Yes 0 = No A. Medical doctor [___] B. Nurse [___] C. Midwife [___] D. Health assistant [___] E. Public Health Supervisor [___] F. Informal provider (Quack) [___] G. Village Health Volunteer/ Community Health Worker [___] H. Other: specify [______] [___] Interviewer read: Now I have some questions about contraceptive implant insertions. P21. Does this outlet/facility provide contraceptive implant insertions? [___]

119

1 = Yes 0 = No GO TO P30 P22. If a client came in today, could she receive a contraceptive implant insertion procedure today?

1 = Yes [___] 0 = No P23. Have you or any other current staff member at this outlet/facility received any training in the last 2 years on contraceptive implant insertions? (This includes pre-service training and stand-alone workshops).

[___] 1 = Yes 0 = No GO TO P25a 98 = Don’t know GO TO P25a P24. From which organization(s) did you, or staff from this facility, receive training on contraceptive implant insertions?

1 = Yes, specify: (name of organizations): [___] [______] [______] [______] [______] 0 = No 98 = Don’t know P25a.Does this facility perform insertion for contraceptive P25b. What is the cost for insertion of an implant bought from implants bought at another outlet/facility? another facility? 1 = Yes 0 = No GO TO P26 [___|___|___|___|___] KYATS

[___] Free = 00000; Refused = 99997; Don’t know = 99998 P26. How many total contraceptive implant procedures have been performed at this facility in the previous 1 month?

[___|___|___|___] contraceptive implant insertion procedures Refused = 9997; Don’t know = 9998 P27. Does facility have a private area for providing contraceptive implant procedures? (Ask to observe.)

1 = Observed [___] 2 = Reported, not seen 0 = Not available 98 = Don’t know

P28. Does facility have the following equipment for providing contraceptive implant procedures: (READ LIST and ask to observe equipment. When asking to locate each piece of equipment, verify each option with PROMPT CARDS.)

1 = Observed 2 = Reported, not seen 0 = Not available 98 = Don’t know A. Trocar (disposable or non-disposable) [___] B. Iodine [___] C. Scalpel with blade (for removal) [___] D. Straight mosquito forceps (for removal) [___] P29. Which providers perform contraceptive implant procedures at this facility? Read all.

1 = Yes 0 = No A. Medical doctor [___] B. Nurse [___] C. Midwife [___] D. Other: specify [______] [___] Interview read: Now I have some questions about IUD insertions.

120

P30. Does this outlet provide IUD insertions? [___] 1 = Yes 0 = No GO TO P39 P31. If a client came in today, could she receive an IUD insertion procedure today? 1 = Yes [___] 0 = No P32. Have you or any other current staff member at this outlet/facility received any training in the last 2 years on IUD insertions? [___] (This includes pre-service training and stand-alone workshops). 1 = Yes 0 = No GO TO P34a 98 = Don’t know GO TO P34a P33. From which organization(s) did you, or staff from this outlet/facility, receive training on IUD insertions?

1 = Yes, specify: (name of organizations): [______] [______] [___] [______] [______] 0 = No 98 = Don’t know P34a. Does this outlet/ facility perform insertion procedures P34b. What is the cost for insertion of an IUD bought from for IUDs bought at another outlet/facility? another facility? 1 = Yes 0 = No GO TO P35 [___|___|___|___|___] KYATS

[___] Free = 0000; Refused = 9997; Don’t know = 9998 P35. How many total IUD insertion procedures have been performed at this outlet/facility in the previous 1 month?

[___|___|___|___] IUD insertion procedures Refused = 9997; Don’t know = 9998 P36. Does outlet/facility have a private area for providing IUD insertion? (Ask to observe.)

1 = Observed 2 = Reported, not seen [___] 0 = Not available 98 = Don’t know P37. Does outlet/facility have the following equipment for providing IUD insertion procedures: (READ LIST and ask to observe equipment. When asking to locate each piece of equipment, verify each option with PROMPT CARDS.)

1 = Observed 2 = Reported, not seen 0 = Not available 98 = Don’t know I. Examination table [___] II. Iodine [___] III. Tenaculum [___] IV. Speculum [___] V. Uterine sound [___] VI. IUD string retriever (for removal) [___] P38: Which providers perform IUD insertions in this outlet? Read all.

1 = Yes 0 = No A. Medical doctor [___] B. Nurse [___] C. Midwife [___] D. Other: specify [______] [___] Interviewer read: Now I have some questions about female tubal ligation. P39. Does this outlet provide female tubal ligations?

121

1 = Yes [___] 0 = No GO TO P45 P40. Which of the following types of female tubal ligation procedures are available at this facility: (READ LIST AND RECORD FOR ALL RESPONSES.)

1 = Yes 0 = No 98 = Don’t know A. Minilaparotomy [___] B. Laparascopy [___] C. Trans-cervical (no surgery) [___] P41. What is the total cost for a female tubal ligation at this outlet/facility?

[___|___|___|___|___|___] KYATS Free = 000000; Refused = 999997; Don’t know = 999998 P42a. How many female tubal ligations have you P42b. How many female tubal ligations have you P42c. Source of performed at this facility in the previous 1 month? performed at this facility in the previous 1 year? information

[___|___|___] female tubal ligations in 1 month [___|___|___] female tubal ligations in 1 year 0 = Provider recall 1 = Outlet records Refused = 997; Don’t know = 998 Refused = 997; Don’t know = 998 [___] P43. Does outlet/facility have the following equipment for providing female tubal ligation procedures: (READ LIST and ask to observe equipment. When asking to locate each piece of equipment, verify each option with PROMPT CARDS.)

1 = Observed 2 = Reported, not seen 0 = Not available 98 = Don’t know A. Surgical/examination table [___] B. Blood pressure apparatus [___] C. Lidocaine [___] D. Sterile needle with syringe [___] E. Scalpel with blade [___] F. Uterine elevator [___] G. Tubal hook [___] P44.Which providers perform female tubal ligation at this facility? Read all.

1 = Yes 0 = No A. Medical doctor [___] B. Nurse [___] C. Other: specify [______] [___] Interviewer read: Now I have some questions about male vasectomy. P45. Does this facility provide male vasectomies? [___]

1 = Yes 0 = No GO TO FP AUDIT SHEET TRACKER P46. Which of the following types of procedures are available at this facility: (READ LIST AND RECORD FOR ALL RESPONSES.)

1 = Yes 0 = No 98 = Don’t know A. Scalpel vasectomy [___] B. No-scalpel vasectomy [___] P47. What is the total cost for a male vasectomy at this facility?

[___|___|___|___|___|___] KYATS

122

Free = 000000; Refused = 999997; Don’t know = 999998 P48a. How many male vasectomies have you P48b. How many male vasectomies have you P48c. Source of performed at this facility in the previous 1 month? performed at this facility in the previous 1 year? information

[___|___|___] male vasectomies in 1 month [___|___|___] male vasectomies in 1 year 0 = Provider recall 1 = Outlet records Refused = 997; Don’t know = 998 Refused = 997; Don’t know = 998 [___]

P49. Does outlet/facility have the following equipment for providing male vasectomy procedures: (READ LIST and ask to observe equipment. When asking to locate each piece of equipment, verify each option with PROMPT CARDS.)

1 = Observed 2 = Reported, not seen 0 = Not available 98 = Don’t know A. Surgical/examination table [___] B. Lidocaine [___] C. Sterile needle with syringe [___] D. Scalpel with blade [___] E. Ringed clamp/forceps [___] F. Dissecting forceps [___] P50. Which providers perform vasectomy procedures at this facility? Read all.

1 = Yes 0 = No I. Medical doctor [___] II. Nurse [___] III. Other: specify [______] [___]

Interviewer: Go to FAMILY PLANNING AUDIT TRACKING SHEET (NEXT PAGE)

123

Family Planning Audit Tracking Sheet

T1. Were there any family planning tablets including oral contraceptives, misoprostol, emergency contraceptives, vaginal foaming tablets and/or birth control patches in stock at this outlet? 1 = Yes [___] 0 = No Go to T4 98 = Don’t know Go to T4 T2. Total number of FP TAB audit sheets completed? [___|___] T3. Did you complete audit sheet information for all available family planning tablets including oral contraceptives, misoprostol, emergency contraceptives, vaginal foaming tablets and/or birth control patches? [___] 1 = Yes, audit complete 0 = No, audit not complete T4. Were there any family planning injections including injectable contraceptives in stock at this outlet?

1 = Yes [___] 0 = No Go to T7 98 = Don’t know Go to T7 T5. Total number of FP INJ audit sheets completed? [___|___] T6. Did you complete audit sheet information for all available family planning injections including injectable contraceptives? [___] 1 = Yes, audit complete 0 = No, audit not complete T7. Were there any family planning insertions including contraceptive implants, IUDs and/or vaginal birth control rings in stock at this outlet? 1 = Yes [___] 0 = No Go to T10 98 = Don’t know Go to T10 T8. Total number of FP INS audit sheets completed? [___|___] T9. Did you complete audit sheet information for all available family planning insertions including contraceptive implants, IUDs and/or vaginal birth control rings? [___] 1 = Yes, audit complete 0 = No, audit not complete T10. COMMENTS: Reason for incomplete audit sheets (if response is no to T3, T6, or T9):

GO TO VISIT RESULT SECTION E: ENDING THE INTERVIEWER

124

Annex 8: Detailed Brand Listing

Contraceptive Brand Brand Commodity ACTINEX NATURAL APHA OK ARROW OKAMOTO CUREU ONE TOUCH DOUBLE BUTTERFLY PLAYSAFE DUAISI ROMANTIC DUREX ROMEO Male condoms (> 5 of ESP SPUR brand listed) FEEL TEAMO IDA TOP INNO TORNADO KAMASUTRA TRULY YOURS KISS TTK LAMOUR UNIDUS LOVEGEAR UNBRANDED MASCULAN Female condoms (> 5 FC2 of brand listed) OK

Contraceptive Country of Brand Formulation Manufacturer Commodity Manufacture Combined oral Levonorgestrel (0.15mg) + contraceptives Ethinylestradiol (0.03mg) + Ferrous (COCs) ANNA Fumerate (75mg) x 28 pills Thai Nakorn Patana Co Ltd THAILAND Gestodene (0.075mg) +

ANNYLYN Ethinylestradiol (0.02mg) x 28 pills Thai Nakorn Patana Co Ltd THAILAND Norethindrone (1mg) + Mestranol

ANAMAI (0.05mg) x 28 pills Thai Nakorn Patana Co Ltd THAILAND Cyproterone Acetate (2mg) +

DIANE 35 Ethinylestradiol (0.035mg) x 21 pills Bayer Healthcare Pharma BRAZIL Norgestrel (0.5mg) + Ethinylestradiol

DIARA 28/JENY 7MP (0.05mg) x 28 pills Thai Nakorn Patana Co Ltd THAILAND Levonorgestrel (0.15mg) +

FAMY ZINNIA Ethinylestradiol (0.03mg) x 21 pills Famy Care Ltd INDIA Desogrestrel (0.15mg) + Famy Care Ltd & INDIA

FOREGINGER Ethinylestradiol (0.03mg) x 28 pills Popular Pharma Ltd BANGLADESH Gestodene (0.075mg) +

GYNERA ED Ethinylestradiol (0.03mg) x 28 pills Bayer Healthcare Pharma BRAZIL Norgestrel (0.3mg) + Ethinylestradiol

LYDIA ROSA (0.03mg) x 28 pills Renata Ltd BANGLADESH Cyproterone Acetate (2mg) +

LYDIA CLAIR Ethinylestradiol (0.035mg) x 21 pills Renata Ltd BANGLADESH Norgestrel (0.5mg) + Ethinylestradiol

MARNON (0.05mg) x 28 pills Asian Union Labs Ltd INDIA Desogrestrel (0.15mg) +

MARVELON 28 Ethinylestradiol (0.03mg) x 28 pills NV Organon OSS NETHERLANDS Desogrestrel (0.15mg) +

MERCILON 28 Ethinylestradiol (0.02mg) x 28 pills Organon Ltd Co IRELAND Levonorgestrel (0.15mg) +

MICROGYNON 30 Ethinylestradiol (0.03mg) x 28 pills Bayer Healthcare Pharma BRAZIL Levonorgestrel (0.15mg) + Ethinylestradiol (0.03mg) + Ferrous MICROGYNON ED FE Fumerate (75mg) x 28 pills Bayer Healthcare Pharma AG GERMANY Levonorgestrel (0.15mg) + Ethinylestradiol (0.03mg) + Ferrous Bayer Co Ltd GERMANY OK PILLS Fumerate (75mg) x 28 pills Myland Co Ltd INDIA Norethindrone (1mg) + Mestranol

ONEDAY (0.05mg) x 28 pills Asian Union Labs Ltd THAILAND Levonorgestrel (0.15mg) + Ethinylestradiol (0.03mg) + Ferrous ORALCON F Fumerate (75mg) x 28 pills Famy Care Ltd INDIA Cyproterone Acetate (2mg) +

PREME Ethinylestradiol (0.035mg) x 21 pills Thai Nakorn Patana Co Ltd THAILAND

125

Levonorgestrel (0.15mg) + Ethinylestradiol (0.03mg) + Ferrous SURE PILL Fumerate (75mg) x 28 pills Famy Care Ltd INDIA Drospirenone (3mg) +

YASMIN Ethinylestradiol (0.03mg) x 21 pills Bayer Healthcare Pharma AG GERMANY Levonorgestrel (0.15mg) + Ethinylestradiol (0.03mg) + Ferrous ZINNIA F Fumerate (75mg) x 28 pills Famy Care Ltd INDIA Progestin-only pills (POPs) EXLUTON Lynestrenol (0.5mg) x 28 pills NV Organon OSS NETHERLANDS MICROLUT Levonorgestrel (0.03mg) x 35 pills Bayer Healthcare Pharma AG GERMANY Emergency contraceptive Hubei Gadian Humanwell pills AMOR Levonorgestrel (0.75mg) x 2 pills Pharma Co CHINA ANLITIN Levonorgestrel (1.5mg) x 1 pill Synmosa Biopharma Corp CHINA CONTRA 72 Levonorgestrel (0.75mg) x 2 pills Calogen Pharma Pvt Ltd INDIA ECEE 2 Levonorgestrel (0.75mg) x 2 pills ZYDUS CADILA INDIA EMCON Levonorgestrel (0.75mg) x 2 pills Renata Ltd BANGLADESH EMERGINOR Levonorgestrel (0.75mg) x 2 pills Nanjing Beijing YCC Pharma Co CHINA DUET Levonorgestrel (0.75mg) x 2 pills Famy Care Ltd INDIA I PILL Levonorgestrel (1.5mg) x 1 pill Cipla Ltd INDIA LEVO 72 Levonorgestrel (0.75mg) x 2 pills West Coast Pharma Ltd INDIA LEVONORGESTREL

RICHTER Levonorgestrel (0.75mg) x 2 pills Gedeon Richter Plc HUNGARY LYDIA SAFE PILL Levonorgestrel (1.5mg) x 1 pill Renata Ltd BANGLADESH MADONNA Levonorgestrel (0.75mg) x 2 pills Biolab Co Ltd THAILAND MIND CHANGE Levonorgestrel (0.75mg) x 2 pills Stada VNJV Co Ltd GERMANY NIEL 72 Levonorgestrel (1.5mg) x 1 pill Akums Drug & Pharma INDIA NORLEVO Levonorgestrel (1.5mg) x 1 pill Delpharma Lille SAS FRANCE OK EC Levonorgestrel (0.75mg) x 2 pills Famy Care Ltd INDIA PILL 72 Levonorgestrel (0.75mg) x 2 pills Cipla Ltd INDIA POSTINOR Levonorgestrel (0.75mg) x 2 pills Gedeon Richter Plc HUNGARY PREGNON Levonorgestrel (0.75mg) x 2 pills Famy Care Ltd INDIA VONSTREL Levonorgestrel (1.5mg) x 1 pill SRS Pharma Pvt Ltd INDIA Contraceptive Medroxyprogesterone Acetate injectables CONTRACEP (150mg/3ml) Thai Nakorn Patana Co Ltd THAILAND Medroxyprogesterone Acetate

DEPOGESTIN (150mg/3ml) LBS Lab Ltd THAILAND Medroxyprogesterone Acetate

DEPO M/DEPO MOXIE (150mg/3ml) Vesco Pharma Co Ltd THAILAND DEPO MEDETON/ Medroxyprogesterone Acetate

DEPOTENE (150mg/3ml) T.P. Drug Labs Co Ltd THAILAND Medroxyprogesterone Acetate

DEPO PROGESTA (150mg/3ml) General Drugs House THAILAND DEPO PROGESTIN/ Medroxyprogesterone Acetate

ANDALAN (150mg/1ml) P.T. Harsen INDONESIA Medroxyprogesterone Acetate

DEPO PROVERA (150mg/1ml) Pfizer Ltd BELGIUM Medroxyprogesterone Acetate

ENAF (150mg/3ml) Umeda Co Ltd THAILAND Medroxyprogesterone Acetate

NON PREG (250mg/1ml) Hubei Pharma Co Ltd CHINA Medroxyprogesterone Acetate

OK 1 MONTH (50mg/1ml) Bayer Healthcare Pharma AG GERMANY Medroxyprogesterone Acetate

OK 3 MONTH (150mg/1ml) P.T. Harsen INDONESIA Contraceptive implants IMPLANON 68mg Etonorgestrel x 1 rod NV Organon OSS NETHERLANDS JADELLE 75mg Levonorgestrel x 2 rods Bayer Pharma Oy FINLAND IUDs LYDIA 375 SLEEK N/A Pregna International Ltd INDIA LYDIA 380A N/A Pregna International Ltd INDIA MEDICO 380A N/A Techno PTE Ltd SINGAPORE OK/MULTILOAD 375 N/A Multilan AG SWITZERLAND PREGNA 375 SLEEK N/A Pregna International Ltd INDIA PREGNA 380A N/A Pregna International Ltd INDIA SMB 380A N/A SMB Corp INDIA T CARE 380A N/A HLL Lifecare Ltd INDIA

126

Annex 9. Sampling Weights Sampling weights were applied for analysis of the Myanmar 2015 – 2016 outlet survey data to account for variations in probability of selection as a result of the sampling design:

1) Stratification: Disproportionate allocation stratification was used to ensure adequate sample size within the regional domains to allow for domain-specific estimates. A representative sample was selected within each domain.

2) One-stage cluster sampling: Metro (urban) wards were selected from a sampling frame using PPS sampling. Within each metro ward, a census of all outlets with the potential to sell or distribute modern contraceptives and/or provide associated contraceptive procedures was conducted.

3) Two-stage cluster sampling: For urban and rural strata, townships were first selected from a urban/rural-specific sampling frame with PPS sampling. Within selected townships, urban wards and rural village tracts were then chosen at a second stage from selected districts using PPS sampling. Within each selected urban ward or rural village tract, a census of all outlets with the potential to sell or distribute modern contraceptives and/or provide associated contraceptive procedures was conducted.

The sampling weights applied during analysis are the inverse of the probability of selection. For metro wards (one-stage): 1 푊푖 = M a × α ∑ Mα

Where:

 Mα = estimated metro ward population size  ΣMα = sum of estimated metro ward population sizes in the entire stratum  a = number of metro wards selected within the stratum

For urban and rural strata, weights were calculated for both township probability of selection and urban ward/rural village tract probability of selection. Final weights were calculated by multiplying the corresponding township weight by a urban ward/rural village tract weight:

The sampling weights applied during analysis are the inverse of the probability of selection. For urban wards and rural villages (two-stage): 1 푊푖 = D M a × α × b × α ∑ Dα ∑ Mα

Where: 1st Stage of selection:

 Dα = estimated district population size  ΣDα = sum of estimated district population sizes  a = number of districts selected

2nd Stage of selection:  Mα = estimated urban ward or rural village population size  ΣMα = sum of estimated urban ward or rural village sizes in the stratum (urban or rural)  b = number of urban wards or rural villages selected within the district

127

Sampling weights are calculated at the cluster level and are applied to all outlets within a given cluster, regardless of outlet type.

The population estimates used to select health areas with PPS and to create sampling weights were obtained from the 2014 Myanmar Housing and Population Census. A sampling frame with population sizes was used for selecting the sample because accurate estimates on the total number of outlets per geographic/administrative unit that may be eligible for a medicine outlet survey do not exist. The major assumption in using population figures for sampling and weighting is that distribution of outlets and/or distribution of medicines moving through outlets in a given cluster is correlated with population size.

128

Annex 10: FPwatch Indicator List

Indicator 1: Modern contraceptive method market composition

Table 1 reports the distribution of outlet types among outlets: 1. With at least one modern contraceptive method available on the day of the survey.

Numerator By outlet type, the number of outlets with any modern contraceptive method in stock at the time of the survey visit, as confirmed by presence of at least 1 brand/generic of 1 modern contraceptive method in the FP commodity audit section or condoms module or contraceptive procedure recorded in the FP provider section.

Denominator Total number of outlets with any modern contraceptive method in stock or available at the time of the survey visit, as confirmed by presence of at least 1 brand/generic of 1 modern contraceptive method (male/female condoms, oral contraceptives, emergency contraceptives, injectables implants, IUDs) recorded in the contraceptive method audit section or condoms section or type of contraceptive procedure in the FP provider section.

Calculation Numerator for each outlet type divided by the denominator.

Handling All outlets with at least 1 modern contraceptive method recorded in the contraceptive audit section missing values or reporting availability of condoms in screening section or reporting availability of at least 1 contraceptive procedure will contribute to the indicator. This includes outlets where the interview was not fully completed (partial interview).

Notes and None. considerations

129

Indicator 2: Availability of at least 1 method of modern contraception

Table 2 reports the proportion of all outlets screened that had any modern contraceptive method (male/female condoms, oral contraceptives, emergency contraceptives, injectables, implants, IUDs, cycle beads) in stock or offering male/female sterilization procedures at the time of the survey visit.

Numerator 1. Number of outlets with any modern contraceptive commodity in stock at the time of the survey visit, as confirmed by presence of at least 1 brand/generic of 1 modern contraceptive commodity recorded in the contraceptive commodity audit section, offering male/female sterilization procedures as indicated in the service provider interview, or reporting availability of condoms in condoms module.

Denominator Number of outlets screened.

Calculation Numerator divided by denominator.

Handling All screened outlets will contribute to the denominator. This includes outlets with missing values commodities/procedures available but: 1) were not interviewed; or 2) the interview was partially completed.

Notes and Given partial or non-completion of interviews among eligible outlets and the inclusion of these outlets considerations in the denominator, these availability indicators can be considered conservative estimates of modern contraceptive method availability. Outlets that only offer procedures for injectables, implants and/or IUDs but do not have the commodity in stock, will not be counted as having the method available.

130

Indicator 3: Availability of selected modern contraceptive methods

Table 3 reports the proportion of modern contraceptive commodity-stocking or procedure-providing (no contraceptive commodities available but providing injections, implant/IUD insertions and/or male/female sterilizations) outlets with specific modern contraceptive commodities in stock at the time of the survey visit.

Numerator Number of outlets with X modern contraceptive commodity/procedure type in stock/available at the time of the survey visit, as confirmed by presence of at least 1 brand/generic of X modern contraceptive commodity for the commodity type recorded in the FP audit section. For condoms, this includes outlets with condoms only as indicated in the condoms module. For procedures, this includes outlets indicating availability of X service in the provider section.

Denominator Number of outlets with any modern contraceptive commodity in stock or providing any contraceptive procedure at the time of the survey visit, as confirmed by presence of at least 1 brand/generic of 1 modern contraceptive commodity recorded in the FP method audit section, reporting availability of condoms in condoms module or reporting availability of at least one modern contraceptive procedure.

Calculation Numerator for each modern contraceptive commodity/service type divided by the denominator.

Handling All outlets with any modern contraceptive method available will contribute to the denominator. This missing values includes outlets with commodities/procedures available but the interview was partially completed.

Notes and Given partial completion of interviews among outlets potentially providing modern contraceptive considerations methods and the inclusion of these outlets in the denominator, these availability indicators can be considered conservative estimates of modern contraceptive method availability.

131

Indicator 4: Availability of range/diversity of modern contraceptive methods

Table 4 reports the proportion of modern contraceptive commodity-stocking and procedure-providing outlets with 3 or more modern FP methods (commodity and/or service) in stock or available at the time of the survey visit, 3 or more methods with at least one method a LARC and 5 or more methods.

Numerator 1. Number of outlets with 3 or more modern contraceptive methods available at the time of the survey visit, as confirmed by presence of at least 1 brand/generic for any 3 or more combinations of modern contraceptive commodities (male condoms, female condoms, oral contraceptives, emergency contraceptives, injectables, implants, IUDs) recorded in the contraceptive method audit section, and/or condoms module and/or types of contraceptive procedures (male/female sterilizations) recorded in the FP provider section. 2. Number of outlets with 3 or more modern FP methods, including at least 1 LARC (implants, IUDs), available at the time of the survey visit, as confirmed by presence of at least 1 brand/generic for any 3 or more combinations, including at least 1 LARC, of modern contraceptive commodities (male condoms, female condoms, oral contraceptives, emergency contraceptives, injectables, implants, IUDs) recorded in the contraceptive audit section and/or condoms module and/or types of contraceptive procedures (male or female sterilizations) recorded in the FP provider section. 3. Number of outlets with 5 or more modern contraceptive methods available at the time of the survey visit, as confirmed by presence of at least 1 brand/generic for any 5 or more combinations of modern contraceptive commodities (male condoms, female condoms, oral contraceptives, emergency contraceptives, injectables, implants, IUDs) recorded in the contraceptive method audit section, and/or condoms module and/or types of contraceptive procedures (male/female sterilizations) recorded in the FP provider section.

Denominator 1. Number of outlets with any modern contraceptive commodity in stock or providing any contraceptive procedure at the time of the survey visit, as confirmed by presence of at least 1 brand/generic of 1 modern contraceptive commodity recorded in the contraceptive method audit section, reporting availability of condoms in condoms module or reporting availability of at least one contraceptive procedure.

Calculation Numerator divided by denominator.

132

Indicator 5: Stock outs

Table 5 reports the proportion of outlets reporting a current stock out of a method (oral contraceptives, emergency contraceptives, injectables, implants, IUDs) that the outlet has reportedly had in stock in the previous 3 months. Stock outs are reported among all outlets.

Numerator Number of outlets reporting a stock out of a method, as confirmed by report of a current stock out in the FP provider section, and the outlet does not have the method currently available, as confirmed in the contraceptive method audit section.

Denominator Number of outlets reportedly offering the method at any point in the previous 3 months.

Calculation Numerator for each modern FP commodity type divided by the denominator.

Handling All outlets reportedly offering the method will contribute to the denominator. This includes outlets missing values with products available but the interview was partially completed.

Notes and This indicator only applies to outlets that reportedly offered the method in the previous three considerations months. Those outlets that did not offer the method in the previous three months but might be expected to carry the product will not appear in this indicator. Instead, they will be seen in the converse (non-availability) of the availability of methods indicator.

133

Indicator 6: Price of modern contraceptive methods

Table 6 provides the median retail price, by method, combining all brands of X method. The IQR is provided as a measure of dispersion. Commodities with a service component (injections, implant and IUD insertions) may include a procedure price in addition to the commodity cost. Methods without a commodity (male/female sterilizations) will be reported on the price of procedure only.

Calculation Median retail price for each modern contraceptive method price in US dollars with IQR.

Handling Contraceptive brands/generics with missing price information are excluded from the median price missing values calculation.

Notes and For methods with an associated procedure (injection, implant and IUD insertion, male/female considerations sterilization), cost will be determined for commodity (if there is commodity) and may include a service charge. Price in US dollars is calculated based on exchange rates available from www.oanda.com using the historical exchange rates tool. The average exchange rate over the entire data collection period is used for converting local currency captured during data collection to US dollars.

134

Indicator 7: Price of modern contraceptive methods in CYP

Table 7 provides the median retail price of 1 CYP by method, combining all brands/generics of X method. The IQR is provided as a measure of dispersion. Commodities with a service component (injections, implant and IUD insertions) may include a procedure price in addition to the commodity cost. Methods without a commodity (male/female sterilizations) will be reported on the price of procedure only.

Calculation Median retail price for 1 CYP of each modern contraceptive method price in US dollars with IQR.

Handling Contraceptive brands/generics with missing price information are excluded from the median price missing values calculation.

Notes and Price per CYP will be determined by multiplying retail price by the CYP conversion factor. CYP considerations conversion factors are used from http://www.cpc.unc.edu/measure/prh/rh_indicators/specific/fp/cyp. See Annex 11 for description of CYP calculation. For methods with an associated procedure (injection, implant and IUD insertion, male/female sterilization), cost will be determined for commodity (if there is commodity) and may include a service charge. Price in US dollars is calculated based on exchange rates available from www.oanda.com using the historical exchange rates tool. The average exchange rate over the entire data collection period is used for converting local currency captured during data collection to US dollars.

135

Indicator 8: Median markup percentage of modern contraceptives

Table 8 provides the median percentage markup (mean of retail price minus wholesale price) by selected methods combining the price for all brands/generics of a given method. The IQR is provided as a measure of dispersion.

Calculation Median with IQR of: [(Retail price – wholesale price)/wholesale price] x 100

Handling Brands/generics with missing retail or wholesale price information will be missing values excluded.

Notes and Given missing information among eligible outlets, potential variation for cost considerations of methods within an outlet and the difficulties in disaggregating service/procedure cost from commodity cost this indicator should be interpreted with caution.

136

Indicator 9: Modern contraceptive method market share

Modern contraceptive method market share is the volume in CYP reportedly sold or distributed in the previous month for a selected contraceptive method as a percentage of the total CYP sold or distributed in the previous month across all method types. Expressed as a percentage, market share is the amount of a specific contraceptive method sold/distributed by a specific outlet type relative to the entire contraceptive market (total volume in CYP across all method types). Totals are reported per modern contraceptive method type. Across modern contraceptive method types, percentages in the entire table sum to 100% (the total market).

Numerator Total number of CYPs sold/distributed for X method and Y outlet.

Denominator Total number of CYP sold/distributed for all methods.

Calculation Numerator divided by denominator.

Handling CYPs sold/distributed are calculated among audited modern contraceptive methods with complete missing values and consistent information. Modern contraceptive methods with incomplete or inconsistent information among key variables that define CYP sold/distributed (package size, amount sold/distributed) are excluded from the calculation.

Notes and See description of CYP calculation in Annex 11. considerations

137

Indicator 10: Modern contraceptive market share within outlet types

Outlet market share is the volume in CYP reportedly sold or distributed in the previous month for a selected method type as a percentage of the total CYP sold or distributed in the previous month across within a given outlet type. Expressed as a percentage, market share is the volume in CYP sold/distributed for a given method relative to the total volume in CYP for that a given outlet type. Outlet types will be broad-based (public vs. private vs. not-for-profit) as well as for major outlet types by country. Within outlet categories, percentages sum to 100% (the total market).

Numerator Total number of CYPs sold/distributed for X method in Y outlet.

Denominator Total number of CYP sold/distributed in Y outlet category.

Calculation Numerator divided by denominator.

Notes and See description of CYP calculation in Annex 11. considerations

138

Indicator 11: Availability of provider skills and certification for contraceptive procedures

Table 11 provides the proportion of outlets with a trained provider available for key modern contraceptive procedures (injection, implant and IUD insertion, male/female sterilization) among: 1. All screened outlets; and 2. Outlets recorded as providing the method, regardless of legality.

Numerator Number of outlets with at least 1 provider having credentials to legally provide X contraceptive procedure (injection, implant and IUD insertion, male/female sterilization).

Denominator 1. All screened outlets; and 2. Outlets reportedly providing X provider-dependent method.

Calculation Numerator divided by denominator 1 and denominator 2, for each method type.

Handling Methods with missing certification/training information will be excluded. missing values Notes and Necessary certifications for provider-dependent FP methods found in the Government of India considerations Guidelines for Family Planning under NHM, available at : http://nrhm.gov.in/nhm/nrhm/guidelines/nrhm-guidelines/family-planning-guidelines.html

139

Indicator 12: Availability of necessary equipment for contraceptive procedures

Table 12 provides the proportion of outlets with a minimum set of necessary equipment available for contraceptive procedures (injection, implant and IUD insertion, male/female sterilization) among: 1. All screened outlets; and 2. Outlets recorded as providing the method, regardless of legality.

Numerator Number of outlets reporting availability of all equipment (see list of equipment for each method below) necessary to provide X contraceptive procedure (injection, implant and IUD insertion, male/female sterilization).

Denominator 1. All screened outlets; and 2. Outlets reportedly providing X provider- dependent method.

Calculation Numerator divided by denominator 1 and denominator 2, for each method type.

Handling Methods with missing information on availability of key equipment will be missing values excluded.

Notes and Contraceptive injection procedure: Equipment: Sterile needle with syringe considerations Contraceptive implant procedure: Equipment: 1. Trocar; 2. Iodine; Equipment for Removal: 1. Scalpel with Blade (removal); 2. Straight Mosquito Forceps (removal) IUD insertion procedure: Equipment: 1. Room; 2. Examination Table; 3. Iodine; 4. Tenaculum; 5. Speculum; 6. Uterine Sound Female sterilization procedure: Equipment: 1. Room; 2. Examination Table; 3. Blood Pressure Apparatus; 4. Lidocaine; 5. Sterile Needle with Syringe; 6. Scalpel with Blade; 7. Uterine elevator; 8. Tubal Hook Male sterilization procedure: Equipment: 1. Room; 2. Examination Table; 3. Lidocaine; 4. Sterile Needle with Syringe; 5. Scalpel with Blade; 6. Ringed clamp/forceps; 7. Dissecting forceps Necessary equipment list taken from Measure Evaluation’s Family Planning and Reproductive Health Indicators Database: http://www.cpc.unc.edu/measure/prh/rh_indicators.

140

Indicator 13: Full service readiness to provide contraceptive procedures

Table 13 provides the proportion of outlets with full service readiness for contraceptive procedures defined as: 1. Having at least one brand/generic of a selected contraceptive commodity available on the day of the survey (for injections, implants, IUDs); 2. Having at least one provider trained/certified for a selected method available at the outlet (for injections, implants, IUDs, sterilizations); and 3. Having a minimum, necessary set of equipment for providing a selected method available at the outlet. Outlets meeting each of these three criteria will be classified as “service ready.”

Numerator Number of outlets reporting availability of commodity and provider credentials and all necessary equipment for a selected method.

Denominator 1. All screened outlets; and 2. Outlets reportedly providing X contraceptive procedure.

Calculation Numerator divided by denominator 1 and denominator 2, for each method type.

Handling Methods with missing information on availability of commodities, provider missing values credentials or key equipment will be excluded.

Notes and None. considerations

141

Annex 11. Couple-Years of Protection Definition

Couple-years of protection (CYP) is the estimated protection provided by modern contraceptive methods during a one-year period, based upon the volume of all contraceptives sold or distributed free of charge to clients during that period. The CYP is calculated by multiplying the quantity of each method sold or distributed to clients by a conversion factor, to yield an estimate of the duration of contraceptive protection per unit of the method. The CYPs for each method are then summed over all methods to obtain a total CYP figure. CYP conversion factors are based on how a method is used, failure rates, wastage, and how many units of the method are typically needed to provide one year of contraceptive protection for a couple. The calculation takes into account that some methods, like condoms and oral contraceptives, for example, may be used incorrectly and then discarded, or that IUDs and implants may be removed before their life span is realized.

FPwatch uses the CYP as a standard unit for price and sale/distribution analyses. Updated (2011) conversion factors, endorsed by USAID, are used in analysis. Updated conversion factors are listed below and can also be accessed from http://www.cpc.unc.edu/measure/prh/rh_indicators/specific/fp/cyp.

Table X3: CYP Conversion Factors

Contraceptive method Dose/unit used for calculating 1 CYP

Oral contraceptives 15 cycles per CYP Condoms (male and female) 120 condoms per CYP Monthly vaginal ring/patch 15 rings/patches per CYP Vaginal foaming tablets 120 tablets per CYP Depo-provera injectable 4 doses (ml) per CYP Noristerat injectable 6 doses per CYP Cyclofem monthly injectable 13 doses per CYP Copper-T 38-A IUD 4.6 CYP per IUD inserted Levonorgestrel intrauterine system (LNG-IUS) 3.3 CYP per LNG-IUS inserted 3-year implant (e.g., Implanon) 2.5 CYP per implant 4-year implant (e.g., Sino-Implant) 3.2 CYP per implant 3.8 CYP per implant 5-year implant (e.g., Jadelle)

Emergency contraceptives 20 doses per CYP Standard days method (e.g., CycleBeads) 1.5 CYP per trained adopter Global: 10 CYP India, Bangladesh, Nepal: 13 CYP Sterilization (male and female) Other Asian Countries: 10.3 CYP Africa: 9.3 CYP

While it is recognized that the use of CYPs may over-simplify and ignore many of the complexities of consumption and use, this analytical approach was selected because it standardizes dosing across method types and across countries (which may sometimes vary) thus permitting comparisons on both prices and volumes calculated on the basis of a CYP.

Additional considerations:

 CYP primarily reflects distribution and not actual use or impact. FPwatch calculates CYP according to contraceptive commodities sold/distributed rather than procedures performed.

 FPwatch calculates CYP according to contraceptive commodities sold/distributed rather than procedures performed. For provider-dependent contraceptive procedures, commodities sold/distributed does not necessarily imply that these commodities have been injected or inserted. We have chosen to count CYP for

142

commodities sold/distributed across all methods, assuming that contraceptive procedures on sold contraceptives requiring a procedure are performed.

Calculation

Price and volume data were entered according to how an outlet reported selling the contraceptive commodity. For example, if they sold oral contraceptives in packages of three blisters, they reported sales for a package of three blisters. If they sold blisters individually, there was an option to report sales by blister rather than package of three. During analysis, price and volume data were divided by how the units were sold. For example, if oral contraceptives are sold in a package of three blisters, volume and price is manipulated to give volume and price for each one unit. The units considered are those listed for CYP conversion rates. No product was sold by less than the CYP unit (e.g., by single oral contraceptive tablet vs. a blister (cycle)).

Price per CYP was determined by multiplying the given price by the CYP conversion factor (if short-acting method because all < 1 year) and dividing by the CYP conversion factor (if long-acting method because all > 1 year). Volume of CYP was determined by dividing the number of units sold by the CYP conversion factor (if short-acting method) and multiplying by the CYP conversion factor (if long-acting method). Some prices/volumes are given for an entire method that may use multiple conversion factors. For example, the volume of implants was reported by combining all 3-, 4- and 5-year implants using each of their appropriate CYP conversion factors.

143

Annex 12: Contraceptive Method Volumes Table X4: Reported Contraceptive Method Volumes: Myanmar CYPs sold or distributed Community Private Not- For- Private For-Profit Private Medical Itinerant Drug Private Other Pharmacy General Retailers Total in previous 1 month by Health Workers Profit Health Facility Total Vendors Total outlet type and Vol CYP Vol CYP Vol CYP Vol CYP Vol CYP Vol CYP Vol CYP Vol CYP Vol CYP contraceptive method (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) type*

191.2 0.0 191.5 1766.3 2149.1 934.4 6.1 940.5 3089.6 1. Male condoms (115.1, 267.3) - (0.0, 407.3) (920.4, 2612.3) (1278.6, 3019.5) (552.4, 1316.4) - (558.6, 1322.4) (2135.1, 4044.0)

0.4 0.0 20.2 0.4 20.9 0.0 0.0 0.0 20.9 2. Female condoms ------

2658.6 226.5 3930.9 29154.9 35970.9 10627.3 65.2 10692.4 46663.3 3. Oral contraceptives (22697.8, (29128.9, (39576.5, (2050.8, 3266.4) - (3032.0, 4829.8) 35612.0) 42812.9) (9423.3, 11831.3) (41.1, 89.2) (9488.4, 11896.5) 53750.1)

Combined oral 2353.8 226.5 3603.6 22632.4 28816.3 4751.6 41.6 4793.2 33609.5 contracepives (17422.0, (23251.8, (27962.5, (1791.0, 2916.5) - (2725.8, 4481.4) 27842.8) 34380.8) (4121.7, 5381.5) (29.7, 53.5) (4162.7, 5423.7) 39256.5)

294.0 0.0 327.2 6522.5 7143.7 5875.7 23.5 5899.3 13043.0 Progestin-only pills (10910.4, (147.2, 440.8) - (213.0, 441.5) (4709.9, 8335.1) (5290.5, 8997.0) (5118.7, 6632.7) - (5142.3, 6656.2) 15175.6)

4. Emergency 38.4 19.5 232.4 4324.5 4614.8 273.2 0.7 273.9 4888.7 contraceptives - - (149.2, 315.6) (2991.3, 5657.8) (3262.0, 5967.7) (173.1, 373.4) - (173.8, 374.0) (3522.3, 6255.1)

5. Contraceptive 15559.7 1492.6 24956.5 51010.4 93019.1 4048.8 855.4 4904.1 97923.2 injectables (14022.2, (20894.9, (28962.5, (69182.9, (74040.1, 17097.1) - 29018.0) 73058.3) 116855.2) (3200.7, 4896.8) (605.9, 1104.9) (4010.3, 5798.0) 121806.3)

15559.7 1492.6 24947.5 51010.4 93010.1 4048.8 855.4 4904.1 97914.2 3 month injectables (14022.2, (20885.8, (28962.5, (69173.8, (74031.0, 17097.1) - 29009.2) 73058.3) 116846.3) (3200.7, 4896.8) (605.9, 1104.9) (4010.3, 5798.0) 121797.4)

1 month injectables 0.0 0.0 9.0 0.0 9.0 0.0 0.0 0.0 9.0

------

144

Table X4: Reported Contraceptive Method Volumes: Myanmar CYPs sold or distributed Community Private Not- For- Private For-Profit Private Medical Itinerant Drug Private Other Pharmacy General Retailers Total in previous 1 month by Health Workers Profit Health Facility Total Vendors Total outlet type and Vol CYP Vol CYP Vol CYP Vol CYP Vol CYP Vol CYP Vol CYP Vol CYP Vol CYP contraceptive method (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) type*

6. Contraceptive 0.0 788.3 158.6 0.0 946.9 0.0 0.0 0.0 946.9 implants - - - - (0.0, 8483.8) - - - (0.0, 8483.8)

0.0 312.8 158.6 0.0 471.4 0.0 0.0 0.0 471.4 Implanon - - - - (0.0, 2317.2) - - - (0.0, 2317.2)

Jadelle 0.0 475.5 0.0 0.0 475.5 0.0 0.0 0.0 475.5

------

596.7 3482.6 3723.5 872.6 8675.4 0.0 0.0 0.0 8675.4 7. IUDs - - - - (3460.3, 13890.5) - - - (3460.3, 13890.5)

15.9 0.0 0.0 0.0 15.9 0.0 0.0 0.0 15.9 8. Male Sterilization ------

0.0 0.0 713.7 0.0 713.7 0.0 0.0 0.0 713.7 9. Female Sterilization - - (0.0, 3191.9) - (0.0, 3191.9) - - - (0.0, 3191.9)

19060.8 6009.4 33927.3 87129.2 146126.7 15883.6 927.4 16811.0 162937.7 Total Volume (16989.9, (28725.8, (58871.6, (114507.3, (14001.5, (14912.3, (131080.5, 21131.8) - 39128.8) 115386.8) 177746.1) 17765.7) (669.5, 1185.3) 18709.7) 194794.9) * A total of 162,363 CYPs (weighted) were reportedly distributed in the previous 1 month in private outlets. This is based on the number of commodities reportedly sold for categories 1-7 (not number of services performed for categories 5-7) and number of sterilizations reportedly performed for categories 8-9.

145

Table X5: Reported Contraceptive Method Volumes: Myanmar – Metropolitan CYPs sold or distributed Community Private Not- For- Private For-Profit Private Medical Itinerant Drug Private Other Pharmacy General Retailers Total in previous 1 month by Health Workers Profit Health Facility Total Vendors Total outlet type and Vol CYP Vol CYP Vol CYP Vol CYP Vol CYP Vol CYP Vol CYP Vol CYP Vol CYP contraceptive method (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) type*

23.5 0.0 35.2 610.4 669.0 578.2 0.0 578.2 1247.2 1. Male condoms (0.0, 106.5) - (16.5, 53.8) (379.7, 841.0) (430.6, 907.4) (234.0, 922.4) - (234.0, 922.4) (813.9, 1680.5)

0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2. Female condoms ------

227.3 116.3 1921.9 8437.9 10703.5 1550.3 0.0 1550.3 12253.8 3. Oral contraceptives (10807.6, (0.0, 456.4) - (1328.4, 2515.4) (7260.0, 9615.8) (9344.8, 12062.1) (1137.4, 1963.2) - (1137.4, 1963.2) 13700.0)

Combined oral 199.6 116.3 1734.8 7071.3 9122.0 902.0 0.0 902.0 10024.0 contracepives (0.0, 413.4) - (1161.9, 2307.7) (6115.9, 8026.8) (7949.5, 10294.5) (651.3, 1152.6) - (651.3, 1152.6) (8785.5, 11262.5)

27.8 0.0 187.1 1366.6 1581.4 648.4 0.0 648.4 2229.8 Progestin-only pills (0.0, 90.4) - (83.3, 290.8) (999.2, 1734.0) (1191.7, 1971.1) (378.5, 918.2) - (378.5, 918.2) (1764.8, 2694.8)

4. Emergency 0.9 16.4 162.6 1246.4 1426.3 179.2 0.0 179.2 1605.5 contraceptives - - (79.5, 245.8) (810.5, 1682.3) (977.2, 1875.3) (90.2, 268.2) - (90.2, 268.2) (1117.3, 2093.6)

5. Contraceptive 835.6 817.9 11051.9 3430.8 16136.1 194.1 0.0 194.1 16330.3 injectables (13071.8, (13261.9, (338.0, 1333.1) - (8612.3, 13491.5) (2508.8, 4352.7) 19200.4) (31.9, 356.3) - (31.9, 356.3) 19398.7)

835.6 817.9 11045.9 3430.8 16130.1 194.1 0.0 194.1 16324.3 3 month injectables (13065.6, (13255.6, (338.0, 1333.1) - (8606.1, 13485.7) (2508.8, 4352.7) 19194.7) (31.9, 356.3) - (31.9, 356.3) 19393.0)

1 month injectables 0.0 0.0 6.0 0.0 6.0 0.0 0.0 0.0 6.0

------6. Contraceptive 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

146

0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Implanon ------

Jadelle 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

------

401.3 1755.8 581.7 0.0 2738.8 0.0 0.0 0.0 2738.8 7. IUDs - - (430.8, 732.7) - (0.0, 7175.5) - - - (0.0, 7175.5)

0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8. Male Sterilization ------

0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9. Female Sterilization ------

1488.5 2706.4 13753.3 13725.5 31673.7 2501.9 0.0 2501.9 34175.5 Total Volume (10856.5, (11522.0, (24937.5, (27477.0, (471.1, 2505.9) - 16650.1) 15928.9) 38409.8) (1853.2, 3150.6) - (1853.2, 3150.6) 40874.1) * A total of 162,363 CYPs (weighted) were reportedly distributed in the previous 1 month in private outlets: 34,176 in metropolitan Myanmar; 104,611 in urban Myanmar, and 24,151in rural Myanmar. This is based on the number of commodities reportedly sold for categories 1-7 (not number of services performed for categories 5-7) and number of sterilizations reportedly performed for categories 8-9.

147

Table X6: Reported Contraceptive Method Volumes: Myanmar – Urban CYPs sold or distributed Community Private Not- For- Private For-Profit Private Medical Itinerant Drug Private Other Pharmacy General Retailers Total in previous 1 month by Health Workers Profit Health Facility Total Vendors Total outlet type and Vol CYP Vol CYP Vol CYP Vol CYP Vol CYP Vol CYP Vol CYP Vol CYP Vol CYP contraceptive method (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) type*

43.5 0.0 152.7 1143.6 1339.9 302.1 2.4 304.5 1644.3 1. Male condoms (0.0, 90.2) - (0.0, 379.1) (322.8, 1964.4) (497.7, 2182.0) (123.4, 480.8) - (125.7, 483.2) (789.6, 2499.0)

0.0 0.0 20.2 0.4 20.6 0.0 0.0 0.0 20.6 2. Female condoms - - - - (0.0, 257.5) - - - (0.0, 257.5)

1057.6 83.4 1874.3 19649.2 22664.5 5283.6 14.3 5298.0 27962.4 3. Oral contraceptives (13282.7, (15941.8, (21024.7, (522.4, 1592.7) - (1191.8, 2556.8) 26015.7) 29387.1) (4226.5, 6340.8) (0.0, 48.7) (4240.6, 6355.4) 34900.2)

Combined oral 907.7 83.4 1769.5 14878.9 17639.5 2390.9 9.3 2400.3 20039.8 contracepives (12184.0, (14521.8, (405.8, 1409.6) - (1096.3, 2442.7) (9741.4, 20016.5) 23095.0) (1853.0, 2928.9) (0.0, 26.8) (1861.9, 2938.7) 25557.7)

149.9 0.0 104.8 4770.3 5025.0 2892.7 5.0 2897.7 7922.6 Progestin-only pills (6.6, 293.2) - (56.5, 153.1) (2990.0, 6550.6) (3209.1, 6840.8) (2231.2, 3554.2) - (2236.2, 3559.2) (5855.7, 9989.6)

4. Emergency 10.8 3.1 68.4 3029.2 3111.6 84.2 0.0 84.2 3195.8 contraceptives (1.6, 20.0) - (51.3, 85.6) (1761.7, 4296.7) (1828.5, 4394.6) (33.3, 135.0) - (33.3, 135.0) (1912.7, 4478.8)

5. Contraceptive 5341.3 625.6 12674.6 44116.7 62758.3 1436.3 192.1 1628.3 64386.6 injectables (22030.0, (39090.3, (40679.2, (4294.2, 6388.5) - (9406.2, 15942.9) 66203.4) 86426.2) (657.9, 2214.6) (3.1, 381.1) (830.2, 2426.5) 88094.0)

5341.3 625.6 12672.8 44116.7 62756.5 1436.3 192.1 1628.3 64384.8 3 month injectables (22030.0, (39088.5, (40677.4, (4294.2, 6388.5) - (9404.4, 15941.2) 66203.4) 86424.5) (657.9, 2214.6) (3.1, 381.1) (830.2, 2426.5) 88092.3)

1 month injectables 0.0 0.0 1.8 0.0 1.8 0.0 0.0 0.0 1.8

------6. Contraceptive 0.0 788.3 158.6 0.0 946.9 0.0 0.0 0.0 946.9

148

0.0 312.8 158.6 0.0 471.4 0.0 0.0 0.0 471.4 Implanon - - - - (0.0, 2317.2) - - - (0.0, 2317.2)

Jadelle 0.0 475.5 0.0 0.0 475.5 0.0 0.0 0.0 475.5

------

53.8 1726.8 3101.2 859.2 5741.1 0.0 0.0 0.0 5741.1 7. IUDs (0.0, 463.0) - (1925.6, 4276.9) (0.0, 2077.3) (2289.3, 9192.9) - - - (2289.3, 9192.9)

0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8. Male Sterilization ------

0.0 0.0 713.7 0.0 713.7 0.0 0.0 0.0 713.7 9. Female Sterilization - - (0.0, 3191.9) - (0.0, 3191.9) - - - (0.0, 3191.9)

6507.0 3227.3 18763.7 68798.4 97296.4 7106.2 208.8 7315.0 104611.4 Total Volume (14419.3, (40567.9, (66346.2, (73432.3, (5116.4, 7897.6) - 23108.2) 97028.8) 128246.6) (5485.6, 8726.8) (21.3, 396.3) (5688.4, 8941.6) 135790.6) * A total of 162,363 CYPs (weighted) were reportedly distributed in the previous 1 month in private outlets: 34,176 in metropolitan Myanmar; 104,611 in urban Myanmar, and 24,151in rural Myanmar. This is based on the number of commodities reportedly sold for categories 1-7 (not number of services performed for categories 5-7) and number of sterilizations reportedly performed for categories 8-9.

149

Table X7: Reported Contraceptive Method Volumes: Myanmar – Rural CYPs sold or distributed Community Private Not- For- Private For-Profit Private Medical Itinerant Drug Private Other Pharmacy General Retailers Total in previous 1 month by Health Workers Profit Health Facility Total Vendors Total outlet type and Vol CYP Vol CYP Vol CYP Vol CYP Vol CYP Vol CYP Vol CYP Vol CYP Vol CYP contraceptive method (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) type* CYPs sold or distributed in previous 124.2 0.0 3.6 12.4 140.2 54.1 3.8 57.8 198.0 1 month by outlet type and contraceptive method type* (72.0, 176.4) - (0.0, 15.2) (6.9, 17.8) (84.6, 195.9) (12.6, 95.5) (0.0, 9.4) (16.6, 99.1) (124.4, 271.7)

0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 1. Male condoms ------

1373.7 26.8 134.7 1067.8 2603.0 3793.3 50.8 3844.1 6447.1 2. Female condoms (1152.3, 1595.1) (0.0, 102.6) (82.9, 186.6) (803.8, 1331.7) (2234.6, 2971.3) (3373.6, 4213.0) (33.2, 68.4) (3424.9, 4263.3) (5866.3, 7027.8)

1246.5 26.8 99.4 682.1 2054.8 1458.6 32.3 1490.9 3545.7 3. Oral contraceptives (1059.1, 1434.0) (0.0, 102.6) (66.1, 132.7) (506.5, 857.8) (1791.9, 2317.7) (1235.7, 1681.6) (23.9, 40.6) (1267.3, 1714.6) (3184.5, 3906.9)

Combined oral 116.4 0.0 35.4 385.6 537.3 2334.7 18.5 2353.2 2890.5 contracepives (53.6, 179.1) - (7.4, 63.4) (251.2, 520.0) (385.0, 689.6) (2069.9, 2599.5) (7.0, 30.1) (2088.3, 2618.1) (2580.0, 3201.1)

26.7 0.0 1.4 48.9 77.0 9.8 0.7 10.5 87.5 Progestin-only pills (10.4, 43.0) - (0.6, 2.1) (30.9, 66.9) (53.2, 100.8) (0.0, 29.2) - (0.0, 28.8) (57.8, 117.2)

4. Emergency 9382.8 49.0 1230.0 3462.9 14124.7 2418.3 663.3 3081.7 17206.3 contraceptives (12525.2, (15501.5, (8349.2, 10416.3) (0.0, 148.1) (960.1, 1499.8) (2288.4, 4637.4) 15724.1) (2053.6, 2783.1) (481.2, 845.4) (2665.4, 3497.9) 18911.1)

5. Contraceptive 9382.8 49.0 1228.8 3462.9 14123.5 2418.3 663.3 3081.7 17205.1 injectables (12524.0, (15500.4, (8349.2, 10416.3) (0.0, 148.1) (958.9, 1498.7) (2288.4, 4637.4) 15722.9) (2053.6, 2783.1) (481.2, 845.4) (2665.4, 3497.9) 18909.8)

0.0 0.0 1.2 0.0 1.2 0.0 0.0 0.0 1.2 3 month injectables ------

150

1 month injectables 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

------

6. Contraceptive 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 implants ------

0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Implanon ------

Jadelle 141.6 0.0 40.6 13.4 195.5 0.0 0.0 0.0 195.5

(55.1, 228.1) - - - (108.2, 282.9) - - - (108.2, 282.9)

15.9 0.0 0.0 0.0 15.9 0.0 0.0 0.0 15.9 7. IUDs ------

0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8. Male Sterilization ------

11065.3 75.8 1410.3 4605.3 17156.6 6275.5 718.6 6994.1 24150.7 9. Female Sterilization (15205.2, (21988.0, (9856.2, 12274.3) (0.0, 222.4) (1078.1, 1742.5) (3204.1, 6006.5) 19108.0) (5548.5, 7002.6) (525.3, 911.9) (6237.7, 7750.6) 26313.5) * A total of 162,363 CYPs (weighted) were reportedly distributed in the previous 1 month in private outlets: 34,176 in metropolitan Myanmar; 104,611 in urban Myanmar, and 24,151in rural Myanmar. This is based on the number of commodities reportedly sold for categories 1-7 (not number of services performed for categories 5-7) and number of sterilizations reportedly performed for categories 8-9.

151